FGL (FGLHF) 10-Q 6 Nov 19 2019 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information Document - shares	9 Months Ended
	Sep. 30, 2019	Nov. 02, 2019
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2019
Document Transition Report	false
Entity File Number	001-37779
Entity Registrant Name	FGL HOLDINGS
Entity Central Index Key	0001668428
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Amendment Flag	false
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1354810
Entity Address, Address Line One	4th Floor
Entity Address, Address Line Two	Boundary Hall, Cricket Square
Entity Address, City or Town	Grand Cayman
Entity Address, Country	KY
Entity Address, Postal Zip Code	KY1-1102
City Area Code	800
Local Phone Number	445-6758
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		221,660,974
Ordinary shares, par value $.0001 per share
Entity Information [Line Items]
Title of 12(b) Security	Ordinary shares, par value $.0001 per share
Trading Symbol	FG
Security Exchange Name	NYSE
Warrants to purchase ordinary shares
Entity Information [Line Items]
Title of 12(b) Security	Warrants to purchase ordinary shares
Trading Symbol	FG WS
Security Exchange Name	NYSE

Investments - Proceeds From The

Investments - Proceeds From The Sale of Fixed-maturity available for-sale-securities - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Debt Securities, Available-for-sale [Line Items]
Document Period End Date			Sep. 30, 2019
Available-for-sale Securities
Debt Securities, Available-for-sale [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:			$ 2,915	$ 5,865
Available-for-sale Securities | Total fixed maturities
Debt Securities, Available-for-sale [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:	$ 828	$ 662	1,764	4,310
Gain on sale of investments	28	1	38	9
Loss on Sale of Investments	$ 9	$ 26	$ 24	$ 91

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Investments:
Fixed maturity securities, available-for-sale, at fair value (amortized cost: September 30, 2019 - $23,047; December 31, 2018 - $22,219)	$ 23,907	$ 21,109
Equity securities, at fair value (cost: September 30, 2019 - $1,104; December 31, 2018 - $1,526)	1,097	1,382
Derivative investments	454	97
Mortgage loans	836	667
Other invested assets	1,078	662
Total investments	27,372	23,917
Cash and cash equivalents	990	571
Accrued investment income	246	216
Funds withheld for reinsurance receivables, at fair value	2,045	757
Reinsurance recoverable	3,250	3,190
Intangibles, net	1,397	1,359
Deferred tax assets, net	92	343
Goodwill	467	467
Other assets	258	125
Total assets	36,117	30,945
LIABILITIES AND SHAREHOLDERS' EQUITY
Contractholder funds	25,355	23,387
Future policy benefits, including $1,887 and $725 at fair value at September 30, 2019 and December 31, 2018, respectively	5,714	4,641
Funds Held under Reinsurance Agreements, Liability	838	722
Liability for policy and contract claims	63	64
Debt	542	541
Revolving credit facility	15	0
Other liabilities	1,015	700
Total liabilities	33,542	30,055
Commitments and contingencies (Note 12)
Shareholders' equity:
Preferred stock ($.0001 par value, 100,000,000 shares authorized, 421,885 and 399,033 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively)	0	0
Common stock ($.0001 par value, 800,000,000 shares authorized, 221,660,974 issued and outstanding at September 30, 2019 and December 31, 2018)	0	0
Additional paid-in capital	2,022	1,998
Retained earnings (Accumulated deficit)	85	(167)
Accumulated other comprehensive income (loss)	520	(937)
Treasury Stock, Value	52	4
Total shareholders' equity	2,575	890
Total liabilities and shareholders' equity	$ 36,117	$ 30,945

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Fixed maturity securities, available-for-sale, at fair value (amortized cost)	$ 23,047
Preferred Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	800,000,000	800,000,000

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Revenues:
Premiums	$ 9	$ 12	$ 33	$ 45
Net investment income	301	267	905	812
Net investment gains (losses)	103	119	478	(74)
Insurance and investment product fees and other	42	46	134	139
Total revenues	455	444	1,550	922
Benefits and expenses:
Benefits and other changes in policy reserves	331	297	938	475
Acquisition and operating expenses, net of deferrals	48	40	239	126
Amortization of intangibles	12	28	54	72
Total benefits and expenses	391	365	1,231	673
Operating income	64	79	319	249
Interest expense	(8)	(8)	(24)	(21)
Income (loss) before income taxes	56	71	295	228
Income tax (expense) benefit	9	(15)	(13)	(67)
Net income (loss)	65	56	282	161
Less Preferred stock dividend	7	7	23	21
Net income (loss) available to common shareholders	$ 58	$ 49	$ 259	$ 140
Net income per common share
Basic (in USD per share)	$ 0.26	$ 0.23	$ 1.19	$ 0.65
Diluted (in USD per share)	$ 0.26	$ 0.23	$ 1.19	$ 0.65
Weighted average common shares used in computing net income (loss) per common share:
Basic (in shares)	216,441,948	214,370,000	217,745,826	214,370,000
Diluted (in shares)	216,540,885	214,418,693	217,814,942	214,390,931
Cash dividend per common share (in dollars per share)	$ 0.01	$ 0	$ 0.03	$ 0
Total other-than-temporary impairments	$ (2)	$ 0	$ (7)	$ (2)
Portion of other-than-temporary impairments included in other comprehensive income	0	0	0	0
Net other-than-temporary impairments	(2)	0	(7)	(2)
Gains (losses) on derivatives and embedded derivatives	65	159	345	58
Other investment gains (losses)	40	(40)	140	(130)
Net investment gains (losses)	$ 103	$ 119	$ 478	$ (74)

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Net income (loss)	$ 65	$ 56	$ 282	$ 161
Unrealized Gain (Loss) on Investments
Net change in unrealized gains/losses on investments	270	35	1,466	(649)
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment	(1)	(1)	(9)	1
Net changes to derive comprehensive income (loss) for the period	269	34	1,457	(648)
Comprehensive income (loss), net of tax	$ 334	$ 90	$ 1,739	$ (487)

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Preferred Stock	Ordinary shares, par value $.0001 per share	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)	Treasury Stock [Member]	Ordinary shares, par value $.0001 per share	Ordinary shares, par value $.0001 per shareAdditional Paid-in Capital	Ordinary shares, par value $.0001 per shareRetained Earnings (Accumulated Deficit)	Preferred Stock	Preferred StockAdditional Paid-in Capital	Preferred StockRetained Earnings (Accumulated Deficit)
Beginning Balance at Dec. 31, 2017	$ 1,963	$ 0	$ 0	$ 2,037	$ (149)	$ 75	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends	(5)			2	(7)
Net income (loss)	65				65
Unrealized investment losses, net	(359)					(359)
Ending Balance at Mar. 31, 2018	1,666	0	0	2,039	(95)	(278)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment	2					2
Beginning Balance at Dec. 31, 2017	1,963	0	0	2,037	(149)	75	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	161
Ending Balance at Sep. 30, 2018	1,474	0	0	2,056	(13)	(569)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment	1
Cumulative Effect of New Accounting Principle in Period of Adoption	0				(4)	4
Beginning Balance at Mar. 31, 2018	1,666	0	0	2,039	(95)	(278)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends	0			7	(7)
Net income (loss)	40				40
Unrealized investment losses, net	(325)					(325)
Ending Balance at Jun. 30, 2018	1,382	0	0	2,047	(62)	(603)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock Issued During Period, Value, Stock Dividend	1			1
Dividends	0			7	(7)
Net income (loss)	56				56
Unrealized investment losses, net	35					35
Ending Balance at Sep. 30, 2018	1,474	0	0	2,056	(13)	(569)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment	(1)					(1)
Stock Issued During Period, Value, Stock Dividend	2			2
Stock Repurchased During Period, Value	(30)						(30)
Beginning Balance at Dec. 31, 2018	890	0	0	1,998	(167)	(937)	(4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends								$ (2)	$ 0	$ (2)	$ 0	$ 8	$ (8)
Net income (loss)	171				171
Unrealized investment losses, net	724					724
Ending Balance at Mar. 31, 2019	1,751	0	0	2,007	(6)	(216)	(34)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment	(3)					(3)
Stock Issued During Period, Value, Stock Dividend	1			1
Stock Repurchased During Period, Value	(48)
Beginning Balance at Dec. 31, 2018	890	0	0	1,998	(167)	(937)	(4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	282
Ending Balance at Sep. 30, 2019	2,575	0	0	2,022	85	520	(52)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment	(9)
Stock Repurchased During Period, Value							(1)
Beginning Balance at Mar. 31, 2019	1,751	0	0	2,007	(6)	(216)	(34)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends	(2)								0	(2)		6	(8)
Net income (loss)					46
Unrealized investment losses, net						472
Ending Balance at Jun. 30, 2019	2,260	0	0	2,014	30	251	(35)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment						(5)
Stock Issued During Period, Value, Stock Dividend				1
Stock Repurchased During Period, Value	(17)						(17)
Dividends	0								$ 0	$ (3)		$ 7	$ (7)
Net income (loss)	65				65
Unrealized investment losses, net						270
Ending Balance at Sep. 30, 2019	2,575	$ 0	$ 0	2,022	$ 85	520	$ (52)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Other Comprehensive Income (Loss), Financial Liability, Fair Value Option, before Tax, after Reclassification Adjustment	$ (1)					$ (1)
Stock Issued During Period, Value, Stock Dividend				$ 1

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Cash flows from operating activities:
Net income (loss)	$ 282	$ 161
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock based compensation	4	3
Amortization	21	40
Increase (Decrease) in Deferred Income Taxes	1	(4)
Interest credited/index credits to contractholder account balances	855	452
Net recognized losses (gains) on investments and derivatives	(478)	74
Charges assessed to contractholders for mortality and administration	(96)	(103)
Intangibles, net	(295)	(237)
Gain (Loss) on Extinguishment of Debt	0	2
Changes in operating assets and liabilities:
Reinsurance recoverable	2	11
Future policy benefits reflected in net income (loss)	1,064	(120)
Funds withheld for reinsurers	(1,077)	11
Collateral (returned) posted	279	(62)
Other assets and other liabilities	(108)	40
Net Cash Provided by (Used in) Operating Activities	454	264
Cash flows from investing activities:
Proceeds from mortgage loans	54	50
Costs of mortgage loans	224	0
Capital expenditures	(10)	(7)
Contingent purchase price payment	0	(57)
Net cash provided by (used in) investing activities	(1,113)	(1,696)
Cash flows from financing activities:
Treasury stock	48	0
Draw on revolving credit facility	15	30
Common stock dividends paid	(7)	0
Contractholder account deposits	3,146	3,020
Contractholder account withdrawals	(2,028)	(1,989)
Net cash provided by (used in) financing activities	1,078	1,161
Change in cash & cash equivalents	419	(271)
Cash & cash equivalents, beginning of period	571	1,215
Cash & cash equivalents, end of period	990	944
Supplemental disclosures of cash flow information:
Interest paid	15	14
Income taxes (refunded) paid	(1)	30
Deferred sales inducements	103	98
Payments of Debt Issuance Costs	0	7
Proceeds from (Repayments of) Debt	0	547
Repayments of Long-term Lines of Credit	0	440
Available-for-sale Securities
Cash flows from investing activities:
Proceeds from available-for-sale investments, sold, matured or repaid:	2,915	5,865
Cost of available-for-sale investments:	(3,340)	(7,345)
Derivative and other
Cash flows from investing activities:
Proceeds from available-for-sale investments, sold, matured or repaid:	212	430
Cost of available-for-sale investments:	$ (720)	$ (632)

Basis of Presentation and Natur

Basis of Presentation and Nature of Business	9 Months Ended
	Sep. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation and Nature of Business	Basis of Presentation FGL Holdings (the “Company”), a Cayman Islands exempted company, markets products through its wholly-owned insurance subsidiaries, Fidelity & Guaranty Life Insurance Company (“FGL Insurance”) and Fidelity & Guaranty Life Insurance Company of New York (“FGL NY Insurance”), which together are licensed in all fifty states and the District of Columbia. F&G Reinsurance Ltd (“F&G Re”), an exempted company incorporated in Bermuda with limited liability, provides a platform for non-affiliated reinsurance business. Front Street Re Cayman Ltd (“FSRC”), an exempted company incorporated in the Cayman Islands with limited liability, has a license to carry on business as an Unrestricted Class “B” Insurer that permits FSRC to conduct offshore direct and reinsurance business. F&G Re and FSRC (together herein referred to as the “F&G Reinsurance Companies”), are indirect wholly owned subsidiaries of the Company and parties to reinsurance transactions. The accompanying unaudited condensed consolidated financial statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and with the instructions for the Securities and Exchange Commission (“SEC”) Quarterly Report on Form 10-Q, including Article 10 of Regulation S-X, consisting of normal recurring items considered necessary for a fair statement of the results for the interim periods presented. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. Therefore, the information contained in the Notes to Consolidated Financial Statements included in the Company's 2018 Form 10-K, should be read in connection with the reading of these interim unaudited condensed consolidated financial statements. In the opinion of management, these statements include all normal recurring adjustments necessary for a fair presentation of the Company’s results. Operating results for the three and nine months ended September 30, 2019 , are not necessarily indicative of the results that may be expected for the full year ending December 31, 2019 . Amounts reclassified out of other comprehensive income are reflected in net investment gains in the unaudited Condensed Consolidated Statements of Operations. Dollar amounts in the accompanying sections are presented in millions, unless otherwise noted.

Significant Accounting Policies

Significant Accounting Policies and Practices	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Significant Accounting Policies and Practices	Adoption of New Accounting Pronouncements Premium Amortization on Purchased Callable Debt Securities In March 2017, the FASB issued new guidance on the amortization of callable securities (ASU 2017-08, Receivables-Nonrefundable Fees and Other Costs (Subtopic 310-20), Premium Amortization on Purchased Callable Debt Securities) , effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The ASU requires premiums paid on purchased debt securities with an explicit call option to be amortized to the earliest call date, as opposed to the maturity date. The updated guidance is applicable to instruments that are callable based on explicit, non-contingent call features that are callable at fixed prices on preset dates. The amendments in this update were to be applied using the modified retrospective method through a cumulative effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company adopted this new accounting guidance effective January 1, 2019, as required, and it had an immaterial impact on its unaudited condensed consolidated financial statements. Amendments to Lease Accounting In February 2016, the FASB issued amended guidance (ASU 2016-02, Leases (Topic 842) ), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Notable amendments in this update: • require entities to recognize the rights and obligations resulting from all leases or lease components of contracts, including operating leases, as lease assets and lease liabilities, with an exception allowed for leases with a term of 12 months or less • create a distinction between finance leases and operating leases, with classification criteria substantially similar to that for distinguishing between capital leases and operating leases under previous guidance • not retain the accounting model for leveraged leases under previous guidance for leases that commence after the effective date of ASU 2016-02 • provide additional guidance on separating the lease components from the nonlease components of a contract • require qualitative disclosures along with specific quantitative disclosures to provide information regarding the amount, timing, and uncertainty of cash flows arising from leases • include modifications to align lessor accounting with the changes to lessee accounting, as well as changes to the requirements of recognizing a transaction as a sale and leaseback transaction, however, these changes will have no impact on the Company's current lease arrangements The amendments were required to be applied at the beginning of the earliest period presented using a modified retrospective approach (including several optional practical expedients related to leases commenced before the effective date). The Company adopted this standard effective January 1, 2019, as required, and it had an immaterial impact on its unaudited condensed consolidated financial statements. Future Accounting Pronouncements Accounting pronouncements that will impact the Company in future periods have been disclosed in the Company’s 2018 Form 10-K. There have not been any additional accounting pronouncements issued during the quarter ended September 30, 2019 that are expected to impact the Company. The following two pronouncements were discussed in the Company's 2018 Form 10-K but have been included below so as to provide an update on the Company’s status of adoption. New Credit Loss Standard In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments , effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Since its release, certain targeted improvements and transition relief amendments have been made to ASU 2016-13 and have been published in ASU 2018-19, ASU 2019-04 and ASU 2019-05. Collectively, these ASUs will change the accounting for impairment of most financial assets and certain other instruments in the following ways: • financial assets (or a group of financial assets) measured at amortized cost will be required to be presented at the net amount expected to be collected, with an allowance for credit losses deducted from the amortized cost basis, resulting in a net carrying value that reflects the amount the entity expects to collect on the financial asset • credit losses relating to AFS fixed maturity securities will be recorded through an allowance for credit losses, rather than reductions in the amortized cost of the securities. The allowance methodology recognizes that value may be realized either through collection of contractual cash flows or through the sale of the security. Therefore, the amount of the allowance for credit losses will be limited to the amount by which fair value is below amortized cost because the classification as available for sale is premised on an investment strategy that recognizes that the investment could be sold at fair value, if cash collection would result in the realization of an amount less than fair value • the income statement will reflect the measurement of expected credit losses for newly recognized financial assets as well as the expected increases or decreases (including the reversal of previously recognized losses) of expected credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount • disclosures will be required to include information around how the credit loss allowance was developed, further details on information currently disclosed about credit quality of financing receivables and net investments in leases, and a rollforward of the allowance for credit losses for AFS fixed maturity securities as well as an aging analysis for securities that are past due The amendments in this ASU may be early adopted during any interim or annual period beginning after December 15, 2018, however the Company has elected not to early adopt. The Company has identified the material asset classes (e.g. available for sale securities, mortgage loans, reinsurance receivables, other miscellaneous receivables) affected by the new guidance and is in the process of assessing the impact that the adoption of this standard will have on our financial statements for all asset classes except mortgage loans where we expect the impact will be immaterial. We expect the adoption of this guidance to significantly impact the operation of our existing processes around assessing the aforementioned asset classes for impairment. Long-Duration Contracts In August 2018, the FASB issued ASU 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts , effective for fiscal years beginning after December 15, 2020 including interim periods within those fiscal years. Under this update: • assumptions used to measure cash flows for traditional and limited-payment contracts must be reviewed at least annually with the effect of changes in those assumptions being recognized in the statement of operations • the discount rate applied to measure the liability for future policy benefits and limited-payment contracts must be updated at each reporting date with the effect of changes in the rate being recognized in other comprehensive income • market risk benefits associated with deposit contracts must be measured at fair value, with the effect of the change in the fair value attributable to a change in the instrument-specific credit risk being recognized in other comprehensive income • deferred acquisition costs are required to be amortized in proportion to premiums, gross profits, or gross margins and those balances must be amortized on a constant level basis over the expected term of the related contracts • deferred acquisition costs must be written off for unexpected contract terminations • disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, market risk benefits, separate account liabilities and deferred acquisition costs, as well as information about significant inputs, judgments, assumptions, and methods used in measurement are required to be disclosed The amendments in this ASU may be early adopted as of the beginning of an annual reporting period for which financial statements have not yet been issued, including interim financial statements. The Company does not currently expect to early adopt this standard. The Company has identified specific areas that will be impacted by the new guidance and is in the process of assessing the accounting, reporting and/or process changes that will be required to comply as well as the impact of the new guidance on its consolidated financial statements.

Significant Risks and Uncertain

Significant Risks and Uncertainties	9 Months Ended
	Sep. 30, 2019
Risks and Uncertainties [Abstract]
Significant Risks and Uncertainties	Significant Risks and Uncertainties Federal Regulation In April 2016, the Department of Labor (“DOL”) issued the “fiduciary” rule which could have had a material impact on the Company, its products, distribution, and business model. The rule had provided that persons who render investment advice for a fee or other compensation with respect to an employer plan or individual retirement account (“IRA”) would be fiduciaries of that plan or IRA and would have expanded the definition of fiduciary under ERISA to apply to commissioned insurance agents who sell the Company’s IRA products. On June 21, 2018, the United States Court of Appeals for the Fifth Circuit formally vacated the DOL fiduciary rule when it issued its mandate following the court’s decision on March 15, 2018, in U.S. Chamber of Commerce v. U.S. Department of Labor, 885 F.3d 360 (5th Cir.2018). Since then, the SEC adopted Regulation Best Interest in June 2019 imposing ostensibly higher sales practice standards on securities brokers. This does not directly impact the Company or its distributors, but has given impetus for the National Association of Insurance Commissioners (NAIC) and individual states to consider their own best interest proposals. FGL NY Insurance has modified certain processes in response to the New York Department of Financial Services (NYDFS) best interest rule despite a relatively low level of sales in New York. Management is following the legal challenge seeking to strike down the NYDFS rule and we will continue to monitor for action by other state officials or federal agencies to implement sales practice rules affecting insurance agents selling fixed insurance or annuity products. Use of Estimates and Assumptions The preparation of the Company's unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions used. The Company periodically, and at least annually, reviews the assumptions associated with reserves for policy benefits, product guarantees, and amortization of intangibles. As a result of the assumption review process that occurred in September 2019, the surrender rates, guaranteed minimum withdrawal benefit (“GMWB”) utilization, IUL premium persistency, maintenance expenses, and earned rate assumptions were updated to reflect the Company's current and expected future experience. These changes in assumptions resulted in a net decrease in future expected margins and a corresponding increase in amortization expense reported as a component of “unlocking” for the period ended September 30, 2019. This resulted in a decrease to intangible assets of $3 . These assumptions are used in the SOP 03-1 liability for GMWB benefits and resulted in a decrease in liability of $13 for the period ended September 30, 2019. The surrender rate assumptions are also used in the reserve calculation and resulted in an increase in embedded derivative liability of $1 for the period ended September 30, 2019. Concentrations of Financial Instruments As of September 30, 2019 and December 31, 2018 , the Company’s most significant investment in one industry, excluding United States ("U.S.") Government securities, was its investment securities in the Banking industry with a fair value of $2,419 or 9% and $2,491 or 10% , respectively, of the invested assets portfolio and an amortized cost of $2,352 and $2,691 , respectively. As of September 30, 2019 , the Company’s holdings in this industry include investments in 103 different issuers with the top ten investments accounting for 37% of the total holdings in this industry. As of September 30, 2019 the Company had no investments in issuers that exceeded 10% of shareholders' equity. As of December 31, 2018 , the Company had 16 investments in issuers that exceeded 10% of shareholders' equity, with a total fair value of $1,634 or 7% of the invested assets portfolio: JP Morgan Chase & Co, Metropolitan Transportation Authority (NY), AT&T Inc, HSBC Holdings, Wells Fargo & Company, General Motors Co, Nationwide Mutual Insurance Company, Goldman Sachs Group Inc, United Mexican States, Energy Transfer Partners, Prudential Financial Inc, Citigroup Inc, HP Enterprise Co, Viacom Inc, Kinder Morgan Energy Partners, and Fuel Trust. The Company's largest concentration in any single issuer as of September 30, 2019 and December 31, 2018 was AT&T with a total fair value of $138 or 1% , and JP Morgan Chase & Co , with a total fair value of $115 or 1% of the invested assets portfolio, respectively. Concentrations of Financial and Capital Markets Risk The Company is exposed to financial and capital markets risk, including changes in interest rates and credit spreads which can have an adverse effect on the Company’s results of operations, financial condition and liquidity. The Company’s exposure to such financial and capital markets risk relates primarily to the market price and cash flow variability associated with changes in interest rates. A rise in interest rates, in the absence of other countervailing changes, will increase the net unrealized loss position of the Company’s investment portfolio and, if long-term interest rates rise dramatically within a six to twelve month time period, certain of the Company’s products may be exposed to disintermediation risk. Disintermediation risk refers to the risk that policyholders surrender their contracts in a rising interest rate environment, requiring the Company to liquidate assets in an unrealized loss position. The Company attempts to mitigate the risk, including changes in interest rates by investing in less rate-sensitive investments, including senior tranches of collateralized loan obligations, non-agency residential mortgage-backed securities, and various types of asset backed securities. Management believes this risk is also mitigated to some extent by surrender charge protection provided by the Company’s products. The Company expects to continue to face these challenges and uncertainties that could adversely affect its results of operations and financial condition. Concentration of Reinsurance Risk The Company has a significant concentration of reinsurance risk with third party reinsurers, Wilton Reassurance Company (“Wilton Re”) and Kubera Insurance (SAC) Ltd. ("Kubera"), that could have a material impact on the Company’s financial position in the event that either Wilton Re or Kubera fail to perform their obligations under the various reinsurance treaties. Wilton Re is a wholly-owned subsidiary of Canada Pension Plan Investment Board ("CPPIB"). CPPIB has an AAA issuer credit rating from Standard & Poor's Ratings Services ("S&P") as of September 30, 2019 . Kubera is not rated, however, management has attempted to mitigate the risk of non-performance through the funds withheld arrangement. As of September 30, 2019 , the net amount recoverable from Wilton Re was $1,519 and the net amount recoverable from Kubera was $852 . The Company monitors both the financial condition of individual reinsurers and risk concentration arising from similar activities and economic characteristics of reinsurers to attempt to reduce the risk of default by such reinsurers. Wilton Re and Kubera are current on all amounts due for periodic treaty settlements as of September 30, 2019 . On March 6, 2019, Scottish Re (U.S.), Inc. (“SRUS”), a Delaware domestic life and health reinsurer of FGL Insurance, was ordered into receivership for purposes of rehabilitation. As of September 30, 2019 , the net amount recoverable from SRUS was $47 . The financial exposure related to these ceded reserves are substantially mitigated via a reinsurance agreement whereby Wilton Re assumes treaty non-performance including credit risk for this business. On July 9, 2019, Pavonia Life Insurance Company of Michigan ("Pavonia"), a Michigan domiciled life, accident, and health insurance company, was placed into rehabilitation. While the court order indicated that Pavonia had a stable financial condition and lack of non-insurance affiliated investments, the Director of the Michigan Department of Insurance and Financial Services ("MDIFS") has concerns relating to Pavonia's parent company. To insulate Pavonia from its parent until a pending acquisition transaction could be consummated, MDIFS placed Pavonia under supervision and rehabilitation. As of September 30, 2019 , the net amount recoverable from Pavonia was $85 . The financial exposure related to these ceded reserves are substantially mitigated via a reinsurance agreement whereby Wilton Re assumes treaty non-performance including credit risk for this business.

Investments

Investments	9 Months Ended
	Sep. 30, 2019
Investments, Debt and Equity Securities [Abstract]
Investments	1.25 1.00 - 1.25 September 30, 2019 LTV Ratios: Less than 50% $ 287 $ 6 $ 293 66 % $ 304 66 % 50% to 60% 140 — 140 32 % 145 32 % 60% to 75% 11 — 11 2 % 11 2 % Commercial mortgage loans $ 438 $ 6 $ 444 100 % $ 460 100 % December 31, 2018 LTV Ratios: Less than 50% $ 296 $ 6 $ 302 63 % $ 302 63 % 50% to 60% 169 — 169 35 % 170 35 % 60% to 75% 11 — 11 2 % 11 2 % Commercial mortgage loans $ 476 $ 6 $ 482 100 % $ 483 100 % The Company establishes a general mortgage loan allowance based upon the underlying risk and quality of the mortgage loan portfolio using DSC ratio and LTV ratio. The Company believes that the LTV ratio is an indicator of the principal recovery risk for loans that default. A higher LTV ratio will result in a higher allowance. The Company believes that the DSC ratio is an indicator of default risk on loans. A higher DSC ratio will result in a lower allowance. The Company recognizes a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At September 30, 2019 and December 31, 2018 , the Company had no CMLs that were delinquent in principal or interest payments. Mortgage loan workouts, refinances or restructures that are classified as troubled debt restructurings ("TDRs") are individually evaluated and measured for impairment. As of September 30, 2019 and December 31, 2018 , our CML portfolio had no impairments, modifications or TDRs. Residential Mortgage Loans Residential mortgage loans ("RMLs") represented approximately 1% of the Company’s total investments as of September 30, 2019 and December 31, 2018 . The Company's residential mortgage loans are closed end, amortizing loans and 100% of the properties are located in the United States. The Company diversifies its RML portfolio by state to attempt to reduce concentration risk. The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables: September 30, 2019 US State: Unpaid Principal Balance % of Total California $ 89 23 % Florida 56 14 % New Jersey 34 9 % All Other States (a) 207 54 % Total mortgage loans $ 386 100 % (a) The individual concentration of each state is less than 9% as of September 30, 2019 . December 31, 2018 US State: Unpaid Principal Balance % of Total Florida $ 25 14 % Illinois 24 13 % New Jersey 17 9 % All Other States (a) 114 64 % Total mortgage loans $ 180 100 % (a) The individual concentration of each state is less than 9% as of December 31, 2018 . Residential mortgage loans have a primary credit quality indicator of either a performing or nonperforming loan. The Company defines non-performing residential mortgage loans as those that are 90 or more days past due or in nonaccrual status which is assessed monthly. The credit quality of RMLs as at September 30, 2019 and December 31, 2018 , respectively, was as follows: September 30, 2019 December 31, 2018 Performance indicators: Carrying Value % of Total Carrying Value % of Total Performing $ 392 100 % $ 185 100 % Non-performing — — % — — % Total residential mortgage loans, gross of valuation allowance $ 392 100 % $ 185 100 % Allowance for loan loss — — % — — % Total residential mortgage loans $ 392 100 % $ 185 100 % Net Investment Income The major sources of “Net investment income” reported on the accompanying unaudited Condensed Consolidated Statements of Operations were as follows: Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Fixed maturity securities, available-for-sale $ 264 $ 249 $ 796 $ 739 Equity securities 16 15 56 51 Mortgage loans 11 5 26 17 Invested cash and short-term investments 4 6 14 13 Funds withheld 18 7 43 21 Limited partnerships 16 5 45 14 Other investments 3 2 10 5 Gross investment income 332 289 990 860 Investment expense (31 ) (22 ) (85 ) (48 ) Net investment income $ 301 $ 267 $ 905 $ 812 Net Investment Gains (Losses) Details underlying “Net investment gains (losses)” reported on the accompanying unaudited Condensed Consolidated Statements of Operations were as follows: Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Net realized gains (losses) on fixed maturity available-for-sale securities $ 19 $ (24 ) $ 11 $ (84 ) Net realized/unrealized gains (losses) on equity securities 19 (19 ) 119 (48 ) Realized gains (losses) on other invested assets — 3 3 — Derivatives and embedded derivatives: Realized gains (losses) on certain derivative instruments (13 ) 27 (42 ) 23 Unrealized gains (losses) on certain derivative instruments 62 135 325 72 Change in fair value of reinsurance related embedded derivatives (a) 16 (3 ) 58 (37 ) Change in fair value of other derivatives and embedded derivatives — — 4 — Realized gains (losses) on derivatives and embedded derivatives 65 159 345 58 Net investment gains (losses) $ 103 $ 119 $ 478 $ (74 ) (a) Change in fair value of reinsurance related embedded derivatives is due to F&G Re and FSRC unaffiliated third party business. The proceeds from the sale of fixed-maturity available for-sale-securities and the gross gains and losses associated with those transactions were as follows: Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Proceeds $ 828 $ 662 $ 1,764 $ 4,310 Gross gains 28 1 38 9 Gross losses (9 ) (26 ) (24 ) (91 ) Unconsolidated Variable Interest Entities FGL Insurance owns investments in VIEs that are not consolidated within the Company’s financial statements. VIEs do not have sufficient equity to finance their own activities without additional financial support and certain of its investors lack certain characteristics of a controlling financial interest. VIE’s are consolidated by their ‘primary beneficiary’, a designation given to an entity that receives both the benefits from the VIE as well as the substantive power to make its key economic decisions. While FGL Insurance participates in the benefits from VIEs in which it invests, the substantive power to make the key economic decisions for each respective VIE resides with entities not under common control with FGL Insurance. It is for this reason that FGL Insurance is not considered the primary beneficiary and why these VIE investments are not consolidated. The Company previously executed a commitment of $75 to purchase common shares in an unaffiliated private business development company ("BDC"). The BDC invests in secured and unsecured fixed maturity and equity securities of middle market companies in the United States. Due to the voting structure of the transaction, the Company does not have voting power. The initial capital call occurred June 30, 2015, with the remaining commitment expected to fund June 2020. The Company has funded $69 as of September 30, 2019 . The Company invests in various limited partnerships as a passive investor. These investments are in credit funds with a current income bias, real assets, or private equity. Limited partnership interests are accounted for under the equity method and are included in “Other invested assets” on the Company’s consolidated balance sheet. The Company's maximum exposure to loss with respect to these investments is limited to the investment carrying amounts reported in the Company's consolidated balance sheet in addition to any required unfunded commitments. As of September 30, 2019 , the Company's maximum exposure to loss was $917 in recorded carrying value and $1,073" id="sjs-B4">Investments The Company’s fixed maturity securities investments have been designated as available-for-sale and are carried at fair value with unrealized gains and losses included in AOCI, net of associated adjustments for deferred acquisition costs ("DAC"), value of business acquired ("VOBA"), deferred sales inducements ("DSI"), unearned revenue ("UREV"), and deferred income taxes. The Company's equity securities investments are carried at fair value with unrealized gains and losses included in net income. The Company’s consolidated investments at September 30, 2019 and December 31, 2018 are summarized as follows: September 30, 2019 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Carrying Value Available-for-sale securities Asset-backed securities $ 5,433 $ 56 $ (94 ) $ 5,395 $ 5,395 Commercial mortgage-backed securities 2,857 185 (2 ) 3,040 3,040 Corporates 11,338 627 (90 ) 11,875 11,875 Hybrids 1,035 39 (7 ) 1,067 1,067 Municipals 1,245 93 (4 ) 1,334 1,334 Residential mortgage-backed securities 964 42 (3 ) 1,003 1,003 U.S. Government 37 1 — 38 38 Foreign Governments 138 17 — 155 155 Total available-for-sale securities 23,047 1,060 (200 ) 23,907 23,907 Equity securities 1,104 15 (22 ) 1,097 1,097 Derivative investments 327 163 (36 ) 454 454 Commercial mortgage loans 444 — — 460 444 Residential mortgage loans 392 — — 397 392 Other invested assets 1,083 — (5 ) 1,068 1,078 Total investments $ 26,397 $ 1,238 $ (263 ) $ 27,383 $ 27,372 December 31, 2018 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Carrying Value Available-for-sale securities Asset-backed securities $ 4,954 $ 15 $ (137 ) $ 4,832 $ 4,832 Commercial mortgage-backed securities 2,568 9 (40 ) 2,537 2,537 Corporates 11,213 16 (848 ) 10,381 10,381 Hybrids 992 — (91 ) 901 901 Municipals 1,216 3 (32 ) 1,187 1,187 Residential mortgage-backed securities 1,027 12 (8 ) 1,031 1,031 U.S. Government 120 — (1 ) 119 119 Foreign Governments 129 — (8 ) 121 121 Total available-for-sale securities 22,219 55 (1,165 ) 21,109 21,109 Equity securities 1,526 1 (145 ) 1,382 1,382 Derivative investments 330 2 (235 ) 97 97 Commercial mortgage loans 482 — — 483 482 Residential mortgage loans 185 — — 187 185 Other invested assets 662 — — 651 662 Total investments $ 25,404 $ 58 $ (1,545 ) $ 23,909 $ 23,917 Included in AOCI were cumulative gross unrealized gains of $0 and gross unrealized losses of $0 related to the non-credit portion of other-than-temporary-impairments ("OTTI") on non-agency residential mortgage backed securities ("RMBS") for both September 30, 2019 and December 31, 2018 . Securities held on deposit with various state regulatory authorities had a fair value of $17,546 and $19,930 at September 30, 2019 and December 31, 2018 , respectively. Under Iowa regulations, insurance companies are required to hold securities on deposit in an amount no less than the legal reserve. At September 30, 2019 and December 31, 2018 , the Company held no material investments that were non-income producing for a period greater than twelve months. In accordance with the Company's FHLB agreements, the investments supporting the funding agreement liabilities are pledged as collateral to secure the FHLB funding agreement liabilities and are not available to the Company for general purposes. The collateral investments had a fair value of $1,286 and $1,401 at September 30, 2019 and December 31, 2018 , respectively. The amortized cost and fair value of fixed maturity available-for-sale securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations. September 30, 2019 Amortized Cost Fair Value Corporates, Non-structured Hybrids, Municipal and Government securities: Due in one year or less $ 112 $ 112 Due after one year through five years 864 869 Due after five years through ten years 2,007 2,053 Due after ten years 10,810 11,435 Subtotal 13,793 14,469 Other securities which provide for periodic payments: Asset-backed securities 5,433 5,395 Commercial mortgage-backed securities 2,857 3,040 Residential mortgage-backed securities 964 1,003 Subtotal 9,254 9,438 Total fixed maturity available-for-sale securities $ 23,047 $ 23,907 The Company's available-for-sale securities with unrealized losses are reviewed for potential OTTI. For factors considered in evaluating whether a decline in value is other-than-temporary, please refer to “Note 2. Significant Accounting Policies and Practices" to the Company’s 2018 Form 10-K. The Company analyzes its ability to recover the amortized cost by comparing the net present value of cash flows expected to be collected with the amortized cost of the security. Additionally, the Company considers other factors, including, but not limited to: whether the issuer is currently meeting its financial obligations and its ability to continue to meet these obligations, its existing cash available, and its access to additional available capital. For mortgage-backed and asset-backed securities, cash flow estimates consider the payment terms of the underlying assets backing a particular security, including interest rate and prepayment assumptions, based on data from widely accepted third-party data sources or internal estimates. In addition to interest rate and prepayment assumptions, cash flow estimates also include other assumptions regarding the underlying collateral including default rates and recoveries, which vary based on the asset type and geographic location, as well as the vintage year of the security. For structured securities, the payment priority within the tranche structure is also considered. For all other fixed maturity securities, cash flow estimates are driven by assumptions regarding probability of default and estimates regarding timing and amount of recoveries associated with a default. If the net present value is less than the amortized cost of the investment, an OTTI is recognized. Based on the results of our process for evaluating available-for-sale securities in unrealized loss positions for OTTI, as discussed above, the Company determined the unrealized losses as of September 30, 2019 decreased due to lower interest rates during the quarter in conjunction with tighter credit spreads over Treasuries. The fair value and gross unrealized losses of available-for-sale securities, aggregated by investment category and duration of fair value below amortized cost, were as follows: September 30, 2019 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale securities Asset-backed securities $ 1,843 $ (52 ) $ 1,347 $ (42 ) $ 3,190 $ (94 ) Commercial mortgage-backed securities 143 (2 ) — — 143 (2 ) Corporates 755 (17 ) 1,177 (73 ) 1,932 (90 ) Hybrids 80 (3 ) 104 (4 ) 184 (7 ) Municipals 1 — 77 (4 ) 78 (4 ) Residential mortgage-backed securities 36 (1 ) 116 (2 ) 152 (3 ) U.S. Government 8 — 2 — 10 — Total available-for-sale securities $ 2,866 $ (75 ) $ 2,823 $ (125 ) $ 5,689 $ (200 ) Total number of available-for-sale securities in an unrealized loss position less than twelve months 382 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 395 Total number of available-for-sale securities in an unrealized loss position 777 December 31, 2018 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale securities Asset-backed securities $ 2,924 $ (116 ) $ 643 $ (21 ) $ 3,567 $ (137 ) Commercial mortgage-backed securities 1,466 (34 ) 262 (6 ) 1,728 (40 ) Corporates 8,016 (772 ) 1,465 (76 ) 9,481 (848 ) Hybrids 858 (90 ) 7 (1 ) 865 (91 ) Municipals 850 (27 ) 172 (5 ) 1,022 (32 ) Residential mortgage-backed securities 139 (3 ) 190 (5 ) 329 (8 ) U.S. Government 69 — 50 (1 ) 119 (1 ) Foreign Government 47 (3 ) 68 (5 ) 115 (8 ) Total available-for-sale securities $ 14,369 $ (1,045 ) $ 2,857 $ (120 ) $ 17,226 $ (1,165 ) Total number of available-for-sale securities in an unrealized loss position less than twelve months 1,551 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 556 Total number of available-for-sale securities in an unrealized loss position 2,107 At September 30, 2019 and December 31, 2018 , securities in an unrealized loss position were primarily concentrated in corporate debt and asset-backed securities. At September 30, 2019 and December 31, 2018 , securities with a fair value of $71 and $132 , respectively, had an unrealized loss greater than 20% of amortized cost (excluding U.S. Government and U.S. Government sponsored agency securities), which were insignificant to the carrying value of all investments, respectively. The following table provides a reconciliation of the beginning and ending balances of the credit loss portion of OTTI on fixed maturity available-for-sale securities held by the Company for the three and nine months ended September 30, 2019 and 2018 , for which a portion of the OTTI was recognized in AOCI: Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Beginning balance $ — $ — $ — $ — Increases attributable to credit losses on securities: OTTI was previously recognized — — — — OTTI was not previously recognized — — — — Ending balance $ — $ — $ — $ — The following table breaks out the credit impairment loss type, the associated amortized cost and fair value of the investments at the balance sheet date and non-credit losses in relation to fixed maturity securities and other invested assets held by the Company for the three and nine months ended September 30, 2019 and 2018 : Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Credit impairment losses in operations $ (2 ) $ — $ (7 ) $ (2 ) Change-of-intent losses in operations — — — — Amortized cost 4 — 4 — Fair value 3 — 4 — Non-credit losses in other comprehensive income for investments which experienced OTTI — — — — Details of OTTI that were recognized in "Net income (loss)" and included in net realized gains on securities were as follows: Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Corporates $ (1 ) $ — $ (6 ) $ (2 ) Equity security (1 ) — (1 ) — Total $ (2 ) $ — $ (7 ) $ (2 ) Mortgage Loans The Company's mortgage loans are collateralized by commercial and residential properties. Commercial Mortgage Loans Commercial mortgage loans ("CMLs") represented approximately 2% of the Company’s total investments as of September 30, 2019 and December 31, 2018 . The Company primarily invests in mortgage loans on income producing properties including hotels, industrial properties, retail buildings, multifamily properties and office buildings. The Company diversifies its CML portfolio by geographic region and property type to attempt to reduce concentration risk. The Company continuously evaluates CMLs based on relevant current information to ensure properties are performing at a consistent and acceptable level to secure the related debt. The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables: September 30, 2019 December 31, 2018 Gross Carrying Value % of Total Gross Carrying Value % of Total Property Type: Hotel $ 21 5 % $ 21 4 % Industrial - General 37 8 % 37 8 % Industrial - Warehouse 20 4 % 20 4 % Multifamily 54 12 % 56 12 % Office 144 33 % 147 30 % Retail 168 38 % 201 42 % Total commercial mortgage loans, gross of valuation allowance $ 444 100 % $ 482 100 % Allowance for loan loss — — Total commercial mortgage loans $ 444 $ 482 U.S. Region: East North Central $ 84 19 % $ 98 20 % East South Central 19 4 % 19 4 % Middle Atlantic 77 17 % 79 17 % Mountain 51 11 % 65 13 % New England 5 1 % 10 2 % Pacific 114 26 % 116 24 % South Atlantic 56 13 % 57 12 % West North Central 13 3 % 13 3 % West South Central 25 6 % 25 5 % Total commercial mortgage loans, gross of valuation allowance $ 444 100 % $ 482 100 % Allowance for loan loss — — Total commercial mortgage loans $ 444 $ 482 All of the Company's investments in CMLs had a loan-to-value ("LTV") ratio of less than 75% at September 30, 2019 and December 31, 2018 , as measured at inception of the loans unless otherwise updated. As of September 30, 2019 , all CMLs are current and have not experienced credit or other events which would require the recording of an impairment loss. LTV and DSC ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.00 indicates that a property’s operations do not generate sufficient income to cover debt payments. We normalize our DSC ratios to a 25-year amortization period for purposes of our general loan allowance evaluation. The following table presents the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios at September 30, 2019 and December 31, 2018 : Debt-Service Coverage Ratios Total Amount % of Total Estimated Fair Value % of Total >1.25 1.00 - 1.25 September 30, 2019 LTV Ratios: Less than 50% $ 287 $ 6 $ 293 66 % $ 304 66 % 50% to 60% 140 — 140 32 % 145 32 % 60% to 75% 11 — 11 2 % 11 2 % Commercial mortgage loans $ 438 $ 6 $ 444 100 % $ 460 100 % December 31, 2018 LTV Ratios: Less than 50% $ 296 $ 6 $ 302 63 % $ 302 63 % 50% to 60% 169 — 169 35 % 170 35 % 60% to 75% 11 — 11 2 % 11 2 % Commercial mortgage loans $ 476 $ 6 $ 482 100 % $ 483 100 % The Company establishes a general mortgage loan allowance based upon the underlying risk and quality of the mortgage loan portfolio using DSC ratio and LTV ratio. The Company believes that the LTV ratio is an indicator of the principal recovery risk for loans that default. A higher LTV ratio will result in a higher allowance. The Company believes that the DSC ratio is an indicator of default risk on loans. A higher DSC ratio will result in a lower allowance. The Company recognizes a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At September 30, 2019 and December 31, 2018 , the Company had no CMLs that were delinquent in principal or interest payments. Mortgage loan workouts, refinances or restructures that are classified as troubled debt restructurings ("TDRs") are individually evaluated and measured for impairment. As of September 30, 2019 and December 31, 2018 , our CML portfolio had no impairments, modifications or TDRs. Residential Mortgage Loans Residential mortgage loans ("RMLs") represented approximately 1% of the Company’s total investments as of September 30, 2019 and December 31, 2018 . The Company's residential mortgage loans are closed end, amortizing loans and 100% of the properties are located in the United States. The Company diversifies its RML portfolio by state to attempt to reduce concentration risk. The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables: September 30, 2019 US State: Unpaid Principal Balance % of Total California $ 89 23 % Florida 56 14 % New Jersey 34 9 % All Other States (a) 207 54 % Total mortgage loans $ 386 100 % (a) The individual concentration of each state is less than 9% as of September 30, 2019 . December 31, 2018 US State: Unpaid Principal Balance % of Total Florida $ 25 14 % Illinois 24 13 % New Jersey 17 9 % All Other States (a) 114 64 % Total mortgage loans $ 180 100 % (a) The individual concentration of each state is less than 9% as of December 31, 2018 . Residential mortgage loans have a primary credit quality indicator of either a performing or nonperforming loan. The Company defines non-performing residential mortgage loans as those that are 90 or more days past due or in nonaccrual status which is assessed monthly. The credit quality of RMLs as at September 30, 2019 and December 31, 2018 , respectively, was as follows: September 30, 2019 December 31, 2018 Performance indicators: Carrying Value % of Total Carrying Value % of Total Performing $ 392 100 % $ 185 100 % Non-performing — — % — — % Total residential mortgage loans, gross of valuation allowance $ 392 100 % $ 185 100 % Allowance for loan loss — — % — — % Total residential mortgage loans $ 392 100 % $ 185 100 % Net Investment Income The major sources of “Net investment income” reported on the accompanying unaudited Condensed Consolidated Statements of Operations were as follows: Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Fixed maturity securities, available-for-sale $ 264 $ 249 $ 796 $ 739 Equity securities 16 15 56 51 Mortgage loans 11 5 26 17 Invested cash and short-term investments 4 6 14 13 Funds withheld 18 7 43 21 Limited partnerships 16 5 45 14 Other investments 3 2 10 5 Gross investment income 332 289 990 860 Investment expense (31 ) (22 ) (85 ) (48 ) Net investment income $ 301 $ 267 $ 905 $ 812 Net Investment Gains (Losses) Details underlying “Net investment gains (losses)” reported on the accompanying unaudited Condensed Consolidated Statements of Operations were as follows: Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Net realized gains (losses) on fixed maturity available-for-sale securities $ 19 $ (24 ) $ 11 $ (84 ) Net realized/unrealized gains (losses) on equity securities 19 (19 ) 119 (48 ) Realized gains (losses) on other invested assets — 3 3 — Derivatives and embedded derivatives: Realized gains (losses) on certain derivative instruments (13 ) 27 (42 ) 23 Unrealized gains (losses) on certain derivative instruments 62 135 325 72 Change in fair value of reinsurance related embedded derivatives (a) 16 (3 ) 58 (37 ) Change in fair value of other derivatives and embedded derivatives — — 4 — Realized gains (losses) on derivatives and embedded derivatives 65 159 345 58 Net investment gains (losses) $ 103 $ 119 $ 478 $ (74 ) (a) Change in fair value of reinsurance related embedded derivatives is due to F&G Re and FSRC unaffiliated third party business. The proceeds from the sale of fixed-maturity available for-sale-securities and the gross gains and losses associated with those transactions were as follows: Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Proceeds $ 828 $ 662 $ 1,764 $ 4,310 Gross gains 28 1 38 9 Gross losses (9 ) (26 ) (24 ) (91 ) Unconsolidated Variable Interest Entities FGL Insurance owns investments in VIEs that are not consolidated within the Company’s financial statements. VIEs do not have sufficient equity to finance their own activities without additional financial support and certain of its investors lack certain characteristics of a controlling financial interest. VIE’s are consolidated by their ‘primary beneficiary’, a designation given to an entity that receives both the benefits from the VIE as well as the substantive power to make its key economic decisions. While FGL Insurance participates in the benefits from VIEs in which it invests, the substantive power to make the key economic decisions for each respective VIE resides with entities not under common control with FGL Insurance. It is for this reason that FGL Insurance is not considered the primary beneficiary and why these VIE investments are not consolidated. The Company previously executed a commitment of $75 to purchase common shares in an unaffiliated private business development company ("BDC"). The BDC invests in secured and unsecured fixed maturity and equity securities of middle market companies in the United States. Due to the voting structure of the transaction, the Company does not have voting power. The initial capital call occurred June 30, 2015, with the remaining commitment expected to fund June 2020. The Company has funded $69 as of September 30, 2019 . The Company invests in various limited partnerships as a passive investor. These investments are in credit funds with a current income bias, real assets, or private equity. Limited partnership interests are accounted for under the equity method and are included in “Other invested assets” on the Company’s consolidated balance sheet. The Company's maximum exposure to loss with respect to these investments is limited to the investment carrying amounts reported in the Company's consolidated balance sheet in addition to any required unfunded commitments. As of September 30, 2019 , the Company's maximum exposure to loss was $917 in recorded carrying value and $1,073

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The carrying amounts of derivative instruments, including derivative instruments embedded in FIA contracts, is as follows: September 30, 2019 December 31, 2018 Assets: Derivative investments: Call options $ 454 $ 97 Futures contracts — — Other invested assets: Other derivatives and embedded derivatives 19 14 $ 473 $ 111 Liabilities: Contractholder funds: FIA embedded derivative $ 3,136 $ 2,476 Other liabilities: Preferred shares reimbursement feature embedded derivative 14 29 $ 3,150 $ 2,505 The change in fair value of derivative instruments included in the accompanying unaudited Condensed Consolidated Statements of Operations is as follows: Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Net investment gains (losses): Call options $ 43 $ 153 $ 261 $ 86 Futures contracts 3 8 17 8 Foreign currency forward 3 1 5 1 Other derivatives and embedded derivatives — — 4 — Reinsurance related embedded derivatives 16 (3 ) 58 (37 ) Total net investment gains (losses) $ 65 $ 159 $ 345 $ 58 Benefits and other changes in policy reserves: FIA embedded derivatives $ 202 $ 231 $ 660 $ 274 Acquisition and operating expenses, net of deferrals: Preferred shares reimbursement feature embedded derivative $ (10 ) $ (2 ) $ (15 ) $ (1 ) Additional Disclosures Other Derivatives and Embedded Derivatives The Company holds a fund-linked note issued by Nomura International Funding Pte. Ltd with a face value of $35 . The note provides for an additional payment at maturity based on the value of an embedded derivative in AnchorPath Dedicated Return Fund (the "AnchorPath Fund"), which was based on the actual return of the fund. At September 30, 2019 , the fair value of the fund-linked note and embedded derivative were $29 and $19 , respectively. At December 31, 2018 , the fair value of the fund-linked note and embedded derivative were $26 and $14 , respectively. At maturity of the fund-linked note, FGL Insurance will receive the $35 face value of the note plus the value of the embedded derivative in the AnchorPath Fund. The additional payment at maturity is an embedded derivative reported in "Other invested assets", while the host is an available-for-sale security reported in "Fixed maturities, available-for-sale". Fixed Index Annuity ("FIA") Embedded Derivative and Call Options and Futures The Company has FIA Contracts that permit the holder to elect an interest rate return or an equity index linked component, where interest credited to the contracts is linked to the performance of various equity indices, primarily the S&P 500 Index. This feature represents an embedded derivative under GAAP. The FIA embedded derivative is valued at fair value and included in the liability for contractholder funds in the accompanying Condensed Consolidated Balance Sheets with changes in fair value included as a component of “Benefits and other changes in policy reserves” in the unaudited Condensed Consolidated Statements of Operations. See a description of the fair value methodology used in "Note 6. Fair Value of Financial Instruments". The Company purchases derivatives consisting of a combination of call options and futures contracts on the applicable market indices to fund the index credits due to FIA contractholders. The call options are one , two , three , and five year options purchased to match the funding requirements of the underlying policies. On the respective anniversary dates of the index policies, the index used to compute the interest credit is reset and the Company purchases new one , two , three , or five year call options to fund the next index credit. The Company manages the cost of these purchases through the terms of its FIA contracts, which permit the Company to change caps, spreads or participation rates, subject to guaranteed minimums, on each contract’s anniversary date. The change in the fair value of the call options and futures contracts is generally designed to offset the portion of the change in the fair value of the FIA embedded derivative related to index performance. The call options and futures contracts are marked to fair value with the change in fair value included as a component of “Net investment gains (losses).” The change in fair value of the call options and futures contracts includes the gains and losses recognized at the expiration of the instrument term or upon early termination and the changes in fair value of open positions. Other market exposures are hedged periodically depending on market conditions and the Company’s risk tolerance. The Company’s FIA hedging strategy economically hedges the equity returns and exposes the Company to the risk that unhedged market exposures result in divergence between changes in the fair value of the liabilities and the hedging assets. The Company uses a variety of techniques, including direct estimation of market sensitivities, to monitor this risk daily. The Company intends to continue to adjust the hedging strategy as market conditions and the Company’s risk tolerance change. Preferred Equity Remarketing Reimbursement Embedded Derivative Liability On November 30, 2017 the Company issued 275,000 Series A cumulative preferred shares and 100,000 Series B cumulative preferred shares (together the “Preferred Shares”). The Preferred Shares do not have a maturity date and are non-callable for the first five years . From and after November 30, 2022, the original holders of the Preferred Shares may request and thus require, the Company (subject to customary blackout provisions) to remarket the Preferred Shares on their existing terms. If the remarketing is successful and the original holders elect to sell their preferred shares at the remarketed price and proceeds from such sale are less than the outstanding balance of the applicable shares (including dividends paid in kind and accumulated but unpaid dividends), the Company will be required to reimburse the sellers, up to a maximum of 10% of the par value of the originally issued preferred shares (including dividends paid in kind and accumulated but unpaid dividends) with such amount payable either in cash, ordinary shares, or any combination thereof, at the Company's option (the “Reimbursement Feature”). The Reimbursement Feature represents an embedded derivative that is not clearly and closely related to the preferred stock host and must be bifurcated. The Reimbursement Feature liability is held at fair value within “Other liabilities” in the accompanying Condensed Consolidated Balance Sheets and it is determined using a Black Derman Toy model incorporating among other things the paid in kind dividend coupon rate and the Company’s call option. Changes in fair value of this derivative are recognized within “Acquisition and operating expenses, net of deferrals” in the accompanying unaudited Condensed Consolidated Statements of Operations. Credit Risk The Company is exposed to credit loss in the event of non-performance by its counterparties on the call options and reflects assumptions regarding this non-performance risk in the fair value of the call options. The non-performance risk is the net counterparty exposure based on the fair value of the open contracts less collateral held. The Company maintains a policy of requiring all derivative contracts to be governed by an International Swaps and Derivatives Association (“ISDA”) Master Agreement. Information regarding the Company’s exposure to credit loss on the call options it holds is presented in the following table: September 30, 2019 Counterparty Credit Rating (Fitch/Moody's/S&P) (a) Notional Fair Value Collateral Net Credit Risk Merrill Lynch A+/*/A+ $ 2,815 $ 70 $ 24 $ 46 Deutsche Bank BBB/A3/BBB+ 804 12 11 1 Morgan Stanley */A1/A+ 1,772 39 36 3 Barclay's Bank A+/A2/A 3,381 165 154 11 Canadian Imperial Bank of Commerce */Aa2/A+ 2,557 81 53 28 Wells Fargo A+/A2/A- 2,075 66 65 1 Goldman Sachs A/A3/BBB+ 1,079 21 19 2 Total $ 14,483 $ 454 $ 362 $ 92 December 31, 2018 Counterparty Credit Rating Notional Fair Value Collateral Net Credit Risk Merrill Lynch A+/*/A+ $ 3,952 $ 25 $ — $ 25 Deutsche Bank A-/A3/BBB+ 1,327 5 6 (1 ) Morgan Stanley */A1/A+ 1,648 9 6 3 Barclay's Bank A+/A2/A 2,205 27 20 7 Canadian Imperial Bank of Commerce */Aa2/A+ 1,716 11 8 3 Wells Fargo A+/A2/A- 1,635 17 16 1 Goldman Sachs A/A3/BBB+ 647 3 3 — Total $ 13,130 $ 97 $ 59 $ 38 (a) An * represents credit ratings that were not available. Collateral Agreements The Company is required to maintain minimum ratings as a matter of routine practice as part of its over-the-counter derivative agreements on ISDA forms. Under some ISDA agreements, the Company has agreed to maintain certain financial strength ratings. A downgrade below these levels provides the counterparty under the agreement the right to terminate the open option contracts between the parties, at which time any amounts payable by the Company or the counterparty would be dependent on the market value of the underlying option contracts. The Company's current rating doesn't allow any counterparty the right to terminate ISDA agreements. In certain transactions, the Company and the counterparty have entered into a collateral support agreement requiring either party to post collateral when the net exposures exceed pre-determined thresholds. For all counterparties, except one, this threshold is set to zero. As of September 30, 2019 and December 31, 2018 , counterparties posted $362 and $59 of collateral, respectively, of which $338 and $59 is included in "Cash and cash equivalents" with an associated payable for this collateral included in "Other liabilities" on the Condensed Consolidated Balance Sheets . The remaining $24 and $0 of non-cash collateral was held by a third-party custodian and may not be sold or re-pledged, except in the event of default, and, therefore, is not included in the Company's Condensed Consolidated Balance Sheets at September 30, 2019 and December 31, 2018 , respectively. This collateral generally consists of U.S. treasury bonds and mortgage-backed securities. Accordingly, the maximum amount of loss due to credit risk that the Company would incur if parties to the call options failed completely to perform according to the terms of the contracts was $92 and $38 at September 30, 2019 and December 31, 2018 , respectively. The Company is required to pay counterparties the effective federal funds rate each day for cash collateral posted to FGL for daily mark to market margin changes. The Company reinvests derivative cash collateral to reduce the interest cost. Cash collateral is invested in overnight investment sweep products which are included in "Cash and cash equivalents" in the accompanying Condensed Consolidated Balance Sheets. The Company held 724 and 664 futures contracts at September 30, 2019 and December 31, 2018 , respectively. The fair value of the futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements). The Company provides cash collateral to the counterparties for the initial and variation margin on the futures contracts which is included in "Cash and cash equivalents" in the accompanying Condensed Consolidated Balance Sheets. The amount of cash collateral held by the counterparties for such contracts was $4 and $3 at September 30, 2019 and December 31, 2018

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2019
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company’s measurement of fair value is based on assumptions used by market participants in pricing the asset or liability, which may include inherent risk, restrictions on the sale or use of an asset, or non-performance risk, which may include the Company’s own credit risk. The Company’s estimate of an exchange price is the price in an orderly transaction between market participants to sell the asset or transfer the liability (“exit price”) in the principal market, or the most advantageous market for that asset or liability in the absence of a principal market as opposed to the price that would be paid to acquire the asset or assume a liability (“entry price”). The Company categorizes financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is defined as follows: Level 1 - Values are unadjusted quoted prices for identical assets and liabilities in active markets accessible at the measurement date. Level 2 - Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices from those willing to trade in markets that are not active, or other inputs that are observable or can be corroborated by market data for the term of the instrument. Such inputs include market interest rates and volatilities, spreads, and yield curves. Level 3 - Certain inputs are unobservable (supported by little or no market activity) and significant to the fair value measurement. Unobservable inputs reflect the Company’s best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date based on the best information available in the circumstances. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. When a determination is made to classify an asset or liability within Level 3 of the fair value hierarchy, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. Because certain securities trade in less liquid or illiquid markets with limited or no pricing information, the determination of fair value for these securities is inherently more difficult. In addition to the unobservable inputs, Level 3 fair value investments may include observable components, which are components that are actively quoted or can be validated to market-based sources. The carrying amounts and estimated fair values of the Company’s financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, with the exception of investment contracts, related party loans, portions of other invested assets and debt which are disclosed later within this footnote, was summarized according to the hierarchy previously described, as follows: September 30, 2019 Level 1 Level 2 Level 3 Fair Value Carrying Amount Assets Cash and cash equivalents $ 990 $ — $ — $ 990 $ 990 Fixed maturity securities, available-for-sale: Asset-backed securities — 4,803 592 5,395 5,395 Commercial mortgage-backed securities — 3,014 26 3,040 3,040 Corporates — 10,446 1,429 11,875 11,875 Hybrids 301 756 10 1,067 1,067 Municipals — 1,292 42 1,334 1,334 Residential mortgage-backed securities — 434 569 1,003 1,003 U.S. Government 30 8 — 38 38 Foreign Governments — 137 18 155 155 Equity securities 429 597 2 1,028 1,028 Derivative investments — 454 — 454 454 Other invested assets — — 44 44 44 Funds withheld for reinsurance receivables, at fair value 447 1,584 14 2,045 2,045 Total financial assets at fair value $ 2,197 $ 23,525 $ 2,746 $ 28,468 $ 28,468 Liabilities Fair value of future policy benefits — — 1,887 1,887 1,887 Derivatives: FIA embedded derivatives, included in contractholder funds — — 3,136 3,136 3,136 Preferred shares reimbursement feature embedded derivative — — 14 14 14 Total financial liabilities at fair value $ — $ — $ 5,037 $ 5,037 $ 5,037 December 31, 2018 Level 1 Level 2 Level 3 Fair Value Carrying Amount Assets Cash and cash equivalents $ 571 $ — $ — $ 571 $ 571 Fixed maturity securities, available-for-sale: Asset-backed securities — 4,388 444 4,832 4,832 Commercial mortgage-backed securities — 2,470 67 2,537 2,537 Corporates — 9,150 1,231 10,381 10,381 Hybrids 265 626 10 901 901 Municipals — 1,150 37 1,187 1,187 Residential mortgage-backed securities — 417 614 1,031 1,031 U.S. Government 114 5 — 119 119 Foreign Governments — 105 16 121 121 Equity securities 454 874 4 1,332 1,332 Derivative investments — 97 — 97 97 Other invested assets — — 39 39 39 Funds withheld for reinsurance receivables, at fair value 177 576 4 757 757 Total financial assets at fair value $ 1,581 $ 19,858 $ 2,466 $ 23,905 $ 23,905 Liabilities Fair value of future policy benefits — — 725 725 725 Derivatives: FIA embedded derivatives, included in contractholder funds — — 2,476 2,476 2,476 Preferred shares reimbursement feature embedded derivative — — 29 29 29 Total financial liabilities at fair value $ — $ — $ 3,230 $ 3,230 $ 3,230 Valuation Methodologies Fixed Maturity Securities & Equity Securities The Company measures the fair value of its securities based on assumptions used by market participants in pricing the security. The most appropriate valuation methodology is selected based on the specific characteristics of the fixed maturity or equity security, and the Company will then consistently apply the valuation methodology to measure the security’s fair value. The Company's fair value measurement is based on a market approach, which utilizes prices and other relevant information generated by market transactions involving identical or comparable securities. Sources of inputs to the market approach include third-party pricing services, independent broker quotations, or pricing matrices. The Company uses observable and unobservable inputs in its valuation methodologies. Observable inputs include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data. In addition, market indicators and industry and economic events are monitored and further market data will be acquired when certain thresholds are met. For certain security types, additional inputs may be used, or some of the inputs described above may not be applicable. The significant input used in the fair value measurement of equity securities for which the market approach valuation technique is employed is yield for comparable securities. Increases or decreases in the yields would result in lower or higher, respectively, fair value measurements. For broker-quoted only securities, quotes from market makers or broker-dealers are obtained from sources recognized to be market participants. Management believes the broker quotes are prices at which trades could be executed based on historical trades executed at broker-quoted or slightly higher prices. The Company has an equity investment in a private business development company which is not traded on an exchange or valued by other sources such as analytics or brokers. The Company based the fair value of this investment on an estimated net asset value provided by the investee. Management did not make any adjustments to this valuation. The Company does analyze the third-party valuation methodologies and related inputs to perform assessments to determine the appropriate level within the fair value hierarchy. However, the Company did not adjust prices received from third parties as of September 30, 2019 or December 31, 2018 . Derivative Financial Instruments The fair value of call option assets is based upon valuation pricing models, which represents what the Company would expect to receive or pay at the balance sheet date if it canceled the options, entered into offsetting positions, or exercised the options. Fair values for these instruments are determined internally, based on valuation pricing models which use market-observable inputs, including interest rates, yield curve volatilities, and other factors. The fair value of futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements) which represents what the Company would expect to receive or pay at the balance sheet date if it canceled the futures contract or entered into offsetting positions. These contracts are classified as Level 1. The fair value measurement of the FIA embedded derivatives included in contractholder funds is determined through a combination of market observable information and significant unobservable inputs using the option budget method. The market observable inputs are the market value of option and interest swap rates. The unobservable inputs are the mortality multiplier, surrender rates, non-performance spread and option costs. The mortality multiplier at September 30, 2019 and December 31, 2018 was applied to the Annuity 2000 mortality tables. Increases or decreases in the market value of an option in isolation would result in a higher or lower, respectively, fair value measurement. Increases or decreases in interest swap rates, mortality multiplier, surrender rates, or non-performance spread in isolation would result in a lower or higher fair value measurement, respectively. Generally, a change in any one unobservable input would not directly result in a change in any other unobservable input. The fair value of the Reimbursement Feature is determined using a Black Derman Toy model, incorporating the paid in kind dividend coupon, the Company's redemption option and the preferred shareholder's remarketing feature. The remarketing feature allows the shareholder to put the preferred shares to the Company for a value of par after five years and, if after a successful remarketing event the amount is less than 90% par, up to a maximum of 10% of liquidation price defined. Fair value of this derivative decreased $10 and $15 during the three and nine months ended September 30, 2019 , respectively, due primarily to changes in the credit spread applied in the discount rate. Other Invested Assets Fair value of the AnchorPath embedded derivative is based on an unobservable input, the net asset value of the AnchorPath fund at the balance sheet date. The embedded derivative is similar to a call option on the net asset value of the AnchorPath fund with a strike price of zero since FGL Insurance will not be required to make any additional payments at maturity of the fund-linked note in order to receive the net asset value of the AnchorPath fund on the maturity date. A Black-Scholes model determines the net asset value of the AnchorPath fund as the fair value of the call option regardless of the values used for the other inputs to the option pricing model. The net asset value of the AnchorPath fund is provided by the fund manager at the end of each calendar month and represents the value an investor would receive if it withdrew its investment on the balance sheet date. Therefore, the key unobservable input used in the Black-Scholes model is the value of the AnchorPath fund. As the value of the AnchorPath fund increases or decreases, the fair value of the embedded derivative will increase or decrease. FSRC and F&G Re Funds Withheld for Reinsurance Receivables and Future Policy Benefits FSRC and F&G Re elected to apply the Fair Value Option to account for its funds withheld receivables and future policy benefits liability related to its assumed reinsurance. FSRC and F&G Re measures the fair value of the Funds Withheld for Reinsurance Receivables based on the fair values of the securities in the underlying funds withheld portfolio held by the cedant. FSRC and F&G Re use a discounted cash flows approach to measure the fair value of the Future Policy Benefits Reserve. The cash flows associated with future policy premiums and benefits are generated using best estimate assumptions (plus a risk margin, where applicable) and are consistent with market prices, where available. Risk margins are typically applied to non-observable, non-hedgeable market inputs such as long term volatility, mortality, morbidity, lapse, etc. The significant unobservable inputs used in the fair value measurement of the FSRC and F&G Re future policy benefit liability are undiscounted cash flows, non-performance risk spread and risk margin to reflect uncertainty. Undiscounted cash flows used in our September 30, 2019 discounted cash flow model equaled $2,399 . Increases or decreases in non-performance risk spread and risk margin to reflect uncertainty would result in a lower or higher fair value measurement, respectively. Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of September 30, 2019 and December 31, 2018 , are as follows: Fair Value at Valuation Technique Unobservable Input(s) Range (Weighted average) September 30, 2019 September 30, 2019 Assets Asset-backed securities $ 566 Broker-quoted Offered quotes 98.65% - 109.06% Asset-backed securities 26 Third-Party Valuation Offered quotes 0.00% - 99.39% Commercial mortgage-backed securities 26 Broker-quoted Offered quotes 100.20% - 126.34% Corporates 1,429 Broker-quoted Offered quotes 83.06% - 122.30% Hybrids 10 Broker-quoted Offered quotes 103.64% - 103.64% Municipals 42 Broker-quoted Offered quotes 128.04% - 128.04% Residential mortgage-backed securities 569 Broker-quoted Offered quotes 15.53% - 106.40% Foreign governments 18 Broker-quoted Offered quotes 108.75% - 115.74% Equity securities (Salus preferred equity) 2 Income-Approach Yield 3.01% Other Invested Assets: Available-for-sale embedded derivative (AnchorPath) 19 Black Scholes model Market value of AnchorPath fund 100.00% Credit Linked Note 25 Broker-quoted Offered quotes 100.00% Funds withheld for reinsurance receivables at fair value 14 Broker-quoted Offered quotes 103.22% Total financial assets at fair value $ 2,746 Liabilities Future policy benefits 1,887 Discounted cash flow Market value of option 0.00% - 7.56% (1.76%) Mortality multiplier 80.00% - 120.00% (94.83%) Surrender rates 0.00% - 55.00% (21.11%) Partial withdrawals 0.00% - 4.00% (2.27%) Non-performance spread 0.00% - 0.10% (0.07%) Option cost 0.00% - 4.58% (1.13%) Risk margin to reflect uncertainty 0.24% - 0.62% (0.30%) Morbidity risk margin 0.00% - 2.00% (0.07%) Derivatives: FIA embedded derivatives included in contractholder funds 3,136 Discounted cash flow Market value of option 0.00% - 28.63% SWAP rates 1.50% - 1.56% Mortality multiplier 80.00% - 80.00% Surrender rates 0.50% - 75.00% Partial withdrawals 1.00% - 2.50% Non-performance spread 0.25% - 0.25% Option cost 0.18% - 16.61% Preferred shares reimbursement feature embedded derivative 14 Black Derman Toy model Credit Spread 3.31% Yield Volatility 20.00% Total financial liabilities at fair value $ 5,037 Fair Value at Valuation Technique Unobservable Input(s) Range (Weighted average) December 31, 2018 December 31, 2018 Assets Asset-backed securities $ 405 Broker-quoted Offered quotes 97.00% - 102.00% (99.77%) Asset-backed securities 24 Matrix Pricing Quoted prices 96.07% - 96.07% (96.07%) Asset-backed securities 15 Third-Party Valuation Offered quotes 0.00% - 99.29% (23.05%) Commercial mortgage-backed securities 43 Broker-quoted Offered quotes 77.12% - 100.08% (85.46%) Commercial mortgage-backed securities 24 Matrix Pricing Quoted prices 117.72% - 117.72% (117.72%) Corporates 577 Broker-quoted Offered quotes 74.63% - 104.62% (97.80%) Corporates 654 Matrix Pricing Quoted prices 91.74% - 113.25% (98.86%) Hybrids 10 Matrix Pricing Quoted prices 96.60% - 96.60% (96.60%) Municipals 37 Broker-quoted Offered quotes 111.23% - 111.23% (111.23%) Residential mortgage-backed securities 614 Broker-quoted Offered quotes 89.80% - 100.99% (100.73%) Foreign governments 16 Broker-quoted Offered quotes 98.38% - 99.01% (98.58%) Equity securities (Salus preferred equity) 4 Income-Approach Yield 7.15% Other Invested Assets: Available-for-sale embedded derivative (AnchorPath) 14 Black Scholes model Market value of AnchorPath fund 100.00% Credit Linked Note 25 Broker-quoted Offered quotes 100.00% Funds withheld for reinsurance receivables, at fair value 4 Matrix pricing Calculated prices 100.00% Total financial assets at fair value $ 2,466 Liabilities Future policy benefits 725 Discounted cash flow Non-Performance risk spread 0.00% - 0.22% (0.18%) Risk margin to reflect uncertainty 0.35% - 0.71% (0.68%) Derivatives: FIA embedded derivatives included in contractholder funds 2,476 Discounted cash flow Market value of option 0.00% - 31.06% (0.94%) SWAP rates 2.57% - 2.71% (2.63%) Mortality multiplier 80.00% - 80.00% (80.00%) Surrender rates 0.50% - 75.00% (5.90%) Partial withdrawals 1.00% - 2.50% (2.00%) Non-performance spread 0.25% - 0.25% (0.25%) Option cost 0.11% - 16.61% (2.18%) Preferred shares reimbursement feature embedded derivative 29 Black Derman Toy model Credit Spread 5.14% Yield Volatility 20.00% Total financial liabilities at fair value $ 3,230 Changes in unrealized losses (gains), net in the Company’s FIA embedded derivatives are included in "Benefits and other changes in policy reserves" in the unaudited Condensed Consolidated Statements of Operations. The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the three and nine months ended September 30, 2019 and 2018 , respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Three months ended September 30, 2019 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 736 $ — $ 3 $ 14 $ — $ (36 ) $ (125 ) $ 592 Commercial mortgage-backed securities 50 — — — — (1 ) (23 ) 26 Corporates 1,319 — 17 107 — (14 ) — 1,429 Hybrids 10 — — — — — — 10 Municipals 39 — 3 — — — — 42 Residential mortgage-backed securities 588 — (2 ) 6 — (23 ) — 569 Foreign Governments 17 — 1 — — — — 18 Equity securities 3 (1 ) — — — — — 2 Other invested assets: Available-for-sale embedded derivative 18 1 — — — — — 19 Credit linked note 25 — — — — — — 25 Funds withheld for reinsurance receivables, at fair value — — — 14 — — — 14 Total assets at Level 3 fair value $ 2,805 $ — $ 22 $ 141 $ — $ (74 ) $ (148 ) $ 2,746 Liabilities Future policy benefits $ 1,787 $ 54 $ 1 $ — $ — $ 45 $ — $ 1,887 FIA embedded derivatives, included in contractholder funds 2,934 202 — — — — — 3,136 Preferred shares reimbursement feature embedded derivative 24 (10 ) 14 Total liabilities at Level 3 fair value $ 4,745 $ 246 $ 1 $ — $ — $ 45 $ — $ 5,037 (a) The net transfers out of Level 3 during the three months ended September 30, 2019 were exclusively to Level 2. Three months ended September 30, 2018 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 330 $ — $ — $ 162 $ — $ (11 ) $ (77 ) $ 404 Commercial mortgage-backed securities 60 — (1 ) — — — (12 ) 47 Corporates 1,190 — (9 ) 53 — (5 ) (21 ) 1,208 Hybrids 10 — (1 ) — — — — 9 Municipals 37 — (1 ) — — — — 36 Residential mortgage-backed securities 242 — (2 ) 375 (1 ) (3 ) (36 ) 575 Foreign Governments 16 — — — — — — 16 Equity securities 3 1 — — — — — 4 Other invested assets: Available-for-sale embedded derivative 17 — — — — — — 17 Affiliated Bank Loans 50 — — — (11 ) — — 39 Funds withheld for reinsurance receivables, at fair value 6 — — — — (4 ) — 2 Total assets at Level 3 fair value $ 1,961 $ 1 $ (14 ) $ 590 $ (12 ) $ (23 ) $ (146 ) $ 2,357 Liabilities Future policy benefits (FSRC) $ 737 $ (26 ) $ 1 $ — $ — $ (28 ) $ — $ 684 FIA embedded derivatives, included in contractholder funds 2,320 231 — — — — — 2,551 Preferred shares reimbursements feature embedded derivative 24 (2 ) — — — — — 22 Total liabilities at Level 3 fair value $ 3,081 $ 203 $ 1 $ — $ — $ (28 ) $ — $ 3,257 (a) The net transfers out of Level 3 during the three months ended September 30, 2018 were exclusively to Level 2. Nine months ended September 30, 2019 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 444 $ — $ 16 $ 390 $ — $ (79 ) $ (179 ) $ 592 Commercial mortgage-backed securities 67 — 4 1 — (10 ) (36 ) 26 Corporates 1,231 (1 ) 67 221 (25 ) (74 ) 10 1,429 Hybrids 10 — — — — — — 10 Municipals 37 — 5 — — — — 42 Residential mortgage-backed securities 614 — 28 19 — (63 ) (29 ) 569 Foreign Governments 16 — 2 — — — — 18 Equity securities 4 (1 ) (1 ) — — — — 2 Other invested assets: Available-for-sale embedded derivative 14 5 — — — — — 19 Credit linked note 25 — — — — — — 25 Funds withheld for reinsurance receivables, at fair value 4 — — 19 (1 ) — (8 ) 14 Total assets at Level 3 fair value $ 2,466 $ 3 $ 121 $ 650 $ (26 ) $ (226 ) $ (242 ) $ 2,746 Liabilities Future policy benefits $ 725 $ 143 $ 9 $ — $ — $ 1,010 $ — $ 1,887 FIA embedded derivatives, included in contractholder funds 2,476 660 — — — — — 3,136 Preferred shares reimbursement feature embedded derivative 29 (15 ) — — — — — 14 Total liabilities at Level 3 fair value $ 3,230 $ 788 $ 9 $ — $ — $ 1,010 $ — $ 5,037 ( a) The net transfers out of Level 3 during the nine months ended September 30, 2019 were exclusively to Level 2. Nine months ended September 30, 2018 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 412 $ — $ (2 ) $ 342 $ — $ (18 ) $ (330 ) $ 404 Commercial mortgage-backed securities 49 — (3 ) 12 — (6 ) (5 ) 47 Corporates 1,169 — (36 ) 252 — (108 ) (69 ) 1,208 Hybrids 10 — (1 ) — — — — 9 Municipals 38 — (2 ) — — — — 36 Residential mortgage-backed securities 66 — — 554 (1 ) (8 ) (36 ) 575 Foreign Governments 17 — (1 ) — — — — 16 Equity securities 3 2 (1 ) — — — — 4 Other invested assets: Available-for-sale embedded derivative 17 — — — — — — 17 Affiliated bank loans — — — 50 (11 ) — — 39 Funds withheld for reinsurance receivables, at fair value 4 — — 2 — (4 ) — 2 Total assets at Level 3 fair value $ 1,785 $ 2 $ (46 ) $ 1,212 $ (12 ) $ (144 ) $ (440 ) $ 2,357 Liabilities Future policy benefits (FSRC) $ 728 $ (43 ) $ (1 ) $ — $ — $ — $ — $ 684 FIA embedded derivatives, included in contractholder funds 2,277 274 — — — — — 2,551 Preferred shares reimbursement feature embedded derivative 23 (1 ) — — — — — 22 Total liabilities at Level 3 fair value $ 3,028 $ 230 $ (1 ) $ — $ — $ — $ — $ 3,257 ( a) The net transfers out of Level 3 during the nine months ended September 30, 2018 were exclusively to Level 2. Valuation Methodologies and Associated Inputs for Financial Instruments Not Carried at Fair Value The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value. Considerable judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange of all of our financial instruments. FHLB Common Stock The fair value of FHLB common stock is based on cost. Mortgage Loans The fair value of mortgage loans is established using a discounted cash flow method based on credit rating, maturity and future income. This yield-based approach is sourced from our third-party vendor. The ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt service coverage, loan-to-value, quality of tenancy, borrower, and payment record. In the event of an impairment, the carrying value is based on the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s market price, or the fair value of the collateral if the loan is collateral-dependent. The inputs used to measure the fair value of our mortgage loans are classified as Level 3 within the fair value hierarchy. Policy Loans (included within Other Invested Assets) Fair values for policy loans are estimated from a discounted cash flow analysis, using interest rates currently being offered for loans with similar credit risk. Loans with similar characteristics are aggregated for purposes of the calculations. Affiliated Other Invested Assets (included within Other Invested Assets) The fair value of the affiliated bank loan is estimated using a discounted cash flow method based on the weighted average cost of capital ("WACC"). This yield-based approach is sourced from a third-party vendor and the WACC establishes a market participant discount rate by determining the hypothetical capital structure for the asset should it be underwritten as of each period end. Investment Contracts Investment contracts include deferred annuities, FIAs, indexed universal life policies ("IULs") and immediate annuities. The fair value of deferred annuity, FIA, and IUL contracts is based on their cash surrender value (i.e. the cost the Company would incur to extinguish the liability) as these contracts are generally issued without an annuitization date. The fair value of immediate annuities contracts is derived by calculating a new fair value interest rate using the updated yield curve and treasury spreads as of the respective reporting date. At September 30, 2019 and December 31, 2018 , this resulted in lower fair value reserves relative to the carrying value. The Company is not required to, and has not, estimated the fair value of the liabilities under contracts that involve significant mortality or morbidity risks, as these liabilities fall within the definition of insurance contracts that are exceptions from financial instruments that require disclosures of fair value. Debt and Revolving Credit Facility The fair value of debt is based on quoted market prices. The inputs used to measure the fair value of our outstanding debt are classified as Level 2 within the fair value hierarchy. Our revolving credit facility debt is classified as Level 3 within the fair value hierarchy, and the estimated fair value reflects the carrying value as the revolver has no maturity date. The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the Condensed Consolidated Balance Sheets at amounts other than fair value, summarized according to the fair value hierarchy previously described. September 30, 2019 Level 1 Level 2 Level 3 Total Estimated Fair Value Carrying Amount Assets FHLB common stock $ — $ 63 $ — $ 63 $ 63 Commercial mortgage loans — — 460 460 444 Residential mortgage loans — — 397 397 392 Policy loans, included in other invested assets — — 17 17 26 Affiliated other invested assets — — 28 28 28 Total $ — $ 63 $ 902 $ 965 $ 953 Liabilities Investment contracts, included in contractholder funds — — 19,077 19,077 22,219 Debt — 583 — 583 542 Revolving credit facility — — 16 16 15 Total $ — $ 583 $ 19,093 $ 19,676 $ 22,776 December 31, 2018 Level 1 Level 2 Level 3 Total Estimated Fair Value Carrying Amount Assets FHLB common stock $ — $ 52 $ — $ 52 $ 52 Commercial mortgage loans — — 483 483 482 Residential mortgage loans — — 187 187 185 Policy loans, included in other invested assets — — 11 11 22 Affiliated other invested assets — — 39 39 39 Total $ — $ 52 $ 720 $ 772 $ 780 Liabilities Investment contracts, included in contractholder funds $ — $ — $ 18,358 $ 18,358 $ 20,911 Debt — 520 — 520 541 Total $ — $ 520 $ 18,358 $ 18,878 $ 21,452 The following table includes assets that have not been classified in the fair value hierarchy as the fair value of these investments are measured using the net asset value per share practical expedient. For further discussion about this adoption see “Note 2. Significant Accounting Policies and Practices” to the Company's 2018 Form 10-K. Carrying Value After Measurement September 30, 2019 December 31, 2018 Equity securities $ 69 $ 50 Limited partnership investment, included in other invested assets 917 510 For investments for which NAV is used as a practical expedient for fair value, the Company does not have any significant restrictions in their ability to liquidate their positions in these investments, other than obtaining general partner approval, nor does the Company believe it is probable a price less than NAV would be received in the event of a liquidation. The Company reviews the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3, or between other levels, at the beginning fair value for the reporting period in which the changes occur. The transfers into and out of Level 3 were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value. The Company’s assessment resulted in gross transfers into and gross transfers out of certain fair value levels by asset class for the three and nine months ended September 30, 2019 and 2018 , are as follows: Transfers Between Fair Value Levels Level 1 Level 2 Level 3 In Out In Out In Out Three months ended September 30, 2019 Asset-backed securities $ — $ — $ 125 $ — $ — $ 125 Commercial mortgage-backed securities — — 23 — — 23 Total transfers $ — $ — $ 148 $ — $ — $ 148 Three months ended September 30, 2018 Asset-backed securities $ — $ — $ 90 $ 13 $ 13 $ 90 Commercial mortgage-backed securities — — 12 — — 12 Corporates — — 21 — — 21 Residential mortgage-backed securities — — 36 — — 36 Equity securities — 30 30 — — — Total transfers $ — $ 30 $ 189 $ 13 $ 13 $ 159 Transfers Between Fair Value Levels Level 1 Level 2 Level 3 In Out In Out In Out Nine months ended September 30, 2019 Asset-backed securities $ — $ — $ 231 $ 52 $ 52 $ 231 Commercial mortgage-backed securities — — 37 1 1 37 Corporates — — 1 11 11 1 Residential mortgage-backed securities — — 29 — — 29 Equity securities 7 18 18 7 16 16 Funds withheld for reinsurance receivables — — 8 — — 8 Total transfers $ 7 $ 18 $ 324 $ 71 $ 80 $ 322 Nine months ended September 30, 2018 Asset-backed securities $ — $ — $ 343 $ 13 $ 13 $ 343 Commercial mortgage-backed securities — — 13 8 8 13 Corporates — — 72 3 3 72 Hybrids 20 — — 20 — — Residential mortgage-backed securities — — 36 — — 36 Equity securities 25 30 30 25 — — Total transfers $ 45 $ 30 $ 494 $ 69 $ 24 $ 464

Intangible Assets

Intangible Assets	9 Months Ended
	Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangibles A summary of the changes in the carrying amounts of the Company's VOBA, DAC and DSI intangible assets are as follows: VOBA DAC DSI Total Balance at December 31, 2018 $ 866 $ 344 $ 149 $ 1,359 Deferrals — 274 103 377 Amortization (75 ) (3 ) (3 ) (81 ) Interest 14 9 3 26 Unlocking 3 (1 ) (1 ) 1 Adjustment for net unrealized investment (gains) losses (178 ) (72 ) (35 ) (285 ) Balance at September 30, 2019 $ 630 $ 551 $ 216 $ 1,397 VOBA DAC DSI Total Balance at December 31, 2017 $ 821 $ 22 $ 10 $ 853 Deferrals — 219 98 317 Amortization (75 ) (6 ) (5 ) (86 ) Interest 15 2 1 18 Unlocking (4 ) — — (4 ) Adjustment for net unrealized investment (gains) losses 96 6 5 107 Balance at September 30, 2018 $ 853 $ 243 $ 109 $ 1,205 Amortization of VOBA, DAC, and DSI is based on the historical, current and future expected gross margins or profits recognized, including investment gains and losses. The interest accrual rate utilized to calculate the accretion of interest on VOBA ranged from 0.05% to 4.01% . The adjustment for unrealized net investment losses (gains) represents the amount of VOBA, DAC, and DSI that would have been amortized if such unrealized gains and losses had been recognized. This is referred to as the “shadow adjustments” as the additional amortization is reflected in AOCI rather than the unaudited Condensed Consolidated Statements of Operations. As of September 30, 2019 and 2018 , the VOBA balances included cumulative adjustments for net unrealized investment (gains) losses of $(103) and $78 , respectively, the DAC balances included cumulative adjustments for net unrealized investment (gains) losses of $(68) and $5 , respectively, and the DSI balance included net unrealized investment (gains) losses of $(32) and $5 , respectively. Estimated amortization expense for VOBA in future fiscal periods is as follows: Estimated Amortization Expense Fiscal Year 2019 16 2020 78 2021 87 2022 82 2023 73 Thereafter 397 The Company had an unearned revenue liability balance of $(34) as of September 30, 2019 , including deferrals of $(30) , amortization of $5 , interest of $(1) , unlocking of $(2) and adjustment for net unrealized investment gains (losses) of $35 . The Company had an unearned revenue liability balance of $(26) as of September 30, 2018 , including deferrals of $(28) , amortization of $18 , unlocking of $2 and adjustment for net unrealized investment gains (losses) of $(18) . Definite and Indefinite Lived Intangible Assets Other intangible assets as of September 30, 2019 consist of the following: Cost Accumulated amortization Net carrying amount Weighted average useful life (years) Trade marks / trade names $ 16 $ 3 $ 13 10 State insurance licenses 6 N/A 6 Indefinite Total $ 19

Debt

Debt	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
Debt	Debt The carrying amount of the Company's outstanding debt as of September 30, 2019 and December 31, 2018 is as follows: September 30, 2019 December 31, 2018 Debt $ 542 $ 541 Revolving credit facility 15 — On September 3, 2019, the Company drew $ 15 on the revolving credit facility (the "revolver"). The $ 15 and $ 0 drawn balances on the revolver carried interest rates equal to 4.85% and 5.27% (had we drawn on the revolver) as of September 30, 2019 and December 31, 2018 , respectively. As of September 30, 2019 and December 31, 2018 , the amount available to be drawn on the revolver was $ 235 and $250 , respectively. On October 3, 2019, the Company drew an additional $ 12 on the revolver and on October 17, 2019, the $ 27 drawn on the revolver was repaid in full. The interest expense and amortization of debt issuance costs for the three and nine months ended September 30, 2019 and 2018 , respectively, were as follows: Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Interest Expense Amortization Interest Expense Amortization Interest Expense Amortization Interest Expense Amortization Debt 8 — 7 1 23 1 20 1 Revolving credit facility — — — — — — 2 — Gain on extinguishment of debt — — — — — — (2 ) —

Equity

Equity	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
Equity	Equity Share Repurchases On December 19, 2018, the Company's Board of Directors authorized a share repurchase program of up to $150 of the Company's outstanding common stock. This program will expire on December 15, 2020 , and may be modified at any time. Under the share repurchase program, the Company may repurchase shares from time to time in open market transactions or through privately negotiated transactions in accordance with applicable federal securities laws. Repurchases may also be made pursuant to a trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934. The extent to which the Company repurchases its shares, and the timing of such purchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other considerations, as determined by the Company. During the three and nine months ended September 30, 2019 , the Company repurchased 2,146 thousand shares for a total cost of $17 , and 6,022 thousand shares for a total cost of $48 , respectively. As of September 30, 2019 , the Company had repurchased a total of 6,622 thousand shares for a total cost of $52 . Dividends The Company declared the following cash dividend to its common shareholders during the three and nine months ended September 30, 2019 . Date Declared Date Paid Date Shareholders of record Shareholders of record (in thousands) Cash Dividend declared (per share) Total cash paid February 27, 2019 April 1, 2019 March 18, 2019 221,661 $0.01 $2 May 7, 2019 June 10, 2019 May 28, 2019 221,661 $0.01 $2 August 7, 2019 September 9, 2019 August 26, 2019 221,661 $0.01 $2 On November 6, 2019, the Company's Board of Directors declared a quarterly cash dividend of $0.01 per share. The dividend will be paid on December 9, 2019 to shareholders of record as of the close of business on November 25, 2019. The Company did not declare a cash dividend to its common shareholders during the three or nine months ended September 30, 2018 . The Company declared the following dividends to its preferred shareholders during the three and nine months ended September 30, 2019 : Type of Preferred Share Date Declared Date Paid Date Shareholders of record Shares outstanding at date of record (in thousands) Method of Payment Total cash paid Total shares paid in kind (in thousands) Series A Preferred Shares March 29, 2019 April 1, 2019 March 15, 2019 298 Paid in kind $— 6 Series B Preferred Shares March 29, 2019 April 1, 2019 March 15, 2019 108 Paid in kind $— 2 Series A Preferred Shares June 28, 2019 July 1, 2019 June 15, 2019 304 Paid in kind $— 6 Series B Preferred Shares June 28, 2019 July 1, 2019 June 15, 2019 110 Paid in kind $— 2 Series A Preferred Shares August 7, 2019 September 9, 2019 August 26, 2019 310 Paid in kind $— 6 Series B Preferred Shares August 7, 2019 September 9, 2019 August 26, 2019 112 Paid in kind $— 2 The Company declared the following dividends to its preferred shareholders during the three and nine months ended September 30, 2018 : Type of Preferred Share Date Declared Date Paid Date Shareholders of record Shares outstanding at date of record (in thousands) Method of Payment Total cash paid Total shares paid in kind (in thousands) Series A Preferred Shares March 29, 2018 April 1, 2018 March 15, 2018 277 Paid in kind $— 5 Series B Preferred Shares March 29, 2018 April 1, 2018 March 15, 2018 101 Paid in kind $— 1 Series A Preferred Shares June 29, 2018 July 1, 2018 June 15, 2018 282 Paid in kind $— 5 Series B Preferred Shares June 29, 2018 July 1, 2018 June 15, 2018 102 Paid in kind $— 2 Series A Preferred Shares September 28, 2018 October 1, 2018 September 15, 2018 287 Paid in kind $— 5 Series B Preferred Shares September 28, 2018 October 1, 2018 September 15, 2018 104 Paid in kind $— 2

Stock Compensation

Stock Compensation	9 Months Ended
	Sep. 30, 2019
Share-based Payment Arrangement [Abstract]
Stock Compensation	Stock Compensation On August 8, 2017, the Company adopted a stock-based incentive plan (the “FGL Incentive Plan”) that permits the granting of awards in the form of qualified stock options, non-qualified stock options, restricted stock, restricted stock units, stock appreciation rights, unrestricted stock, performance-based awards, dividend equivalents, cash awards and any combination of the foregoing. The Company’s Compensation Committee is authorized to grant up to 15,006 thousand equity awards under the Incentive Plan. At September 30, 2019 , 5,689 thousand equity awards are available for future issuance. FGL Incentive Plan The Company granted the following options, including vesting conditions, to certain officers during the nine months ended September 30, 2019: Grant Date February 26, 2019 May 20, 2019 August 6, 2019 Total granted 1,699 850 700 Total fair value (at grant date) $ 3 $ 1 $ 1 Vesting mechanism Vest Dates Number of options subject to these vesting conditions Service Each March 15 from 2020 through 2023; subject to continued service 485 242 233 Service and return on equity performance March 15 2020, 2021 and 2022 subject to continued service and targeted return on equity 607 304 233 Service and stock price performance Each March 15 from 2020 through 2023; subject to continued service and target stock price goals being achieved — 304 234 Service and stock price performance Each March 15 from 2019 through 2023; subject to continued service and target stock price goals being achieved 607 — — Additionally, on August 6, 2019, the Company established vesting conditions for certain performance based options issued on December 21, 2018, thus establishing the accounting grant date. The total fair value of these options granted on August 6, 2019 was $3 . The following table summarizes their vesting conditions: Vesting mechanism Vest Dates Number of options subject to these vesting conditions Service and return on equity performance December 2019, 2020, 2021, 2022 and 2023 subject to continued service and targeted return on equity 1,250 Service and stock price performance December 2019, 2020, 2021, 2022 and 2023; subject to continued service and target stock price goals being achieved 1,250 The fair value of the options is expensed over the requisite service period, which generally corresponds to the vesting period. At September 30, 2019 , the intrinsic value of stock options outstanding or expected to vest was $3 . At September 30, 2019 , the weighted average remaining contractual term of stock options outstanding, exercisable and vested or expected to vest was 6 , 6 and 6 , respectively. At September 30, 2019 there were 436 thousand options that were exercisable. A summary of the Company’s outstanding stock options as of September 30, 2019 , and related activity during the nine months ended September 30, 2019 , is as follows (share amount in thousands): Stock Option Awards Options Weighted Average Exercise Price Stock options outstanding at December 31, 2018 13,007 $ 9.68 Granted 5,749 8.92 Exercised — — Forfeited or expired (3,519 ) 10.00 Stock options outstanding at September 30, 2019 15,237 9.31 Exercisable at September 30, 2019 436 10.00 Vested or projected to vest at September 30, 2019 15,237 9.31 To value the options granted with service and return on equity performance vesting conditions, we used a Black Scholes valuation model. To value the options granted with stock price market performance vesting conditions, we used a Monte Carlo simulation. The following inputs and assumptions were used in the determination of the grant date fair values of the grants made in the nine months ended September 30, 2019 . Black-Scholes Model Monte Carlo Model Serviced based ROE Performance based Stock Price Performance based Source of input/ assumption Weighted average fair value per options granted $1.72 $1.63 $0.97 N/A Risk-free interest rate 1.53%-2.48% 1.53%-2.50% 1.62%-2.30% US Treasury Curve Assumed dividend yield 0.46% - 0.56% 0.46% - 0.56% 0.46% - 0.56% Internal projection Expected option term 4.5-5.8 years 4.8-6.0 years N/A Internal model Contractual term N/A N/A 6.0-7.0 years Employee option agreement Volatility 26.00% 26.00% 26.00% Predecessor and peer group experience Early exercise multiple N/A N/A 2.8 Hull White model Cost of equity N/A N/A 9.39% - 10.50% Capital asset pricing model - 20 year risk free rate The Company granted 147 thousand restricted shares to directors in the nine months ended September 30, 2019 . These shares will vest on December 31, 2019. The total fair value of the restricted shares granted in the nine months ended September 30, 2019 was $1 . A summary of the Company’s nonvested restricted shares outstanding as of September 30, 2019 , and related activity during the nine months ended , is as follows (share amount in thousands): Restricted Stock Awards Shares Weighted Average Grant Date Fair Value Restricted shares outstanding at December 31, 2018 — $ — Granted 147 6.82 Vested or expected to vest at September 30, 2019 147 6.82 Management Incentive Plan In the nine months ended September 30, 2019 , the Company granted 541 thousand phantom units to members of management under a management incentive plan (the "Management Incentive Plan"). The total fair value of the restricted shares granted in the nine months ended September 30, 2019 was $5 . One half of the phantom units vest in three equal installments on each March 15 th from 2020 to 2022, subject to awardees continued service with the Company. The other half will begin vesting on March 15, 2021 and cliff vest on March 15, 2022 based on continued service and attainment of a performance metric: adjusted operating income return on equity. At September 30, 2019 , the liability for phantom units of $1 was based on the number of units granted, the elapsed portion of the service period and the fair value of the Company’s common stock on that date which was $7.98 . A summary of the Management Incentive Plan nonvested phantom units outstanding as of September 30, 2019 , and related activity during the nine months ended , is as follows (share amount in thousands): Phantom units Shares Weighted Average Grant Date Fair Value Phantom units outstanding at December 31, 2018 356 $ 8.95 Granted 541 8.54 Vested (59 ) 10.00 Forfeited or expired (87 ) 9.37 Phantom units outstanding at September 30, 2019 751 9.02 The Company recognized total stock compensation expense related to the FGL Incentive Plan and Management Incentive Plan is as follows: Three months ended Nine months ended September 30, 2019 September 30, 2019 FGL Incentive Plan Stock options $ — $ 2 Restricted shares 1 1 1 3 Management Incentive Plan Phantom units — 1 — 1 Total stock compensation expense 1 4 Related tax benefit — 1 Net stock compensation expense $ 1 $ 3 The stock compensation expense is included in "Acquisition and operating expenses, net of deferrals" in the unaudited Condensed Consolidated Statements of Operations. Total compensation expense related to the FGL Incentive Plan and Management Incentive Plan not yet recognized as of September 30, 2019 and the weighted-average period over which this expense will be recognized are as follows: Unrecognized Compensation Weighted Average Recognition FGL Incentive Plan Stock options $ 18 3 Restricted shares — 0 18 Management Incentive Plan Phantom units 3 2 3 Total unrecognized stock compensation expense $ 21 3

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2019
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company is a Cayman-domiciled corporation that has operations in Bermuda and the U.S. Neither the Cayman Islands nor Bermuda impose a corporate income tax. The Company’s U.S. non-life subsidiaries file a consolidated non-life U.S. Federal income tax return. The Company’s U.S. life insurance subsidiaries file a separate life consolidated U.S. Federal income tax return. The life insurance companies will be eligible to join in a consolidated filing with the U.S. non-life companies in 2022. The provision for income taxes represents federal income taxes. The effective tax rate for the three and nine months ended September 30, 2019 was (16)% and 4% , respectively. The effective tax rate for the three and nine months ended September 30, 2018 was 21% and 29% , respectively. The effective tax rate on pre-tax income for the nine months ended September 30, 2019 differs from the U.S Federal statutory rate for 2019 of 21% primarily due to three factors. First, in 2018, a partial valuation allowance was established against the U.S. Life companies' unrealized loss deferred tax assets because there were not sufficient sources of income to recover those assets. During the first quarter of 2019, the unrealized loss position recovered enough that the valuation allowance was no longer needed and it was released. Secondly, the Company had substantial income in jurisdictions that do not impose an income tax. Thirdly, a valuation allowance release was recorded for FSRC for all of its deferred tax assets, with the exception of its capital deferred tax assets, as of September 30, 2019 based on positive evidence including: cumulative three year income, future projected earnings, and management’s ability to implement a future tax planning strategy if needed. The effective tax rate on pre-tax income for the three months ended September 30, 2019 differs from the U.S. Federal statutory rate for 2019 of 21% primarily due to income incurred in jurisdictions that do not impose an income tax, and the valuation allowance release for FSRC on all of its deferred tax assets with the exception of its capital deferred tax assets. The effective tax rate on pre-tax income for the nine months ended September 30, 2018 differed from the U.S. Federal statutory rate for 2018 of 21% primarily due to the impact of an intended tax election. During the first quarter of 2018, there was uncertainty surrounding the impact of the Base-Erosion and Anti-Abuse Tax ("BEAT") that was enacted as part of the Tax Cut and Jobs Act and how it would impact the reinsurance agreement between F&G Life Re and FGL Insurance. As a result of the uncertainty, F&G Life Re intended to make an election under IRC Code Section 953(d) for the 2018 tax year to be treated as if it were a U.S. taxpayer for the year. As such, an opening balance sheet deferred tax liability was set up resulting in a discrete expense being recorded in the first quarter of 2018 that increased the first quarter effective rate. Based on clarifying guidance, the Company ultimately decided not to make that election in the fourth quarter of 2018. As of September 30, 2019 , the Company had a partial valuation allowance of $11 against its deferred tax assets of $103 . The valuation allowance is an offset to the non-life companies deferred tax assets and FSRC capital deferred tax assets. The non-life insurance company subsidiaries have a history of losses and insufficient sources of future income that would allow for recognition of any of their deferred tax assets. FSRC does not have a source of capital earnings to recognize against its capital deferred tax assets. The valuation allowance is reviewed quarterly and will be maintained until there is sufficient positive evidence to support a release. At each reporting date, management considers new evidence, both positive and negative, that could impact the future realization of deferred tax assets. Management will consider a release of the valuation allowance once there is sufficient positive evidence that it is more likely than not that the deferred tax assets will be realized. Any release of the valuation allowance will be recorded as a tax benefit increasing net income or other comprehensive income. All other deferred tax assets are more likely than not to be realized based on expectations as to our future taxable income and considering all other available evidence, both positive and negative.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Commitments The Company has unfunded investment commitments as of September 30, 2019 based upon the timing of when investments are executed compared to when the actual investments are funded, as some investments require that funding occur over a period of months or years. A summary of unfunded commitments by invested asset class are included below: September 30, 2019 Asset Type Other invested assets $ 1,073 Equity securities 7 Fixed maturity securities, available-for-sale 17 Other assets 46 Bank loans 5 Residential mortgage loans 8 Total $ 1,156 As of September 30, 2019 , the Company had unfunded commitments in affiliated investments which are included in the table above. See "Note 14. Related Party Transactions" for further information. Lease Commitments The Company leases office space under non-cancelable operating leases that expire in May 2021. Rent expense and minimum rental commitments under non-cancelable leases are immaterial. Contingencies Regulatory and Litigation Matters The Company is involved in various pending or threatened legal proceedings, including purported class actions, arising in the ordinary course of business. In some instances, these proceedings include claims for unspecified or substantial punitive damages and similar types of relief in addition to amounts for alleged contractual liability or requests for equitable relief. In the opinion of the Company's management and in light of existing insurance and other potential indemnification, reinsurance and established accruals, such litigation is not expected to have a material adverse effect on the Company's financial position, although it is possible that the results of operations and cash flows could be materially affected by an unfavorable outcome in any one period. The Company is assessed amounts by state guaranty funds to cover losses to policyholders of insolvent or rehabilitated insurance companies. Those mandatory assessments may be partially recovered through a reduction in future premium taxes in certain states. At September 30, 2019 , the Company has accrued $ 2 for guaranty fund assessments that is expected to be offset by estimated future premium tax deductions of $ 2 . The Company has received inquiries from a number of state regulatory authorities regarding our use of the U.S. Social Security Administration’s Death Master File (“Death Master File”) and compliance with state claims practices regulations and unclaimed property or escheatment laws. We have established procedures to periodically compare our in-force life insurance and annuity policies against the Death Master File or similar databases; investigate any identified potential matches to confirm the death of the insured; and determine whether benefits are due and attempt to locate the beneficiaries of any benefits due or, if no beneficiary can be located, escheat the benefit to the state as unclaimed property. We believe we have established sufficient reserves with respect to these matters; however, it is possible that third parties could dispute these amounts and additional payments or additional unreported claims or liabilities could be identified which could be significant and could have a material adverse effect on our results of operations. On June 30, 2017, a putative class action complaint was filed against FGL Insurance, FGL, and FS Holdco II Ltd in the United States District Court for the District of Maryland, captioned Brokerage Insurance Partners v. Fidelity & Guaranty Life Insurance Company, Fidelity & Guaranty Life, FS Holdco II Ltd, and John Doe, No. 17-cv-1815. The complaint alleges that FGL Insurance breached the terms of its agency agreement with Brokerage Insurance Partners (“BIP”) and other agents by changing certain compensation terms. The complaint asserts, among other causes of action, breach of contract, defamation, tortious interference with contract, negligent misrepresentation, and violation of the Racketeer Influenced and Corrupt Organizations Act (“RICO”). The complaint seeks to certify a class composed of all persons who entered into an agreement with FGL Insurance to sell life insurance and who sold at least one life insurance policy between January 1, 2015 and January 1, 2017. The complaint seeks unspecified compensatory, consequential, and punitive damages in an amount not presently determinable, among other forms of relief. On September 1, 2017, FGL Insurance filed a counterclaim against BIP and John and Jane Does 1-10, asserting, among other causes of action, breach of contract, fraud, civil conspiracy and violations of RICO. On September 22, 2017, Plaintiff filed an Amended Complaint, and on October 16, 2017, FGL Insurance filed an Amended Counterclaim against BIP, Agent Does 1-10, and Other Person Does 1-10. The parties also filed cross-Motions to Dismiss in Part. On August 17, 2018, the Court in the BIP Litigation denied all pending Motions to Dismiss filed by all parties without prejudice, pending a decision as to whether the BIP Litigation will be consolidated into related litigation, captioned Fidelity & Guaranty Life Insurance Company v. Network Partners, et al., Case No. 17-cv-1508. On August 31, 2018, FGL Insurance filed its Answer to BIP’s Amended Complaint. Also on that date, FGL Insurance filed its Answer to Amended Complaint, Affirmative Defenses, and Counterclaim, Filed Pursuant to Fed. R. Civ. P. 12(a)(4)(A). On October 15, 2019, BIP filed with the Court an Unopposed Motion for Preliminary Approval of Settlement and Class Certification, along with a copy of the Class Action Settlement Agreement signed by all parties. Final settlement is subject to, among other requirements, both preliminary and final approval by the Court after Court-approved Notice has been provided to the absent members of the putative class.

Reinsurance

Reinsurance	9 Months Ended
	Sep. 30, 2019
Reinsurance Disclosures [Abstract]
Reinsurance	Reinsurance The Company reinsures portions of its policy risks with other insurance companies. The use of indemnity reinsurance does not discharge an insurer from liability on the insurance ceded. The insurer is required to pay in full the amount of its insurance liability regardless of whether it is entitled to or able to receive payment from the reinsurer. The portion of risks exceeding the Company's retention limit is reinsured. The Company primarily seeks reinsurance coverage in order to limit its exposure to mortality losses and enhance capital management. The Company follows reinsurance accounting when there is adequate risk transfer. Otherwise, the deposit method of accounting is followed. The Company also assumes policy risks from other insurance companies. The effect of reinsurance on net premiums earned and net benefits incurred (benefits incurred and reserve changes) for the three and nine months ended September 30, 2019 and 2018 were as follows: Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Direct 50 336 54 336 158 1,067 172 653 Assumed — 42 — 12 — 23 — (14 ) Ceded (41 ) (47 ) (42 ) (51 ) (125 ) (152 ) (127 ) (164 ) Net 9 331 12 297 33 938 45 475 Amounts payable or recoverable for reinsurance on paid and unpaid claims are not subject to periodic or maximum limits. The Company did not write off any significant reinsurance balances during the nine months ended September 30, 2019 and 2018 . The Company did not commute any ceded reinsurance treaties during the nine months ended September 30, 2019 or 2018 . No policies issued by the Company have been reinsured with any foreign company, which is controlled, either directly or indirectly, by a party not primarily engaged in the business of insurance. The Company has not entered into any reinsurance agreements in which the reinsurer may unilaterally cancel any reinsurance for reasons other than non-payment of premiums or other similar credit issues. Effective January 1, 2017, FGL Insurance entered into an indemnity reinsurance agreement with Hannover Re, a third party reinsurer, to reinsure an inforce block of its FIA and fixed deferred annuity contracts with GMWB and Guaranteed Minimum Death Benefit (“GMDB”) guarantees. In accordance with the terms of this agreement, FGL Insurance cedes a quota share percentage of the net retention of guarantee payments in excess of account value for GMWB and GMDB guarantees. The effects of this agreement are not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP, since it is not “reasonably possible” that the reinsurer may realize significant loss from assuming the insurance risk. Effective July 1, 2017, FGL Insurance extended this agreement to include new business issued during 2017. Effective January 1, 2018 FGL Insurance extended this agreement to include new business issued during 2018, and extended the recapture period from 8 to 12 years. Effective January 1, 2019, FGL Insurance extended this agreement to include new business issued during 2019. FGL Insurance incurred risk charge fees of $4 and $12 during the three and nine months ended September 30, 2019 , in relation to this reinsurance agreement. Effective December 31, 2018, FGL Insurance entered into a reinsurance agreement with Kubera to cede approximately $758 of certain MYGA and deferred annuity GAAP reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. In accordance with the terms of this agreement, FGL Insurance cedes a quota share percentage of MYGA and deferred annuity policies for certain issue years to Kubera. Effective June 30, 2019, FGL Insurance and Kubera executed a letter of intent to amend this agreement and cede an additional $185 of MYGA GAAP reserves on a coinsurance funds withheld basis via a quota share percentage of certain issue years. The amended reinsurance agreement was executed on July 31, 2019. Effective December 31, 2018, FGL Insurance entered into a reinsurance agreement with Kubera to cede approximately $4 billion of certain FIA statutory reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. In accordance with the terms of this agreement, FGL Insurance cedes a quota share percentage of FIA policies for certain issue years to Kubera. The effects of this agreement are not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP, since it is not “reasonably possible” that the reinsurer may realize significant loss from assuming the insurance risk. Effective June 30, 2019, FGL Insurance and Kubera executed a letter of intent to amend this agreement and cede an additional $1 billion of FIA statutory reserves on a coinsurance funds withheld basis via a quota share percentage of certain issue years. The amended reinsurance agreement was executed on July 31, 2019. The effects of the amendment are also not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP. F&G Reinsurance Companies FSRC has entered into various reinsurance agreements on a funds withheld basis, meaning that funds are withheld by the ceding company from the coinsurance premium owed to FSRC as collateral for FSRC's payment obligations. Accordingly, the collateral assets remain under the ultimate ownership of the ceding company. FSRC manages the assets supporting the reserves assumed in accordance with the internal investment policy of the ceding companies and applicable law. At September 30, 2019 , FSRC had $308 of funds withheld receivables and $282 of insurance reserves related to these reinsurance treaties. F&G Re has entered into multiple reinsurance agreements on a funds withheld basis with unaffiliated parties. At September 30, 2019 , F&G Re had $1,737 of funds withheld receivables and $1,605 of insurance reserves related to these reinsurance treaties. Effective April 1, 2019, F&G Re entered into a reinsurance agreement with an unaffiliated company to reinsure an inforce block of fixed deferred annuity contracts on a 100% coinsurance funds withheld basis. In accordance with the terms of this agreement, F&G Re established a fair value of funds withheld asset and future policy benefits liability of $ 983 and $ 896 , respectively. See a description of FSRC’s and F&G Re's accounting policy for its assumed reinsurance contracts in "Note 2. Significant Accounting Policies and Practices" within the Company's 2018 Form 10-K.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2019
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions Affiliated Investments The Company, and certain subsidiaries of the Company, entered into investment management agreements with Blackstone ISG-I Advisors LLC ("BISGA"), a wholly-owned subsidiary of The Blackstone Group LP ("Blackstone") on December 1, 2017. Pursuant to the terms of the investment management agreements, BISGA may delegate certain of its investment management services to sub-managers and any fees or other remuneration payable to such sub-managers is payable by the Company out of the assets managed by such sub-managers. BISGA has delegated certain investment management services to its affiliates, Blackstone Real Estate Special Situations Advisors L.L.C. (“BRESSA”) and GSO Capital Advisors II LLC (“GSO Capital Advisors II”), pursuant to sub-management agreements executed between BISGA and each of BRESSA and GSO Capital Advisors. As of September 30, 2019 and December 31, 2018 , the Company has a net liability of $30 and $20 , respectively, for the services consumed under the investment management agreements and related sub-management agreements, partially offset by fees received and expense reimbursements from BISGA. During the three and nine months ended September 30, 2019 and 2018 , the Company received expense reimbursements from BISGA for the services consumed under these agreements. Fees received for these types of services are $2 and $7 for the three and nine months ended September 30, 2019 , respectively, and $2 and $7 for the three and nine months ended September 30, 2018 , respectively. The Company holds certain fixed income security interests, limited partnerships and bank loans issued by portfolio companies that are affiliates of Blackstone Tactical Opportunities, an affiliate of Blackstone Tactical Opportunities LR Associates-B (Cayman) Ltd (the “Blackstone Fixed Income Securities”) both on a direct and indirect basis. Indirect investments include an investment made in an affiliates’ asset backed fund while direct investments are an investment in affiliates' equity or debt securities. As of September 30, 2019 and December 31, 2018 , the Company held $1,932 and $1,461 in affiliated investments, respectively, which includes foreign exchange unrealized loss of $ (6) and $ (2) , respectively. As of September 30, 2019 and December 31, 2018 , the Company had unfunded commitments relating to affiliated investments of $927 and $990 , respectively. The Company purchased $37 and $185 of residential loans from Finance of America Holdings LLC, a Blackstone affiliate, during the nine months ended September 30, 2019 and on December 17, 2018, respectively. On December 1, 2017, the Company executed an agreement with Blackstone Tactical Opportunities Advisors LLC ("BTO Advisors") and Fidelity National Financial, Inc. ("FNF"), to provide the Company transactional and operational services and advice through December 31, 2018. The agreement was amended on November 2, 2018 and August 23, 2019 to provide services through June 30, 2020. As of September 30, 2019 , the Company has a liability of $ 4 for services and advice provided under this agreement. The Company paid-in-kind dividends on preferred shares held by GSO Capital Partners, an indirect wholly owned subsidiary of The Blackstone Group LP, of 6 thousand shares and 18 thousand shares for the three and nine months ended September 30, 2019 , respectively. The Company paid-in-kind dividends on preferred shares held by GSO Capital Partners of 5 thousand shares and 15 thousand shares for the three and nine months ended September 30, 2018 , respectively. The Company had no gross realized gains or realized impairment losses on related party investments during the three and nine months ended September 30, 2019 and 2018

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2019
Earnings Per Share [Abstract]
Earnings Per Share	Earnings Per Share The following table sets forth the computation of basic and diluted earnings per share (share amounts in thousands): Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Net income (loss) $ 65 $ 56 $ 282 $ 161 Less Preferred stock dividend 7 7 23 21 Net income (loss) available to common shares 58 49 259 140 Weighted-average common shares outstanding - basic 216,442 214,370 217,746 214,370 Dilutive effect of unvested restricted stock 99 49 69 21 Weighted-average shares outstanding - diluted 216,541 214,419 217,815 214,391 Net income (loss) per common share: Basic $ 0.26 $ 0.23 $ 1.19 $ 0.65 Diluted $ 0.26 $ 0.23 $ 1.19 $ 0.65 The number of shares of common stock outstanding used in calculating the weighted average thereof reflects the actual number of FGL Holdings shares of common stock outstanding, excluding unvested restricted stock and shares held in treasury. The calculation of diluted earnings per share for the three and nine months ended September 30, 2019 excludes the incremental effect of 6 million weighted average common stock warrants outstanding due to their anti-dilutive effect. This calculation also excludes the potential dilutive effect of the 422 thousand preferred stock shares outstanding as of September 30, 2019 as the contingency that would allow for the preferred shares to be converted to common shares has not yet been met. The calculation of diluted earnings per share for the three and nine months ended September 30, 2019 excludes the incremental effect related to certain outstanding stock options due to their anti-dilutive effect. The number of weighted average equivalent shares excluded is 1,591 thousand and 1,569 thousand shares for the three and nine months ended September 30, 2019 . The calculation of diluted earnings per share for the three and nine months ended September 30, 2018 excludes the potential dilutive effective of the 70 million weighted average common stock warrants outstanding due to their anti-dilutive effect. This calculation also excludes the potential dilutive effect of the 391 thousand preferred stock shares outstanding as of September 30, 2018 as the contingency that would allow for the preferred shares to be converted to common shares has not yet been met. The calculation of diluted earnings per share for the three and nine months ended September 30, 2018 excludes the incremental effect related to certain outstanding stock options due to their anti-dilutive effect. The number of weighted average equivalent shares excluded is 1,384 thousand and 609 thousand shares for the three and nine months ended September 30, 2018

Insurance Subsidiary Financial

Insurance Subsidiary Financial Information and Regulatory Matters	9 Months Ended
	Sep. 30, 2019
Insurance [Abstract]
Insurance Subsidiary Financial Information and Regulatory Matters	Insurance Subsidiary Financial Information and Regulatory Matters The Company’s U.S. insurance subsidiaries file financial statements with state insurance regulatory authorities and the National Association of Insurance Commissioners (“NAIC”) that are prepared in accordance with Statutory Accounting Principles (“SAP”) prescribed or permitted by such authorities, which may vary materially from GAAP. Prescribed SAP includes the Accounting Practices and Procedures Manual of the NAIC as well as state laws, regulations and administrative rules. Permitted SAP encompasses all accounting practices not so prescribed. The principal differences between SAP financial statements and financial statements prepared in accordance with GAAP are that SAP financial statements do not reflect DAC, DSI and VOBA, some bond portfolios may be carried at amortized cost, assets and liabilities are presented net of reinsurance, contractholder liabilities are generally valued using more conservative assumptions and certain assets are non-admitted. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items. FSRC (Cayman), F&G Re (Bermuda), and F&G Life Re (Bermuda) file financial statements with their respective regulators that are based on U.S. GAAP. Effective April 1, 2019, Raven Re and FGL Insurance executed the third amended and restated Reinsurance Agreement (the "CARVM treaty"). The amendment allowed Raven Re to declare and pay a one-time dividend of up to $30 to FGL Insurance provided that the dividend was paid on or before June 30, 2020 and subject to other provisions outlined in the amendment. The Vermont Department of Financial Regulation approved the amendment on April 15, 2019. Pursuant to the provisions of the amended CARVM treaty, Raven Re paid a $20 dividend to FGL Insurance in June 2019. FGL Insurance applies Iowa-prescribed accounting practices that permit Iowa-domiciled insurers to report equity call options used to economically hedge FIA index credits at amortized cost for statutory accounting purposes and to calculate FIA statutory reserves such that index credit returns will be included in the reserve only after crediting to the annuity contract. This resulted in a $ 95 decrease and $30 increase to statutory capital and surplus at September 30, 2019 and December 31, 2018 , respectively. FGL Insurance’s statutory carrying value of Raven Re reflects the effect of permitted practices Raven Re received to treat the available amount of a letter of credit as an admitted asset which increased Raven Re’s statutory capital and surplus by $ 100 and $110 at September 30, 2019 and December 31, 2018 , respectively. Raven Re is also permitted to follow Iowa prescribed statutory accounting practice for its reserves on reinsurance assumed from FGL Insurance which increased Raven Re’s statutory capital and surplus by $ 3 and $0 at September 30, 2019 and December 31, 2018 , respectively. Without such permitted statutory accounting practices Raven Re’s statutory capital and surplus (deficit) would be $ (19) and $(16) as of September 30, 2019 and December 31, 2018 , respectively, and its risk-based capital would fall below the minimum regulatory requirements. The letter of credit facility is collateralized by NAIC 1 rated debt securities. If the permitted practice was revoked, the letter of credit could be replaced by the collateral assets with Nomura’s consent. FGL Insurance’s statutory carrying value of Raven Re at September 30, 2019 and December 31, 2018 was $ 84 and $94 , respectively. As of September 30, 2019 , FGL NY Insurance did not follow any prescribed or permitted statutory accounting practices that differ from the NAIC's statutory accounting practices.

Significant Accounting Polici_2

Significant Accounting Policies and Practices (Policies)	9 Months Ended
	Sep. 30, 2019
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and all other entities in which the Company has a controlling financial interest and any variable interest entities ("VIEs") in which we are the primary beneficiary. All intercompany accounts and transactions have been eliminated in consolidation.
VIE	We are involved in certain entities that are considered VIEs as defined under GAAP. Our involvement with VIEs is primarily to invest in assets that allow us to gain exposure to a broadly diversified portfolio of asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support or where investors lack certain characteristics of a controlling financial interest. We assess our relationships to determine if we have the ability to direct the activities, or otherwise exert control, to evaluate if we are the primary beneficiary of the VIE. If we determine we are the primary beneficiary of a VIE, we consolidate the assets and liabilities of the VIE in our unaudited condensed consolidated financial statements . The Company has determined that we are not the primary beneficiary of any VIEs as of September 30, 2019 . See "Note 4. Investments" to the Company’s unaudited condensed consolidated financial statements for additional information on the Company’s investments in unconsolidated VIEs.
Significant Accounting Policies and Practices	Adoption of New Accounting Pronouncements Premium Amortization on Purchased Callable Debt Securities In March 2017, the FASB issued new guidance on the amortization of callable securities (ASU 2017-08, Receivables-Nonrefundable Fees and Other Costs (Subtopic 310-20), Premium Amortization on Purchased Callable Debt Securities) , effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The ASU requires premiums paid on purchased debt securities with an explicit call option to be amortized to the earliest call date, as opposed to the maturity date. The updated guidance is applicable to instruments that are callable based on explicit, non-contingent call features that are callable at fixed prices on preset dates. The amendments in this update were to be applied using the modified retrospective method through a cumulative effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company adopted this new accounting guidance effective January 1, 2019, as required, and it had an immaterial impact on its unaudited condensed consolidated financial statements. Amendments to Lease Accounting In February 2016, the FASB issued amended guidance (ASU 2016-02, Leases (Topic 842) ), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Notable amendments in this update: • require entities to recognize the rights and obligations resulting from all leases or lease components of contracts, including operating leases, as lease assets and lease liabilities, with an exception allowed for leases with a term of 12 months or less • create a distinction between finance leases and operating leases, with classification criteria substantially similar to that for distinguishing between capital leases and operating leases under previous guidance • not retain the accounting model for leveraged leases under previous guidance for leases that commence after the effective date of ASU 2016-02 • provide additional guidance on separating the lease components from the nonlease components of a contract • require qualitative disclosures along with specific quantitative disclosures to provide information regarding the amount, timing, and uncertainty of cash flows arising from leases • include modifications to align lessor accounting with the changes to lessee accounting, as well as changes to the requirements of recognizing a transaction as a sale and leaseback transaction, however, these changes will have no impact on the Company's current lease arrangements The amendments were required to be applied at the beginning of the earliest period presented using a modified retrospective approach (including several optional practical expedients related to leases commenced before the effective date). The Company adopted this standard effective January 1, 2019, as required, and it had an immaterial impact on its unaudited condensed consolidated financial statements. Future Accounting Pronouncements Accounting pronouncements that will impact the Company in future periods have been disclosed in the Company’s 2018 Form 10-K. There have not been any additional accounting pronouncements issued during the quarter ended September 30, 2019 that are expected to impact the Company. The following two pronouncements were discussed in the Company's 2018 Form 10-K but have been included below so as to provide an update on the Company’s status of adoption. New Credit Loss Standard In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments , effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Since its release, certain targeted improvements and transition relief amendments have been made to ASU 2016-13 and have been published in ASU 2018-19, ASU 2019-04 and ASU 2019-05. Collectively, these ASUs will change the accounting for impairment of most financial assets and certain other instruments in the following ways: • financial assets (or a group of financial assets) measured at amortized cost will be required to be presented at the net amount expected to be collected, with an allowance for credit losses deducted from the amortized cost basis, resulting in a net carrying value that reflects the amount the entity expects to collect on the financial asset • credit losses relating to AFS fixed maturity securities will be recorded through an allowance for credit losses, rather than reductions in the amortized cost of the securities. The allowance methodology recognizes that value may be realized either through collection of contractual cash flows or through the sale of the security. Therefore, the amount of the allowance for credit losses will be limited to the amount by which fair value is below amortized cost because the classification as available for sale is premised on an investment strategy that recognizes that the investment could be sold at fair value, if cash collection would result in the realization of an amount less than fair value • the income statement will reflect the measurement of expected credit losses for newly recognized financial assets as well as the expected increases or decreases (including the reversal of previously recognized losses) of expected credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount • disclosures will be required to include information around how the credit loss allowance was developed, further details on information currently disclosed about credit quality of financing receivables and net investments in leases, and a rollforward of the allowance for credit losses for AFS fixed maturity securities as well as an aging analysis for securities that are past due The amendments in this ASU may be early adopted during any interim or annual period beginning after December 15, 2018, however the Company has elected not to early adopt. The Company has identified the material asset classes (e.g. available for sale securities, mortgage loans, reinsurance receivables, other miscellaneous receivables) affected by the new guidance and is in the process of assessing the impact that the adoption of this standard will have on our financial statements for all asset classes except mortgage loans where we expect the impact will be immaterial. We expect the adoption of this guidance to significantly impact the operation of our existing processes around assessing the aforementioned asset classes for impairment. Long-Duration Contracts In August 2018, the FASB issued ASU 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts , effective for fiscal years beginning after December 15, 2020 including interim periods within those fiscal years. Under this update: • assumptions used to measure cash flows for traditional and limited-payment contracts must be reviewed at least annually with the effect of changes in those assumptions being recognized in the statement of operations • the discount rate applied to measure the liability for future policy benefits and limited-payment contracts must be updated at each reporting date with the effect of changes in the rate being recognized in other comprehensive income • market risk benefits associated with deposit contracts must be measured at fair value, with the effect of the change in the fair value attributable to a change in the instrument-specific credit risk being recognized in other comprehensive income • deferred acquisition costs are required to be amortized in proportion to premiums, gross profits, or gross margins and those balances must be amortized on a constant level basis over the expected term of the related contracts • deferred acquisition costs must be written off for unexpected contract terminations • disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, market risk benefits, separate account liabilities and deferred acquisition costs, as well as information about significant inputs, judgments, assumptions, and methods used in measurement are required to be disclosed The amendments in this ASU may be early adopted as of the beginning of an annual reporting period for which financial statements have not yet been issued, including interim financial statements. The Company does not currently expect to early adopt this standard. The Company has identified specific areas that will be impacted by the new guidance and is in the process of assessing the accounting, reporting and/or process changes that will be required to comply as well as the impact of the new guidance on its consolidated financial statements.

Investments (Tables)

Investments (Tables)	9 Months Ended
	Sep. 30, 2019
Investments, Debt and Equity Securities [Abstract]
Consolidated Investments	The Company's equity securities investments are carried at fair value with unrealized gains and losses included in net income. The Company’s consolidated investments at September 30, 2019 and December 31, 2018 are summarized as follows: September 30, 2019 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Carrying Value Available-for-sale securities Asset-backed securities $ 5,433 $ 56 $ (94 ) $ 5,395 $ 5,395 Commercial mortgage-backed securities 2,857 185 (2 ) 3,040 3,040 Corporates 11,338 627 (90 ) 11,875 11,875 Hybrids 1,035 39 (7 ) 1,067 1,067 Municipals 1,245 93 (4 ) 1,334 1,334 Residential mortgage-backed securities 964 42 (3 ) 1,003 1,003 U.S. Government 37 1 — 38 38 Foreign Governments 138 17 — 155 155 Total available-for-sale securities 23,047 1,060 (200 ) 23,907 23,907 Equity securities 1,104 15 (22 ) 1,097 1,097 Derivative investments 327 163 (36 ) 454 454 Commercial mortgage loans 444 — — 460 444 Residential mortgage loans 392 — — 397 392 Other invested assets 1,083 — (5 ) 1,068 1,078 Total investments $ 26,397 $ 1,238 $ (263 ) $ 27,383 $ 27,372 December 31, 2018 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Carrying Value Available-for-sale securities Asset-backed securities $ 4,954 $ 15 $ (137 ) $ 4,832 $ 4,832 Commercial mortgage-backed securities 2,568 9 (40 ) 2,537 2,537 Corporates 11,213 16 (848 ) 10,381 10,381 Hybrids 992 — (91 ) 901 901 Municipals 1,216 3 (32 ) 1,187 1,187 Residential mortgage-backed securities 1,027 12 (8 ) 1,031 1,031 U.S. Government 120 — (1 ) 119 119 Foreign Governments 129 — (8 ) 121 121 Total available-for-sale securities 22,219 55 (1,165 ) 21,109 21,109 Equity securities 1,526 1 (145 ) 1,382 1,382 Derivative investments 330 2 (235 ) 97 97 Commercial mortgage loans 482 — — 483 482 Residential mortgage loans 185 — — 187 185 Other invested assets 662 — — 651 662 Total investments $ 25,404 $ 58 $ (1,545 ) $ 23,909 $ 23,917
Investments Classified by Contractual Maturity Date [Table Text Block]	The amortized cost and fair value of fixed maturity available-for-sale securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations. September 30, 2019 Amortized Cost Fair Value Corporates, Non-structured Hybrids, Municipal and Government securities: Due in one year or less $ 112 $ 112 Due after one year through five years 864 869 Due after five years through ten years 2,007 2,053 Due after ten years 10,810 11,435 Subtotal 13,793 14,469 Other securities which provide for periodic payments: Asset-backed securities 5,433 5,395 Commercial mortgage-backed securities 2,857 3,040 Residential mortgage-backed securities 964 1,003 Subtotal 9,254 9,438 Total fixed maturity available-for-sale securities $ 23,047 $ 23,907
Fair Value and Gross Unrealized Losses of Available-for-Sale-Securities	The fair value and gross unrealized losses of available-for-sale securities, aggregated by investment category and duration of fair value below amortized cost, were as follows: September 30, 2019 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale securities Asset-backed securities $ 1,843 $ (52 ) $ 1,347 $ (42 ) $ 3,190 $ (94 ) Commercial mortgage-backed securities 143 (2 ) — — 143 (2 ) Corporates 755 (17 ) 1,177 (73 ) 1,932 (90 ) Hybrids 80 (3 ) 104 (4 ) 184 (7 ) Municipals 1 — 77 (4 ) 78 (4 ) Residential mortgage-backed securities 36 (1 ) 116 (2 ) 152 (3 ) U.S. Government 8 — 2 — 10 — Total available-for-sale securities $ 2,866 $ (75 ) $ 2,823 $ (125 ) $ 5,689 $ (200 ) Total number of available-for-sale securities in an unrealized loss position less than twelve months 382 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 395 Total number of available-for-sale securities in an unrealized loss position 777 December 31, 2018 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Available-for-sale securities Asset-backed securities $ 2,924 $ (116 ) $ 643 $ (21 ) $ 3,567 $ (137 ) Commercial mortgage-backed securities 1,466 (34 ) 262 (6 ) 1,728 (40 ) Corporates 8,016 (772 ) 1,465 (76 ) 9,481 (848 ) Hybrids 858 (90 ) 7 (1 ) 865 (91 ) Municipals 850 (27 ) 172 (5 ) 1,022 (32 ) Residential mortgage-backed securities 139 (3 ) 190 (5 ) 329 (8 ) U.S. Government 69 — 50 (1 ) 119 (1 ) Foreign Government 47 (3 ) 68 (5 ) 115 (8 ) Total available-for-sale securities $ 14,369 $ (1,045 ) $ 2,857 $ (120 ) $ 17,226 $ (1,165 ) Total number of available-for-sale securities in an unrealized loss position less than twelve months 1,551 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 556 Total number of available-for-sale securities in an unrealized loss position 2,107
Reconciliation of Other-than-Temporary Impairment on Fixed Maturity	Details of OTTI that were recognized in "Net income (loss)" and included in net realized gains on securities were as follows: Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Corporates $ (1 ) $ — $ (6 ) $ (2 ) Equity security (1 ) — (1 ) — Total $ (2 ) $ — $ (7 ) $ (2 ) The following table provides a reconciliation of the beginning and ending balances of the credit loss portion of OTTI on fixed maturity available-for-sale securities held by the Company for the three and nine months ended September 30, 2019 and 2018 , for which a portion of the OTTI was recognized in AOCI: Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Beginning balance $ — $ — $ — $ — Increases attributable to credit losses on securities: OTTI was previously recognized — — — — OTTI was not previously recognized — — — — Ending balance $ — $ — $ — $ — The following table breaks out the credit impairment loss type, the associated amortized cost and fair value of the investments at the balance sheet date and non-credit losses in relation to fixed maturity securities and other invested assets held by the Company for the three and nine months ended September 30, 2019 and 2018 : Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Credit impairment losses in operations $ (2 ) $ — $ (7 ) $ (2 ) Change-of-intent losses in operations — — — — Amortized cost 4 — 4 — Fair value 3 — 4 — Non-credit losses in other comprehensive income for investments which experienced OTTI — — — —
Schedule of Accounts, Notes, Loans and Financing Receivable	The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables: September 30, 2019 December 31, 2018 Gross Carrying Value % of Total Gross Carrying Value % of Total Property Type: Hotel $ 21 5 % $ 21 4 % Industrial - General 37 8 % 37 8 % Industrial - Warehouse 20 4 % 20 4 % Multifamily 54 12 % 56 12 % Office 144 33 % 147 30 % Retail 168 38 % 201 42 % Total commercial mortgage loans, gross of valuation allowance $ 444 100 % $ 482 100 % Allowance for loan loss — — Total commercial mortgage loans $ 444 $ 482 U.S. Region: East North Central $ 84 19 % $ 98 20 % East South Central 19 4 % 19 4 % Middle Atlantic 77 17 % 79 17 % Mountain 51 11 % 65 13 % New England 5 1 % 10 2 % Pacific 114 26 % 116 24 % South Atlantic 56 13 % 57 12 % West North Central 13 3 % 13 3 % West South Central 25 6 % 25 5 % Total commercial mortgage loans, gross of valuation allowance $ 444 100 % $ 482 100 % Allowance for loan loss — — Total commercial mortgage loans $ 444 $ 482
Schedule of Investment in Mortgage Loans by Loan to Value and Debt Service Coverage Ratios	The following table presents the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios at September 30, 2019 and December 31, 2018 : Debt-Service Coverage Ratios Total Amount % of Total Estimated Fair Value % of Total >1.25 1.00 - 1.25 September 30, 2019 LTV Ratios: Less than 50% $ 287 $ 6 $ 293 66 % $ 304 66 % 50% to 60% 140 — 140 32 % 145 32 % 60% to 75% 11 — 11 2 % 11 2 % Commercial mortgage loans $ 438 $ 6 $ 444 100 % $ 460 100 % December 31, 2018 LTV Ratios: Less than 50% $ 296 $ 6 $ 302 63 % $ 302 63 % 50% to 60% 169 — 169 35 % 170 35 % 60% to 75% 11 — 11 2 % 11 2 % Commercial mortgage loans $ 476 $ 6 $ 482 100 % $ 483 100 %

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]	The carrying amounts of derivative instruments, including derivative instruments embedded in FIA contracts, is as follows: September 30, 2019 December 31, 2018 Assets: Derivative investments: Call options $ 454 $ 97 Futures contracts — — Other invested assets: Other derivatives and embedded derivatives 19 14 $ 473 $ 111 Liabilities: Contractholder funds: FIA embedded derivative $ 3,136 $ 2,476 Other liabilities: Preferred shares reimbursement feature embedded derivative 14 29 $ 3,150 $ 2,505
FGL's Exposure to Credit Loss on Call Options Held	Information regarding the Company’s exposure to credit loss on the call options it holds is presented in the following table: September 30, 2019 Counterparty Credit Rating (Fitch/Moody's/S&P) (a) Notional Fair Value Collateral Net Credit Risk Merrill Lynch A+/*/A+ $ 2,815 $ 70 $ 24 $ 46 Deutsche Bank BBB/A3/BBB+ 804 12 11 1 Morgan Stanley */A1/A+ 1,772 39 36 3 Barclay's Bank A+/A2/A 3,381 165 154 11 Canadian Imperial Bank of Commerce */Aa2/A+ 2,557 81 53 28 Wells Fargo A+/A2/A- 2,075 66 65 1 Goldman Sachs A/A3/BBB+ 1,079 21 19 2 Total $ 14,483 $ 454 $ 362 $ 92 December 31, 2018 Counterparty Credit Rating Notional Fair Value Collateral Net Credit Risk Merrill Lynch A+/*/A+ $ 3,952 $ 25 $ — $ 25 Deutsche Bank A-/A3/BBB+ 1,327 5 6 (1 ) Morgan Stanley */A1/A+ 1,648 9 6 3 Barclay's Bank A+/A2/A 2,205 27 20 7 Canadian Imperial Bank of Commerce */Aa2/A+ 1,716 11 8 3 Wells Fargo A+/A2/A- 1,635 17 16 1 Goldman Sachs A/A3/BBB+ 647 3 3 — Total $ 13,130 $ 97 $ 59 $ 38 (a) An * represents credit ratings that were not available.
Derivative Instruments, Gain (Loss) [Table Text Block]	The change in fair value of derivative instruments included in the accompanying unaudited Condensed Consolidated Statements of Operations is as follows: Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Net investment gains (losses): Call options $ 43 $ 153 $ 261 $ 86 Futures contracts 3 8 17 8 Foreign currency forward 3 1 5 1 Other derivatives and embedded derivatives — — 4 — Reinsurance related embedded derivatives 16 (3 ) 58 (37 ) Total net investment gains (losses) $ 65 $ 159 $ 345 $ 58 Benefits and other changes in policy reserves: FIA embedded derivatives $ 202 $ 231 $ 660 $ 274 Acquisition and operating expenses, net of deferrals: Preferred shares reimbursement feature embedded derivative $ (10 ) $ (2 ) $ (15 ) $ (1 )

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2019
Fair Value Disclosures [Abstract]
Assets and Liabilities Carrying at Fair Value on Recurring Basis	The carrying amounts and estimated fair values of the Company’s financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, with the exception of investment contracts, related party loans, portions of other invested assets and debt which are disclosed later within this footnote, was summarized according to the hierarchy previously described, as follows: September 30, 2019 Level 1 Level 2 Level 3 Fair Value Carrying Amount Assets Cash and cash equivalents $ 990 $ — $ — $ 990 $ 990 Fixed maturity securities, available-for-sale: Asset-backed securities — 4,803 592 5,395 5,395 Commercial mortgage-backed securities — 3,014 26 3,040 3,040 Corporates — 10,446 1,429 11,875 11,875 Hybrids 301 756 10 1,067 1,067 Municipals — 1,292 42 1,334 1,334 Residential mortgage-backed securities — 434 569 1,003 1,003 U.S. Government 30 8 — 38 38 Foreign Governments — 137 18 155 155 Equity securities 429 597 2 1,028 1,028 Derivative investments — 454 — 454 454 Other invested assets — — 44 44 44 Funds withheld for reinsurance receivables, at fair value 447 1,584 14 2,045 2,045 Total financial assets at fair value $ 2,197 $ 23,525 $ 2,746 $ 28,468 $ 28,468 Liabilities Fair value of future policy benefits — — 1,887 1,887 1,887 Derivatives: FIA embedded derivatives, included in contractholder funds — — 3,136 3,136 3,136 Preferred shares reimbursement feature embedded derivative — — 14 14 14 Total financial liabilities at fair value $ — $ — $ 5,037 $ 5,037 $ 5,037 December 31, 2018 Level 1 Level 2 Level 3 Fair Value Carrying Amount Assets Cash and cash equivalents $ 571 $ — $ — $ 571 $ 571 Fixed maturity securities, available-for-sale: Asset-backed securities — 4,388 444 4,832 4,832 Commercial mortgage-backed securities — 2,470 67 2,537 2,537 Corporates — 9,150 1,231 10,381 10,381 Hybrids 265 626 10 901 901 Municipals — 1,150 37 1,187 1,187 Residential mortgage-backed securities — 417 614 1,031 1,031 U.S. Government 114 5 — 119 119 Foreign Governments — 105 16 121 121 Equity securities 454 874 4 1,332 1,332 Derivative investments — 97 — 97 97 Other invested assets — — 39 39 39 Funds withheld for reinsurance receivables, at fair value 177 576 4 757 757 Total financial assets at fair value $ 1,581 $ 19,858 $ 2,466 $ 23,905 $ 23,905 Liabilities Fair value of future policy benefits — — 725 725 725 Derivatives: FIA embedded derivatives, included in contractholder funds — — 2,476 2,476 2,476 Preferred shares reimbursement feature embedded derivative — — 29 29 29 Total financial liabilities at fair value $ — $ — $ 3,230 $ 3,230 $ 3,230 The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the Condensed Consolidated Balance Sheets at amounts other than fair value, summarized according to the fair value hierarchy previously described. September 30, 2019 Level 1 Level 2 Level 3 Total Estimated Fair Value Carrying Amount Assets FHLB common stock $ — $ 63 $ — $ 63 $ 63 Commercial mortgage loans — — 460 460 444 Residential mortgage loans — — 397 397 392 Policy loans, included in other invested assets — — 17 17 26 Affiliated other invested assets — — 28 28 28 Total $ — $ 63 $ 902 $ 965 $ 953 Liabilities Investment contracts, included in contractholder funds — — 19,077 19,077 22,219 Debt — 583 — 583 542 Revolving credit facility — — 16 16 15 Total $ — $ 583 $ 19,093 $ 19,676 $ 22,776 December 31, 2018 Level 1 Level 2 Level 3 Total Estimated Fair Value Carrying Amount Assets FHLB common stock $ — $ 52 $ — $ 52 $ 52 Commercial mortgage loans — — 483 483 482 Residential mortgage loans — — 187 187 185 Policy loans, included in other invested assets — — 11 11 22 Affiliated other invested assets — — 39 39 39 Total $ — $ 52 $ 720 $ 772 $ 780 Liabilities Investment contracts, included in contractholder funds $ — $ — $ 18,358 $ 18,358 $ 20,911 Debt — 520 — 520 541 Total $ — $ 520 $ 18,358 $ 18,878 $ 21,452
Schedule of Unobservable Inputs Used for Level Three Fair Value Measurements of Financial Instruments on Recurring Basis	Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of September 30, 2019 and December 31, 2018 , are as follows: Fair Value at Valuation Technique Unobservable Input(s) Range (Weighted average) September 30, 2019 September 30, 2019 Assets Asset-backed securities $ 566 Broker-quoted Offered quotes 98.65% - 109.06% Asset-backed securities 26 Third-Party Valuation Offered quotes 0.00% - 99.39% Commercial mortgage-backed securities 26 Broker-quoted Offered quotes 100.20% - 126.34% Corporates 1,429 Broker-quoted Offered quotes 83.06% - 122.30% Hybrids 10 Broker-quoted Offered quotes 103.64% - 103.64% Municipals 42 Broker-quoted Offered quotes 128.04% - 128.04% Residential mortgage-backed securities 569 Broker-quoted Offered quotes 15.53% - 106.40% Foreign governments 18 Broker-quoted Offered quotes 108.75% - 115.74% Equity securities (Salus preferred equity) 2 Income-Approach Yield 3.01% Other Invested Assets: Available-for-sale embedded derivative (AnchorPath) 19 Black Scholes model Market value of AnchorPath fund 100.00% Credit Linked Note 25 Broker-quoted Offered quotes 100.00% Funds withheld for reinsurance receivables at fair value 14 Broker-quoted Offered quotes 103.22% Total financial assets at fair value $ 2,746 Liabilities Future policy benefits 1,887 Discounted cash flow Market value of option 0.00% - 7.56% (1.76%) Mortality multiplier 80.00% - 120.00% (94.83%) Surrender rates 0.00% - 55.00% (21.11%) Partial withdrawals 0.00% - 4.00% (2.27%) Non-performance spread 0.00% - 0.10% (0.07%) Option cost 0.00% - 4.58% (1.13%) Risk margin to reflect uncertainty 0.24% - 0.62% (0.30%) Morbidity risk margin 0.00% - 2.00% (0.07%) Derivatives: FIA embedded derivatives included in contractholder funds 3,136 Discounted cash flow Market value of option 0.00% - 28.63% SWAP rates 1.50% - 1.56% Mortality multiplier 80.00% - 80.00% Surrender rates 0.50% - 75.00% Partial withdrawals 1.00% - 2.50% Non-performance spread 0.25% - 0.25% Option cost 0.18% - 16.61% Preferred shares reimbursement feature embedded derivative 14 Black Derman Toy model Credit Spread 3.31% Yield Volatility 20.00% Total financial liabilities at fair value $ 5,037 Fair Value at Valuation Technique Unobservable Input(s) Range (Weighted average) December 31, 2018 December 31, 2018 Assets Asset-backed securities $ 405 Broker-quoted Offered quotes 97.00% - 102.00% (99.77%) Asset-backed securities 24 Matrix Pricing Quoted prices 96.07% - 96.07% (96.07%) Asset-backed securities 15 Third-Party Valuation Offered quotes 0.00% - 99.29% (23.05%) Commercial mortgage-backed securities 43 Broker-quoted Offered quotes 77.12% - 100.08% (85.46%) Commercial mortgage-backed securities 24 Matrix Pricing Quoted prices 117.72% - 117.72% (117.72%) Corporates 577 Broker-quoted Offered quotes 74.63% - 104.62% (97.80%) Corporates 654 Matrix Pricing Quoted prices 91.74% - 113.25% (98.86%) Hybrids 10 Matrix Pricing Quoted prices 96.60% - 96.60% (96.60%) Municipals 37 Broker-quoted Offered quotes 111.23% - 111.23% (111.23%) Residential mortgage-backed securities 614 Broker-quoted Offered quotes 89.80% - 100.99% (100.73%) Foreign governments 16 Broker-quoted Offered quotes 98.38% - 99.01% (98.58%) Equity securities (Salus preferred equity) 4 Income-Approach Yield 7.15% Other Invested Assets: Available-for-sale embedded derivative (AnchorPath) 14 Black Scholes model Market value of AnchorPath fund 100.00% Credit Linked Note 25 Broker-quoted Offered quotes 100.00% Funds withheld for reinsurance receivables, at fair value 4 Matrix pricing Calculated prices 100.00% Total financial assets at fair value $ 2,466 Liabilities Future policy benefits 725 Discounted cash flow Non-Performance risk spread 0.00% - 0.22% (0.18%) Risk margin to reflect uncertainty 0.35% - 0.71% (0.68%) Derivatives: FIA embedded derivatives included in contractholder funds 2,476 Discounted cash flow Market value of option 0.00% - 31.06% (0.94%) SWAP rates 2.57% - 2.71% (2.63%) Mortality multiplier 80.00% - 80.00% (80.00%) Surrender rates 0.50% - 75.00% (5.90%) Partial withdrawals 1.00% - 2.50% (2.00%) Non-performance spread 0.25% - 0.25% (0.25%) Option cost 0.11% - 16.61% (2.18%) Preferred shares reimbursement feature embedded derivative 29 Black Derman Toy model Credit Spread 5.14% Yield Volatility 20.00% Total financial liabilities at fair value $ 3,230
Changes in Fair Value of Financial Instruments - Assets	The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the three and nine months ended September 30, 2019 and 2018 , respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Three months ended September 30, 2019 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 736 $ — $ 3 $ 14 $ — $ (36 ) $ (125 ) $ 592 Commercial mortgage-backed securities 50 — — — — (1 ) (23 ) 26 Corporates 1,319 — 17 107 — (14 ) — 1,429 Hybrids 10 — — — — — — 10 Municipals 39 — 3 — — — — 42 Residential mortgage-backed securities 588 — (2 ) 6 — (23 ) — 569 Foreign Governments 17 — 1 — — — — 18 Equity securities 3 (1 ) — — — — — 2 Other invested assets: Available-for-sale embedded derivative 18 1 — — — — — 19 Credit linked note 25 — — — — — — 25 Funds withheld for reinsurance receivables, at fair value — — — 14 — — — 14 Total assets at Level 3 fair value $ 2,805 $ — $ 22 $ 141 $ — $ (74 ) $ (148 ) $ 2,746 Liabilities Future policy benefits $ 1,787 $ 54 $ 1 $ — $ — $ 45 $ — $ 1,887 FIA embedded derivatives, included in contractholder funds 2,934 202 — — — — — 3,136 Preferred shares reimbursement feature embedded derivative 24 (10 ) 14 Total liabilities at Level 3 fair value $ 4,745 $ 246 $ 1 $ — $ — $ 45 $ — $ 5,037 (a) The net transfers out of Level 3 during the three months ended September 30, 2019 were exclusively to Level 2. Three months ended September 30, 2018 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 330 $ — $ — $ 162 $ — $ (11 ) $ (77 ) $ 404 Commercial mortgage-backed securities 60 — (1 ) — — — (12 ) 47 Corporates 1,190 — (9 ) 53 — (5 ) (21 ) 1,208 Hybrids 10 — (1 ) — — — — 9 Municipals 37 — (1 ) — — — — 36 Residential mortgage-backed securities 242 — (2 ) 375 (1 ) (3 ) (36 ) 575 Foreign Governments 16 — — — — — — 16 Equity securities 3 1 — — — — — 4 Other invested assets: Available-for-sale embedded derivative 17 — — — — — — 17 Affiliated Bank Loans 50 — — — (11 ) — — 39 Funds withheld for reinsurance receivables, at fair value 6 — — — — (4 ) — 2 Total assets at Level 3 fair value $ 1,961 $ 1 $ (14 ) $ 590 $ (12 ) $ (23 ) $ (146 ) $ 2,357 Liabilities Future policy benefits (FSRC) $ 737 $ (26 ) $ 1 $ — $ — $ (28 ) $ — $ 684 FIA embedded derivatives, included in contractholder funds 2,320 231 — — — — — 2,551 Preferred shares reimbursements feature embedded derivative 24 (2 ) — — — — — 22 Total liabilities at Level 3 fair value $ 3,081 $ 203 $ 1 $ — $ — $ (28 ) $ — $ 3,257 (a) The net transfers out of Level 3 during the three months ended September 30, 2018 were exclusively to Level 2. Nine months ended September 30, 2019 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 444 $ — $ 16 $ 390 $ — $ (79 ) $ (179 ) $ 592 Commercial mortgage-backed securities 67 — 4 1 — (10 ) (36 ) 26 Corporates 1,231 (1 ) 67 221 (25 ) (74 ) 10 1,429 Hybrids 10 — — — — — — 10 Municipals 37 — 5 — — — — 42 Residential mortgage-backed securities 614 — 28 19 — (63 ) (29 ) 569 Foreign Governments 16 — 2 — — — — 18 Equity securities 4 (1 ) (1 ) — — — — 2 Other invested assets: Available-for-sale embedded derivative 14 5 — — — — — 19 Credit linked note 25 — — — — — — 25 Funds withheld for reinsurance receivables, at fair value 4 — — 19 (1 ) — (8 ) 14 Total assets at Level 3 fair value $ 2,466 $ 3 $ 121 $ 650 $ (26 ) $ (226 ) $ (242 ) $ 2,746 Liabilities Future policy benefits $ 725 $ 143 $ 9 $ — $ — $ 1,010 $ — $ 1,887 FIA embedded derivatives, included in contractholder funds 2,476 660 — — — — — 3,136 Preferred shares reimbursement feature embedded derivative 29 (15 ) — — — — — 14 Total liabilities at Level 3 fair value $ 3,230 $ 788 $ 9 $ — $ — $ 1,010 $ — $ 5,037 ( a) The net transfers out of Level 3 during the nine months ended September 30, 2019 were exclusively to Level 2. Nine months ended September 30, 2018 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 412 $ — $ (2 ) $ 342 $ — $ (18 ) $ (330 ) $ 404 Commercial mortgage-backed securities 49 — (3 ) 12 — (6 ) (5 ) 47 Corporates 1,169 — (36 ) 252 — (108 ) (69 ) 1,208 Hybrids 10 — (1 ) — — — — 9 Municipals 38 — (2 ) — — — — 36 Residential mortgage-backed securities 66 — — 554 (1 ) (8 ) (36 ) 575 Foreign Governments 17 — (1 ) — — — — 16 Equity securities 3 2 (1 ) — — — — 4 Other invested assets: Available-for-sale embedded derivative 17 — — — — — — 17 Affiliated bank loans — — — 50 (11 ) — — 39 Funds withheld for reinsurance receivables, at fair value 4 — — 2 — (4 ) — 2 Total assets at Level 3 fair value $ 1,785 $ 2 $ (46 ) $ 1,212 $ (12 ) $ (144 ) $ (440 ) $ 2,357 Liabilities Future policy benefits (FSRC) $ 728 $ (43 ) $ (1 ) $ — $ — $ — $ — $ 684 FIA embedded derivatives, included in contractholder funds 2,277 274 — — — — — 2,551 Preferred shares reimbursement feature embedded derivative 23 (1 ) — — — — — 22 Total liabilities at Level 3 fair value $ 3,028 $ 230 $ (1 ) $ — $ — $ — $ — $ 3,257 ( a) The net transfers out of Level 3 during the nine months ended September 30, 2018 were exclusively to Level 2.
Changes in Fair Value of Financial Instruments - Liabilities	The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the three and nine months ended September 30, 2019 and 2018 , respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Three months ended September 30, 2019 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 736 $ — $ 3 $ 14 $ — $ (36 ) $ (125 ) $ 592 Commercial mortgage-backed securities 50 — — — — (1 ) (23 ) 26 Corporates 1,319 — 17 107 — (14 ) — 1,429 Hybrids 10 — — — — — — 10 Municipals 39 — 3 — — — — 42 Residential mortgage-backed securities 588 — (2 ) 6 — (23 ) — 569 Foreign Governments 17 — 1 — — — — 18 Equity securities 3 (1 ) — — — — — 2 Other invested assets: Available-for-sale embedded derivative 18 1 — — — — — 19 Credit linked note 25 — — — — — — 25 Funds withheld for reinsurance receivables, at fair value — — — 14 — — — 14 Total assets at Level 3 fair value $ 2,805 $ — $ 22 $ 141 $ — $ (74 ) $ (148 ) $ 2,746 Liabilities Future policy benefits $ 1,787 $ 54 $ 1 $ — $ — $ 45 $ — $ 1,887 FIA embedded derivatives, included in contractholder funds 2,934 202 — — — — — 3,136 Preferred shares reimbursement feature embedded derivative 24 (10 ) 14 Total liabilities at Level 3 fair value $ 4,745 $ 246 $ 1 $ — $ — $ 45 $ — $ 5,037 (a) The net transfers out of Level 3 during the three months ended September 30, 2019 were exclusively to Level 2. Three months ended September 30, 2018 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 330 $ — $ — $ 162 $ — $ (11 ) $ (77 ) $ 404 Commercial mortgage-backed securities 60 — (1 ) — — — (12 ) 47 Corporates 1,190 — (9 ) 53 — (5 ) (21 ) 1,208 Hybrids 10 — (1 ) — — — — 9 Municipals 37 — (1 ) — — — — 36 Residential mortgage-backed securities 242 — (2 ) 375 (1 ) (3 ) (36 ) 575 Foreign Governments 16 — — — — — — 16 Equity securities 3 1 — — — — — 4 Other invested assets: Available-for-sale embedded derivative 17 — — — — — — 17 Affiliated Bank Loans 50 — — — (11 ) — — 39 Funds withheld for reinsurance receivables, at fair value 6 — — — — (4 ) — 2 Total assets at Level 3 fair value $ 1,961 $ 1 $ (14 ) $ 590 $ (12 ) $ (23 ) $ (146 ) $ 2,357 Liabilities Future policy benefits (FSRC) $ 737 $ (26 ) $ 1 $ — $ — $ (28 ) $ — $ 684 FIA embedded derivatives, included in contractholder funds 2,320 231 — — — — — 2,551 Preferred shares reimbursements feature embedded derivative 24 (2 ) — — — — — 22 Total liabilities at Level 3 fair value $ 3,081 $ 203 $ 1 $ — $ — $ (28 ) $ — $ 3,257 (a) The net transfers out of Level 3 during the three months ended September 30, 2018 were exclusively to Level 2. Nine months ended September 30, 2019 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 444 $ — $ 16 $ 390 $ — $ (79 ) $ (179 ) $ 592 Commercial mortgage-backed securities 67 — 4 1 — (10 ) (36 ) 26 Corporates 1,231 (1 ) 67 221 (25 ) (74 ) 10 1,429 Hybrids 10 — — — — — — 10 Municipals 37 — 5 — — — — 42 Residential mortgage-backed securities 614 — 28 19 — (63 ) (29 ) 569 Foreign Governments 16 — 2 — — — — 18 Equity securities 4 (1 ) (1 ) — — — — 2 Other invested assets: Available-for-sale embedded derivative 14 5 — — — — — 19 Credit linked note 25 — — — — — — 25 Funds withheld for reinsurance receivables, at fair value 4 — — 19 (1 ) — (8 ) 14 Total assets at Level 3 fair value $ 2,466 $ 3 $ 121 $ 650 $ (26 ) $ (226 ) $ (242 ) $ 2,746 Liabilities Future policy benefits $ 725 $ 143 $ 9 $ — $ — $ 1,010 $ — $ 1,887 FIA embedded derivatives, included in contractholder funds 2,476 660 — — — — — 3,136 Preferred shares reimbursement feature embedded derivative 29 (15 ) — — — — — 14 Total liabilities at Level 3 fair value $ 3,230 $ 788 $ 9 $ — $ — $ 1,010 $ — $ 5,037 ( a) The net transfers out of Level 3 during the nine months ended September 30, 2019 were exclusively to Level 2. Nine months ended September 30, 2018 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Included in Included in Assets Fixed maturity securities available-for-sale: Asset-backed securities $ 412 $ — $ (2 ) $ 342 $ — $ (18 ) $ (330 ) $ 404 Commercial mortgage-backed securities 49 — (3 ) 12 — (6 ) (5 ) 47 Corporates 1,169 — (36 ) 252 — (108 ) (69 ) 1,208 Hybrids 10 — (1 ) — — — — 9 Municipals 38 — (2 ) — — — — 36 Residential mortgage-backed securities 66 — — 554 (1 ) (8 ) (36 ) 575 Foreign Governments 17 — (1 ) — — — — 16 Equity securities 3 2 (1 ) — — — — 4 Other invested assets: Available-for-sale embedded derivative 17 — — — — — — 17 Affiliated bank loans — — — 50 (11 ) — — 39 Funds withheld for reinsurance receivables, at fair value 4 — — 2 — (4 ) — 2 Total assets at Level 3 fair value $ 1,785 $ 2 $ (46 ) $ 1,212 $ (12 ) $ (144 ) $ (440 ) $ 2,357 Liabilities Future policy benefits (FSRC) $ 728 $ (43 ) $ (1 ) $ — $ — $ — $ — $ 684 FIA embedded derivatives, included in contractholder funds 2,277 274 — — — — — 2,551 Preferred shares reimbursement feature embedded derivative 23 (1 ) — — — — — 22 Total liabilities at Level 3 fair value $ 3,028 $ 230 $ (1 ) $ — $ — $ — $ — $ 3,257 ( a) The net transfers out of Level 3 during the nine months ended September 30, 2018 were exclusively to Level 2.
Schedule of Net Asset Value	The following table includes assets that have not been classified in the fair value hierarchy as the fair value of these investments are measured using the net asset value per share practical expedient. For further discussion about this adoption see “Note 2. Significant Accounting Policies and Practices” to the Company's 2018 Form 10-K. Carrying Value After Measurement September 30, 2019 December 31, 2018 Equity securities $ 69 $ 50 Limited partnership investment, included in other invested assets 917 510
Gross Transfers Into and Out of Certain Fair Value Levels by Asset Class	The Company’s assessment resulted in gross transfers into and gross transfers out of certain fair value levels by asset class for the three and nine months ended September 30, 2019 and 2018 , are as follows: Transfers Between Fair Value Levels Level 1 Level 2 Level 3 In Out In Out In Out Three months ended September 30, 2019 Asset-backed securities $ — $ — $ 125 $ — $ — $ 125 Commercial mortgage-backed securities — — 23 — — 23 Total transfers $ — $ — $ 148 $ — $ — $ 148 Three months ended September 30, 2018 Asset-backed securities $ — $ — $ 90 $ 13 $ 13 $ 90 Commercial mortgage-backed securities — — 12 — — 12 Corporates — — 21 — — 21 Residential mortgage-backed securities — — 36 — — 36 Equity securities — 30 30 — — — Total transfers $ — $ 30 $ 189 $ 13 $ 13 $ 159 Transfers Between Fair Value Levels Level 1 Level 2 Level 3 In Out In Out In Out Nine months ended September 30, 2019 Asset-backed securities $ — $ — $ 231 $ 52 $ 52 $ 231 Commercial mortgage-backed securities — — 37 1 1 37 Corporates — — 1 11 11 1 Residential mortgage-backed securities — — 29 — — 29 Equity securities 7 18 18 7 16 16 Funds withheld for reinsurance receivables — — 8 — — 8 Total transfers $ 7 $ 18 $ 324 $ 71 $ 80 $ 322 Nine months ended September 30, 2018 Asset-backed securities $ — $ — $ 343 $ 13 $ 13 $ 343 Commercial mortgage-backed securities — — 13 8 8 13 Corporates — — 72 3 3 72 Hybrids 20 — — 20 — — Residential mortgage-backed securities — — 36 — — 36 Equity securities 25 30 30 25 — — Total transfers $ 45 $ 30 $ 494 $ 69 $ 24 $ 464

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]
Information Regarding Intangible Assets, VOBA and DAC	A summary of the changes in the carrying amounts of the Company's VOBA, DAC and DSI intangible assets are as follows: VOBA DAC DSI Total Balance at December 31, 2018 $ 866 $ 344 $ 149 $ 1,359 Deferrals — 274 103 377 Amortization (75 ) (3 ) (3 ) (81 ) Interest 14 9 3 26 Unlocking 3 (1 ) (1 ) 1 Adjustment for net unrealized investment (gains) losses (178 ) (72 ) (35 ) (285 ) Balance at September 30, 2019 $ 630 $ 551 $ 216 $ 1,397 VOBA DAC DSI Total Balance at December 31, 2017 $ 821 $ 22 $ 10 $ 853 Deferrals — 219 98 317 Amortization (75 ) (6 ) (5 ) (86 ) Interest 15 2 1 18 Unlocking (4 ) — — (4 ) Adjustment for net unrealized investment (gains) losses 96 6 5 107 Balance at September 30, 2018 $ 853 $ 243 $ 109 $ 1,205 Amortization of VOBA, DAC, and DSI is based on the historical, current and future expected gross margins or profits recognized, including investment gains and losses. The interest accrual rate utilized to calculate the accretion of interest on VOBA ranged from 0.05% to 4.01% . The adjustment for unrealized net investment losses (gains) represents the amount of VOBA, DAC, and DSI that would have been amortized if such unrealized gains and losses had been recognized. This is referred to as the “shadow adjustments” as the additional amortization is reflected in AOCI rather than the unaudited Condensed Consolidated Statements of Operations. As of September 30, 2019 and 2018 , the VOBA balances included cumulative adjustments for net unrealized investment (gains) losses of $(103) and $78 , respectively, the DAC balances included cumulative adjustments for net unrealized investment (gains) losses of $(68) and $5 , respectively, and the DSI balance included net unrealized investment (gains) losses of $(32) and $5 , respectively.
Estimated Amortization Expense for VOBA in Future Fiscal Periods	Estimated amortization expense for VOBA in future fiscal periods is as follows: Estimated Amortization Expense Fiscal Year 2019 16 2020 78 2021 87 2022 82 2023 73 Thereafter 397

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2019
Debt Disclosure [Abstract]
Schedule of Debt	The interest expense and amortization of debt issuance costs for the three and nine months ended September 30, 2019 and 2018 , respectively, were as follows: Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Interest Expense Amortization Interest Expense Amortization Interest Expense Amortization Interest Expense Amortization Debt 8 — 7 1 23 1 20 1 Revolving credit facility — — — — — — 2 — Gain on extinguishment of debt — — — — — — (2 ) —

Equity (Tables)

Equity (Tables)	9 Months Ended
	Sep. 30, 2019
Equity [Abstract]
Dividends Declared	The Company declared the following cash dividend to its common shareholders during the three and nine months ended September 30, 2019 . Date Declared Date Paid Date Shareholders of record Shareholders of record (in thousands) Cash Dividend declared (per share) Total cash paid February 27, 2019 April 1, 2019 March 18, 2019 221,661 $0.01 $2 May 7, 2019 June 10, 2019 May 28, 2019 221,661 $0.01 $2 August 7, 2019 September 9, 2019 August 26, 2019 221,661 $0.01 $2 On November 6, 2019, the Company's Board of Directors declared a quarterly cash dividend of $0.01 per share. The dividend will be paid on December 9, 2019 to shareholders of record as of the close of business on November 25, 2019. The Company did not declare a cash dividend to its common shareholders during the three or nine months ended September 30, 2018 . The Company declared the following dividends to its preferred shareholders during the three and nine months ended September 30, 2019 : Type of Preferred Share Date Declared Date Paid Date Shareholders of record Shares outstanding at date of record (in thousands) Method of Payment Total cash paid Total shares paid in kind (in thousands) Series A Preferred Shares March 29, 2019 April 1, 2019 March 15, 2019 298 Paid in kind $— 6 Series B Preferred Shares March 29, 2019 April 1, 2019 March 15, 2019 108 Paid in kind $— 2 Series A Preferred Shares June 28, 2019 July 1, 2019 June 15, 2019 304 Paid in kind $— 6 Series B Preferred Shares June 28, 2019 July 1, 2019 June 15, 2019 110 Paid in kind $— 2 Series A Preferred Shares August 7, 2019 September 9, 2019 August 26, 2019 310 Paid in kind $— 6 Series B Preferred Shares August 7, 2019 September 9, 2019 August 26, 2019 112 Paid in kind $— 2

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
Summary of Unfunded Commitments	summary of unfunded commitments by invested asset class are included below: September 30, 2019 Asset Type Other invested assets $ 1,073 Equity securities 7 Fixed maturity securities, available-for-sale 17 Other assets 46 Bank loans 5 Residential mortgage loans 8 Total $ 1,156 As of September 30, 2019 , the Company had unfunded commitments in affiliated investments which are included in the table above. See "Note 14. Related Party Transactions" for further information.

Reinsurance (Tables)

Reinsurance (Tables)	9 Months Ended
	Sep. 30, 2019
Reinsurance Disclosures [Abstract]
Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes	The effect of reinsurance on net premiums earned and net benefits incurred (benefits incurred and reserve changes) for the three and nine months ended September 30, 2019 and 2018 were as follows: Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Direct 50 336 54 336 158 1,067 172 653 Assumed — 42 — 12 — 23 — (14 ) Ceded (41 ) (47 ) (42 ) (51 ) (125 ) (152 ) (127 ) (164 ) Net 9 331 12 297 33 938 45 475

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2019
Earnings Per Share [Abstract]
Summary of Basic and Diluted EPS	The following table sets forth the computation of basic and diluted earnings per share (share amounts in thousands): Three months ended Nine months ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Net income (loss) $ 65 $ 56 $ 282 $ 161 Less Preferred stock dividend 7 7 23 21 Net income (loss) available to common shares 58 49 259 140 Weighted-average common shares outstanding - basic 216,442 214,370 217,746 214,370 Dilutive effect of unvested restricted stock 99 49 69 21 Weighted-average shares outstanding - diluted 216,541 214,419 217,815 214,391 Net income (loss) per common share: Basic $ 0.26 $ 0.23 $ 1.19 $ 0.65 Diluted $ 0.26 $ 0.23 $ 1.19 $ 0.65

Basis of Presentation and Nat_2

Basis of Presentation and Nature of Business - Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Goodwill	$ 467	$ 467

Significant Accounting Polici_3

Significant Accounting Policies and Practices (Details)	9 Months Ended
	Sep. 30, 2019
Condensed Balance Sheet Statements, Captions [Line Items]
Document Period End Date	Sep. 30, 2019

Significant Risks and Uncerta_2

Significant Risks and Uncertainties - Narrative (Details) $ in Millions	Sep. 30, 2019USD ($)issuer	Dec. 31, 2018USD ($)issuer
Concentration Risk [Line Items]
Exposure of FGL's invested assets	10.00%	7.00%
Fair Value In Investments		$ 1,634
Number of issuers in investment | issuer	0	16
Wilton Reassurance Company
Concentration Risk [Line Items]
Net amount recoverable	$ 1,519
Kubera Reassurance Company [Member]
Concentration Risk [Line Items]
Net amount recoverable	852
Scottish Re [Member]
Concentration Risk [Line Items]
Net amount recoverable	47
Pavonia Life Insurance Company [Member]
Concentration Risk [Line Items]
Net amount recoverable	85
All Financial Instruments
Concentration Risk [Line Items]
FGL's investment securities in the banking industry	$ 2,419	$ 2,491
Exposure of FGL's invested assets	9.00%	10.00%
Single Issuer
Concentration Risk [Line Items]
FGL's investment securities in the banking industry	$ 138	$ 115
Exposure of FGL's invested assets	1.00%	1.00%
Banking Industry | All Financial Instruments
Concentration Risk [Line Items]
Investment securities held by subsidiaries subject to specialized industry accounting principles, amortized cost	$ 2,352	$ 2,691
Top Ten Holdings [Member]
Concentration Risk [Line Items]
Exposure of FGL's invested assets	37.00%
Number of issuers in investment | issuer	103
Minimum
Concentration Risk [Line Items]
Exposure of FGL's invested assets		10.00%

Investments - Available-for-Sa

Investments - Available-for-Sale Securities Table (Details) $ in Millions	Sep. 30, 2019USD ($)Security	Dec. 31, 2018USD ($)Security
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	$ 23,047	$ 22,219
Available-for sale securities
Gross Unrealized Gains	1,060	55
Gross Unrealized Losses	(200)	(1,165)
Fair Value	23,907	21,109
Carrying Value	23,907	21,109
Equity Securities, Amortized Cost Basis	1,104	1,526
Investments, Cost or Amortized Cost	26,397	25,404
Investments, Accumulated Gross Unrealized Gain, before Tax	1,238	58
Investments, Accumulated Gross Unrealized Loss, before Tax	263	1,545
Investments, Fair Value Disclosure	27,383	23,909
Equity Securities, Accumulated Gross Unrealized Gain, before Tax	15	1
Equity Securities, Accumulated Gross Unrealized Loss, before tax	(22)	(145)
Equity Securities, Fair Value	1,097	1,382
Equity Securities, Carrying Value	1,097	1,382
Derivative investments
Amortized Cost	327	330
Gross Unrealized Gains	163	2
Gross Unrealized Losses	(36)	(235)
Fair Value	454	97
Carrying Value	454	97
Commercial mortgage loans
Loans and Leases Receivable, Net Amount	836	667
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	2,823	2,857
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(125)	(120)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	5,689	17,226
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	$ (200)	$ (1,165)
Total number of available-for-sale securities in an unrealized loss position less than twelve months | Security	382	1,551
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | Security	395	556
Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions | Security	777	2,107
Investments	$ 27,372	$ 23,917
Asset-backed securities
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	5,433	4,954
Available-for sale securities
Gross Unrealized Gains	56	15
Gross Unrealized Losses	(94)	(137)
Fair Value	5,395	4,832
Carrying Value	5,395	4,832
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	1,347	643
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(42)	(21)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	3,190	3,567
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(94)	(137)
Commercial mortgage-backed securities
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	2,857	2,568
Available-for sale securities
Gross Unrealized Gains	185	9
Gross Unrealized Losses	(2)	(40)
Fair Value	3,040	2,537
Carrying Value	3,040	2,537
Total investments
Available-for-sale securities, Fair Value, 12 months or longer		262
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss		(6)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	143	1,728
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(2)	(40)
Corporates
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	11,338	11,213
Available-for sale securities
Gross Unrealized Gains	627	16
Gross Unrealized Losses	(90)	(848)
Fair Value	11,875	10,381
Carrying Value	11,875	10,381
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	1,177	1,465
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(73)	(76)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	1,932	9,481
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(90)	(848)
Hybrids
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	1,035	992
Available-for sale securities
Gross Unrealized Gains	39	0
Gross Unrealized Losses	(7)	(91)
Fair Value	1,067	901
Carrying Value	1,067	901
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	104	7
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(4)	(1)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	184	865
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(7)	(91)
Municipals
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	1,245	1,216
Available-for sale securities
Gross Unrealized Gains	93	3
Gross Unrealized Losses	(4)	(32)
Fair Value	1,334	1,187
Carrying Value	1,334	1,187
Residential mortgage-backed securities
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	964	1,027
Available-for sale securities
Gross Unrealized Gains	42	12
Gross Unrealized Losses	(3)	(8)
Fair Value	1,003	1,031
Carrying Value	1,003	1,031
U.S. Government
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	37	120
Available-for sale securities
Gross Unrealized Gains	1	0
Gross Unrealized Losses	0	(1)
Fair Value	38	119
Carrying Value	38	119
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	2	50
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	0	(1)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	10	119
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	0	(1)
Foreign Governments
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	138	129
Available-for sale securities
Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax	17	0
Gross Unrealized Losses	0	(8)
Fair Value	155	121
Carrying Value	155	121
Total investments
Available-for-sale securities, Fair Value, 12 months or longer		68
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss		(5)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value		115
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss		(8)
Other invested assets
Schedule of Investments [Line Items]
Available-for-sale Securities, Amortized Cost Basis	1,083	662
Available-for sale securities
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(5)	0
Fair Value	1,068	651
Carrying Value	1,078	662
Municipals
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	77	172
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(4)	(5)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	78	1,022
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(4)	(32)
Residential mortgage-backed securities
Total investments
Available-for-sale securities, Fair Value, 12 months or longer	116	190
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(2)	(5)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	152	329
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(3)	(8)
Commercial Portfolio Segment [Member]
Commercial mortgage loans
Investment, Commercial Mortgage Loans, Amortized Cost	444	482
Investments, Commercial Mortgage Loans, Accumulated Gross Unrealized Gain before Tax	0	0
Investments, Commercial Mortgage Loans, Accumulated Gross Unrealized Loss before Tax	0	0
Investments, Commercial Mortgage Loans, Fair Value Disclosure	460	483
Loans and Leases Receivable, Net Amount	444	482
Residential Portfolio Segment [Member]
Commercial mortgage loans
Loans and Leases Receivable, Net Amount	392	185
Investment, Residential Mortgage Loans, Amortized Cost	392	185
Investments, Residential Mortgage Loans, Accumulated Gross Unrealized Gain before Tax	0	0
Residential mortgage loans	$ 397	$ 187

Investments - Credit Impairment

Investments - Credit Impairment Loss Type (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Schedule of Investments [Line Items]
Other Than Temporary Impairment Credit Losses Recognized In Earnings Additions Including Credit Impairments	$ (2)	$ 0	$ (7)	$ (2)
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Reductions, Change in Status	0	0	0	0
Other than temporary impairment, non-credit losses recognized in OCI	0	0	0	0
Asset Backed Securities and Corporate Securities [Member]
Schedule of Investments [Line Items]
Amortized cost	4	0	4	0
Fair value	$ 3	$ 0	$ 4	$ 0

Investments - Amortized Cost a

Investments - Amortized Cost and Fair Value of Fixed Maturity Available-for-Sale Securities (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Debt Securities, Available-for-sale [Line Items]
Document Period End Date	Sep. 30, 2019
Equity Securities, Amortized Cost Basis	$ 1,104	$ 1,526
Due in one year or less, Amortized Cost	112
Due after one year through five years, Amortized Cost	864
Due after five years through ten years, Amortized Cost	2,007
Due after ten years, Amortized Cost	10,810
Subtotal, Amortized Cost	13,793
Other securities which provide for periodic payments, Amortized Cost	9,254
Total fixed maturity available-for-sale securities, Amortized Cost	23,047
Due in one year or less, Fair Value	112
Due after one year through five years, Fair Value	869
Due after five years through ten years, Fair Value	2,053
Due after ten years, Fair Value	11,435
Subtotal, Fair Value	14,469
Other securities which provide for periodic payments, Fair Value	9,438
Total fixed maturity available-for-sale securities, Fair Value	23,907
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Other securities which provide for periodic payments, Amortized Cost	5,433
Other securities which provide for periodic payments, Fair Value	5,395
Commercial mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Other securities which provide for periodic payments, Amortized Cost	2,857
Other securities which provide for periodic payments, Fair Value	3,040
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Other securities which provide for periodic payments, Amortized Cost	964
Other securities which provide for periodic payments, Fair Value	$ 1,003

Investments - Fair Value and G

Investments - Fair Value and Gross Unrealized Losses of Available-for-Sale Securities (Details)	9 Months Ended
	Sep. 30, 2019USD ($)Security	Dec. 31, 2018USD ($)Security
Debt Securities, Available-for-sale [Line Items]
Document Period End Date	Sep. 30, 2019
Available-for-sale securities, Fair Value, Less than 12 months	$ 2,866,000,000	$ 14,369,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(75,000,000)	(1,045,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	2,823,000,000	2,857,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(125,000,000)	(120,000,000)
Available-for-sale securities, Fair Value, Total	5,689,000,000	17,226,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	$ (200,000,000)	$ (1,165,000,000)
Total number of available-for-sale securities in an unrealized loss position less than twelve months | Security	382	1,551
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | Security	395	556
Total number of available-for-sale securities in an unrealized loss position | Security	777	2,107
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Unrealized Losses Related To Non Credit Portion Of Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income	$ 0	$ 0
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	1,843,000,000	2,924,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(52,000,000)	(116,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	1,347,000,000	643,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(42,000,000)	(21,000,000)
Available-for-sale securities, Fair Value, Total	3,190,000,000	3,567,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(94,000,000)	(137,000,000)
Commercial mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	143,000,000	1,466,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(2,000,000)	(34,000,000)
Available-for-sale securities, Fair Value, 12 months or longer		262,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer		(6,000,000)
Available-for-sale securities, Fair Value, Total	143,000,000	1,728,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(2,000,000)	(40,000,000)
Corporates
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	755,000,000	8,016,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(17,000,000)	(772,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	1,177,000,000	1,465,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(73,000,000)	(76,000,000)
Available-for-sale securities, Fair Value, Total	1,932,000,000	9,481,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(90,000,000)	(848,000,000)
Hybrids
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	80,000,000	858,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(3,000,000)	(90,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	104,000,000	7,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(4,000,000)	(1,000,000)
Available-for-sale securities, Fair Value, Total	184,000,000	865,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(7,000,000)	(91,000,000)
Municipals
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	1,000,000	850,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	0	(27,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	77,000,000	172,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(4,000,000)	(5,000,000)
Available-for-sale securities, Fair Value, Total	78,000,000	1,022,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(4,000,000)	(32,000,000)
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	36,000,000	139,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(1,000,000)	(3,000,000)
Available-for-sale securities, Fair Value, 12 months or longer	116,000,000	190,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(2,000,000)	(5,000,000)
Available-for-sale securities, Fair Value, Total	152,000,000	329,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	(3,000,000)	(8,000,000)
U.S. Government
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	8,000,000	69,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months		0
Available-for-sale securities, Fair Value, 12 months or longer	2,000,000	50,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	0	(1,000,000)
Available-for-sale securities, Fair Value, Total	10,000,000	119,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total	$ 0	(1,000,000)
Foreign Governments
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months		47,000,000
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months		(3,000,000)
Available-for-sale securities, Fair Value, 12 months or longer		68,000,000
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer		(5,000,000)
Available-for-sale securities, Fair Value, Total		115,000,000
Available-for-sale Securities, Gross Unrealized Losses, Total		$ (8,000,000)

Investments - Reconciliation o

Investments - Reconciliation of Other than Temporary Impairment on Fixed Maturity (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Line Items]
Document Period End Date			Sep. 30, 2019
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Roll Forward]
Balance at the beginning of the period			$ 0	$ 0
Increases attributable to credit losses on securities:
OTTI was previously recognized	$ 0	$ 0	0	0
OTTI was not previously recognized	0	0	0	0
Balance at the end of the period	$ 0	$ 0	$ 0	$ 0

Investments - Other-than-Tempo

Investments - Other-than-Temporary Impairments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Schedule of Investments [Line Items]
Document Period End Date			Sep. 30, 2019
Total other-than-temporary impairments	$ (2)	$ 0	$ (7)	$ (2)
Other than Temporary Impairment Losses, Investments	2	0	7	2
Corporates
Schedule of Investments [Line Items]
Total other-than-temporary impairments	(1)	0	(6)	(2)
Equity securities
Schedule of Investments [Line Items]
Total other-than-temporary impairments	$ (1)	$ 0	$ (1)	$ 0

Investments - Schedule of Comm

Investments - Schedule of Commercial Mortgage Loan Investment (Details) $ in Millions	Sep. 30, 2019USD ($)loan	Dec. 31, 2018USD ($)loan	Sep. 30, 2019USD ($)
Schedule of Investments [Line Items]
Document Period End Date			Sep. 30, 2019
Impaired loans, number | loan	0	0
Commercial mortgage loans, % of total	100.00%	100.00%	100.00%
Loans and Leases Receivable, Gross	$ 444	$ 482	$ 444
Loans Receivable, Gross, Residential, Mortgage		482
Loans and Leases Receivable, Net Amount	$ 836	$ 667	$ 836
Hotel
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	5.00%	4.00%	5.00%
Loans and Leases Receivable, Gross	$ 21	$ 21	$ 21
Industrial - General
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	8.00%	8.00%	8.00%
Loans and Leases Receivable, Gross	$ 37	$ 37	$ 37
Industrial - Warehouse
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	4.00%	4.00%	4.00%
Loans and Leases Receivable, Gross	$ 20	$ 20	$ 20
Multifamily
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	12.00%	12.00%	12.00%
Loans and Leases Receivable, Gross	$ 54	$ 56	$ 54
Office
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	33.00%	30.00%	33.00%
Loans and Leases Receivable, Gross	$ 144	$ 147	$ 144
Retail
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	38.00%	42.00%	38.00%
Loans and Leases Receivable, Gross	$ 168	$ 201	$ 168
LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	66.00%	63.00%	66.00%
Loans Receivable, Gross, Residential, Mortgage	$ 293	$ 302	$ 293
LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	32.00%	35.00%	32.00%
Loans Receivable, Gross, Residential, Mortgage	$ 140	$ 169	$ 140
LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	2.00%	2.00%	2.00%
Loans Receivable, Gross, Residential, Mortgage	$ 11	$ 11	$ 11
East North Central
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	19.00%	20.00%	19.00%
Loans and Leases Receivable, Gross	$ 84	$ 98	$ 84
East South Central
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	4.00%	4.00%	4.00%
Loans and Leases Receivable, Gross	$ 19	$ 19	$ 19
Middle Atlantic
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	17.00%	17.00%	17.00%
Loans and Leases Receivable, Gross	$ 77	$ 79	$ 77
Mountain
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	11.00%	13.00%	11.00%
Loans and Leases Receivable, Gross	$ 51	$ 65	$ 51
New England
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	1.00%	2.00%	1.00%
Loans and Leases Receivable, Gross	$ 5	$ 10	$ 5
Pacific
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	26.00%	24.00%	26.00%
Loans and Leases Receivable, Gross	$ 114	$ 116	$ 114
South Atlantic
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	13.00%	12.00%	13.00%
Loans and Leases Receivable, Gross	$ 56	$ 57	$ 56
West North Central
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	3.00%	3.00%	3.00%
Loans and Leases Receivable, Gross	$ 13	$ 13	$ 13
West South Central
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	6.00%	5.00%	6.00%
Loans and Leases Receivable, Gross	$ 25	$ 25	$ 25
Greater than 1.25
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	438	476	438
Greater than 1.25 | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	287	296	287
Greater than 1.25 | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	140	169	140
Greater than 1.25 | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	11	11	11
Greater than 1.00 but less than 1.25
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	6	6	6
Greater than 1.00 but less than 1.25 | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	6	6	6
Greater than 1.00 but less than 1.25 | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	0	0	0
Greater than 1.00 but less than 1.25 | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	$ 0	$ 0	$ 0
Fair Value
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	100.00%	100.00%	100.00%
Loans Receivable, Gross, Residential, Mortgage	$ 460	$ 483	$ 460
Fair Value | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	66.00%	63.00%	66.00%
Loans Receivable, Gross, Residential, Mortgage	$ 304	$ 302	$ 304
Fair Value | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	32.00%	35.00%	32.00%
Loans Receivable, Gross, Residential, Mortgage	$ 145	$ 170	$ 145
Fair Value | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	2.00%	2.00%	2.00%
Loans Receivable, Gross, Residential, Mortgage	$ 11	$ 11	$ 11
Commercial Portfolio Segment [Member]
Schedule of Investments [Line Items]
Commercial mortgage loans, % of total	100.00%	100.00%	100.00%
Loans and Leases Receivable, Gross	$ 444	$ 482	$ 444
Loans Receivable, Gross, Residential, Mortgage	444		444
Allowance for loan loss	0	0	0
Loans and Leases Receivable, Net Amount	$ 444	$ 482	$ 444

Investments - Net Investment I

Investments - Net Investment Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Schedule of Investments [Line Items]
Document Period End Date			Sep. 30, 2019
Gross investment income	$ 332	$ 289	$ 990	$ 860
Investment expense	(31)	(22)	(85)	(48)
Net investment income	301	267	905	812
Fixed maturity securities, available-for-sale
Schedule of Investments [Line Items]
Gross investment income	264	249	796	739
Equity securities
Schedule of Investments [Line Items]
Gross investment income	16	15	56	51
Commercial mortgage loans
Schedule of Investments [Line Items]
Gross investment income	11	5	26	17
Invested cash and short-term investments
Schedule of Investments [Line Items]
Gross investment income	4	6	14	13
Other investments
Schedule of Investments [Line Items]
Gross investment income	3	2	10	5
Funds Withheld [Member]
Schedule of Investments [Line Items]
Gross investment income	18	7	43	21
Limited Partnership [Member]
Schedule of Investments [Line Items]
Gross investment income	$ 16	$ 5	$ 45	$ 14

Investments - Net Investment G

Investments - Net Investment Gains (Losses) (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Gain (Loss) on Securities [Line Items]
Document Period End Date			Sep. 30, 2019
Net realized losses on fixed maturity available-for-sale securities	$ 19	$ (24)	$ 11	$ (84)
Realized gains on equity securities	19	(19)	119	(48)
Change in fair value of other derivatives and embedded derivatives	0	0	4	0
Realized losses on other invested assets	0	3	3	0
Realized gains (losses) on certain derivative instruments	(13)	27		23
Debt and Equity Securities, Gain (Loss)			(42)
Unrealized gains (losses) on certain derivative instruments	62	135	325	72
Derivative, Gain (Loss) on Derivative, Net	16	(3)	58	(37)
Change In Fair Value Derivatives, Including Other Derivatives	65	159	345	58
Realized gains (losses) on hedging derivatives and reinsurance-related embedded derivatives	65	159	345	58
Net investment gains (losses)	$ 103	$ 119	$ 478	$ (74)

Investments - Narrative (Detai

Investments - Narrative (Details)	Sep. 30, 2019USD ($)loan	Dec. 31, 2018USD ($)loan	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Jun. 30, 2015USD ($)
Debt Securities, Available-for-sale [Line Items]
Non-income producing investment fair value	$ 0	$ 0	$ 0		$ 0
FHLB collateral pledged	1,286,000,000	1,401,000,000	1,286,000,000		1,286,000,000
Available for sale depressed securities fair value disclosure	71,000,000	132,000,000	71,000,000		$ 71,000,000
Percentage of available for sale depressed securities above amortized cost					20.00%
Other than temporary impairment credit losses recognized in earnings, including credit impairments			2,000,000	$ 0	$ 7,000,000	$ 2,000,000
Other than temporary impairment credit losses recognized in earnings, reductions, change in status			0	0	0	0
Amortized cost	23,047,000,000	22,219,000,000	23,047,000,000		23,047,000,000
Fair Value	$ 23,907,000,000	$ 21,109,000,000	23,907,000,000		23,907,000,000
Other than temporary impairment, non-credit losses recognized in OCI			0	0	0	0
Realized gains (losses) on other invested assets			0	3,000,000	3,000,000	0
Impaired loans, number | loan	0	0
Unrealized Gain (Loss) on Investments			270,000,000	35,000,000	1,466,000,000	(649,000,000)
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Unrealized Gain Related To Non Credit Portion Of Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income	$ 0	$ 0	0		0
Unrealized losses related to non-credit portion of OTTI included in AOCI	0	0	0		0
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Amortized cost	964,000,000	1,027,000,000	964,000,000		964,000,000
Fair Value	1,003,000,000	1,031,000,000	1,003,000,000		1,003,000,000
Available-for-sale Securities
Debt Securities, Available-for-sale [Line Items]
Assets held by insurance regulators	$ 17,546,000,000	$ 19,930,000,000	$ 17,546,000,000		17,546,000,000
Proceeds from available-for-sale investments, sold, matured or repaid:					$ 2,915,000,000	5,865,000,000
Commercial mortgage loans
Debt Securities, Available-for-sale [Line Items]
Loan to value, threshold	75.00%	75.00%	75.00%		75.00%
Total fixed maturities | Available-for-sale Securities
Debt Securities, Available-for-sale [Line Items]
Proceeds from available-for-sale investments, sold, matured or repaid:			$ 828,000,000	662,000,000	$ 1,764,000,000	4,310,000,000
Gain on sale of investments			28,000,000	1,000,000	38,000,000	9,000,000
Loss on sale of investments			(9,000,000)	$ (26,000,000)	(24,000,000)	$ (91,000,000)
Commitment to Invest
Debt Securities, Available-for-sale [Line Items]
Unfunded investment commitment	$ 1,156,000,000		1,156,000,000		1,156,000,000
Crescent Capital BDC Inc. | Commitment to Invest
Debt Securities, Available-for-sale [Line Items]
Unfunded investment commitment							$ 75,000,000
Other Investments	69,000,000		69,000,000		69,000,000
Golub Capital Partners 10, L.P. [Member] | Commitment to Invest
Debt Securities, Available-for-sale [Line Items]
Unfunded investment commitment	917,000,000		917,000,000		917,000,000
Other Investments	$ 1,073,000,000		$ 1,073,000,000		$ 1,073,000,000

Investments Impact of Adoption

Investments Impact of Adoption of New Accounting Pronouncement (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net investment gains (losses)	$ 103	$ 119	$ 478	$ (74)
Gain (Loss) on Sale of Equity Investments	19	(19)	119	(48)
Unrealized Gain (Loss) on Investments	$ 270	$ 35	$ 1,466	$ (649)

Investments Schedule of Residen

Investments Schedule of Residential Mortgage Loan Investment (Details) - USD ($)	9 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Document Period End Date	Sep. 30, 2019
Loans Receivable, Gross, Residential, Mortgage		$ 482,000,000
Residential Mortgage Receivable, Percentage of Total	100.00%	100.00%
FLORIDA
Loans Receivable, Gross, Residential, Mortgage	$ 89,000,000	$ 25,000,000
Residential Mortgage Receivable, Percentage of Total	23.00%	14.00%
ILLINOIS
Loans Receivable, Gross, Residential, Mortgage	$ 56,000,000	$ 24,000,000
Residential Mortgage Receivable, Percentage of Total	14.00%	13.00%
NEW JERSEY
Loans Receivable, Gross, Residential, Mortgage	$ 34,000,000	$ 17,000,000
Residential Mortgage Receivable, Percentage of Total	9.00%
All Other States [Member]
Loans Receivable, Gross, Residential, Mortgage	$ 207,000,000	$ 114,000,000
Residential Mortgage Receivable, Percentage of Total	54.00%	64.00%
Total Mortgage Loans [Member]
Loans Receivable, Gross, Residential, Mortgage	$ 386,000,000	$ 180,000,000
Residential Portfolio Segment [Member]
Loans Receivable, Gross, Residential, Mortgage	$ 392,000,000	$ 185,000,000
Residential Mortgage Receivable, Percentage of Total	100.00%	100.00%
Loans and Leases Receivable, Allowance	$ 0	$ 0
Performing [Member]
Loans Receivable, Gross, Residential, Mortgage	$ 392,000,000	$ 185,000,000
Residential Mortgage Receivable, Percentage of Total	100.00%	100.00%
Non-performing [Member]
Loans Receivable, Gross, Residential, Mortgage	$ 0	$ 0
Residential Mortgage Receivable, Percentage of Total	0.00%	0.00%
Maximum | All Other States [Member]
Residential Mortgage Receivable, Percentage of Total		9.00%

Derivative Financial Instrume_3

Derivative Financial Instruments - Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Derivative [Line Items]
Total asset derivatives	$ 473	$ 111
Total liability derivatives	3,150	2,505
Call options | Derivative Instruments
Derivative [Line Items]
Total asset derivatives	454	97
Futures contracts | Derivative Instruments
Derivative [Line Items]
Total asset derivatives	0	0
Other derivatives and embedded derivatives | Other invested assets
Derivative [Line Items]
Total asset derivatives	19	14
FIA embedded derivative | Contractholder funds
Derivative [Line Items]
Total liability derivatives	3,136	2,476
Preferred shares reimbursement feature embedded derivative | Other Liabilities [Member]
Derivative [Line Items]
Total liability derivatives	$ 14	$ 29

Derivative Financial Instrume_4

Derivative Financial Instruments - Schedule of Change in Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	$ 16	$ (3)	$ 58	$ (37)
Change In Fair Value Of Derivatives	65	159	345	58
Call options | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	43	153	261	86
Futures contracts | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	3	8	17	8
Foreign Exchange Forward [Member] | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	3	1	5	1
Other derivatives and embedded derivatives | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	0	0	4	0
Reinsurance related embedded derivative | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	16	(3)	58	(37)
Preferred shares reimbursement feature embedded derivative | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	(10)	(2)	(15)	(1)
FIA embedded derivative
Derivative [Line Items]
Change in fair value of reinsurance related embedded derivatives	$ 202	$ 231	$ 660	$ 274

Derivative Financial Instrume_5

Derivative Financial Instruments - FGL's Exposure to Credit Loss on Call Options Held (Detail) - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Derivatives, Fair Value [Line Items]
Fair Value	$ 473	$ 111
Merrill Lynch
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A+/*/A+	A+/*/A+
Deutsche Bank
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	BBB/A3/BBB+	A-/A3/BBB+
Notional Amount	$ 804	$ 1,327
Fair Value	12	5
Collateral	11	6
Net Credit Risk	$ 1	$ (1)
Morgan Stanley
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	*/A1/A+	*/A1/A+
Notional Amount	$ 1,772	$ 1,648
Fair Value	39	9
Collateral	36	6
Net Credit Risk	$ 3	$ 3
Barclay's Bank
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A+/A2/A	A+/A2/A
Notional Amount	$ 3,381	$ 2,205
Fair Value	165	27
Collateral	154	20
Net Credit Risk	$ 11	$ 7
Canadian Imperial Bank of Commerce [Member]
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	*/Aa2/A+	*/Aa2/A+
Notional Amount	$ 2,557	$ 1,716
Fair Value	81	11
Collateral	53	8
Net Credit Risk	$ 28	$ 3
Wells Fargo [Member]
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A+/A2/A-	A+/A2/A-
Notional Amount	$ 2,075	$ 1,635
Fair Value	66	17
Collateral	65	16
Net Credit Risk	$ 1	$ 1
GOLDMAN SACH MTF [Member]
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P) (a)	A/A3/BBB+	A/A3/BBB+
Notional Amount	$ 1,079	$ 647
Fair Value	21	3
Collateral	19	3
Net Credit Risk	2	0
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivatives, Fair Value [Line Items]
Notional Amount	14,483	13,130
Fair Value	454	97
Collateral	362	59
Net Credit Risk	92	38
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options | Merrill Lynch
Derivatives, Fair Value [Line Items]
Notional Amount	2,815	3,952
Fair Value	70	25
Collateral	24	0
Net Credit Risk	$ 46	$ 25

Derivative Financial Instrume_6

Derivative Financial Instruments - Narrative (Details) $ in Millions	Nov. 30, 2017shares	Sep. 30, 2019USD ($)contract	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)contract	Sep. 30, 2018USD ($)	Dec. 31, 2018USD ($)contract	Jun. 30, 2018USD ($)	Dec. 31, 2017USD ($)	Jun. 16, 2014USD ($)
Derivative [Line Items]
Fair Value		$ 473		$ 473		$ 111
Fair value of assets			$ 2,357		$ 2,357		$ 1,961	$ 1,785
Derivative, Gain (Loss) on Derivative, Net		$ 16	(3)	$ 58	(37)
Other derivatives and embedded derivatives
Derivative [Line Items]
Term of contract, term one				1 year
Term of contract, term two				2 years
Term of contract, term three				3 years
Term of contract, term four				5 years
Futures contracts
Derivative [Line Items]
Number of instruments held | contract		724,000,000		724,000,000		664,000,000
Collateral held		$ 4		$ 4		$ 3
Other invested assets | Other derivatives and embedded derivatives
Derivative [Line Items]
Fair Value		19		19		14
Derivative investments | Call options
Derivative [Line Items]
Fair Value		454		454		97
Derivative investments | Futures contracts
Derivative [Line Items]
Fair Value		0		0		0
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Fair Value		454		454		97
Derivative notional amount		14,483		14,483		13,130
Collateral posted		362		362		59
Maximum amount of loss due to credit risk		92		92		38
Cash and Cash Equivalents | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Collateral posted		338		338		59
Other Investments Asset | Other invested assets
Derivative [Line Items]
Fixed maturities securities, available-for-sale, at fair value		29		29		26			$ 35
Merrill Lynch [Member] | Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Fair Value		70		70		25
Derivative notional amount		2,815		2,815		3,952
Collateral posted		24		24		0
Maximum amount of loss due to credit risk		46		46		$ 25
Preferred Stock
Derivative [Line Items]
Preferred Stock, Call Features, Minimum Term	5 years
Preferred stock dividend rate	10.00%
Series A Cumulative Preferred Stock [Member] | Preferred Stock
Derivative [Line Items]
Stock Issued During Period, Shares, New Issues | shares	275,000
Series B Cumulative Preferred Stock [Member] | Preferred Stock
Derivative [Line Items]
Stock Issued During Period, Shares, New Issues | shares	100,000
Net investment (losses) gains | Foreign Exchange Forward [Member]
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		3	1	5	1
Net investment (losses) gains | Other derivatives and embedded derivatives
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		0	0	4	0
Net investment (losses) gains | Call options
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		43	153	261	86
Net investment (losses) gains | Futures contracts
Derivative [Line Items]
Derivative, Gain (Loss) on Derivative, Net		$ 3	$ 8	$ 17	$ 8

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Assets and Liabilities Carrying at Fair Value Measured on a Recurring Basis (Details) - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	$ 23,907	$ 21,109
Derivative investments	454	97
Total financial assets at fair value	2,746	2,466
Funds withheld for reinsurance receivables, at fair value	2,045	757
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	990	571
Equity securities	429	454
Derivative investments	0	0
Other invested assets		0
Total financial assets at fair value	2,197	1,581
Total financial liabilities at fair value	0	0
FHLB common stock	0	0
Commercial mortgage loans	0	0
Residential mortgage loans	0	0
Policy loans, included in other invested assets	0	0
Affiliated other invested assets	0	0
Total assets carried on balance sheet at amounts other than fair value	0	0
Investment contracts, included in contractholder funds	0	0
Debt	0	0
Total liabilities carried on balance sheet at amounts other than fair value	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0	0
Equity securities	597	874
Derivative investments	454	97
Other invested assets		0
Total financial assets at fair value	23,525	19,858
Total financial liabilities at fair value	0	0
FHLB common stock	63	52
Commercial mortgage loans	0	0
Residential mortgage loans	0	0
Policy loans, included in other invested assets	0	0
Affiliated other invested assets	0	0
Total assets carried on balance sheet at amounts other than fair value	63	52
Investment contracts, included in contractholder funds	0	0
Debt	583	520
Total liabilities carried on balance sheet at amounts other than fair value	583	520
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0	0
Equity securities	2	4
Derivative investments	0	0
Other invested assets		39
Total financial assets at fair value	2,746	2,466
Total financial liabilities at fair value	5,037	3,230
FHLB common stock	0	0
Commercial mortgage loans	460	483
Residential mortgage loans	397	187
Policy loans, included in other invested assets	17	11
Affiliated other invested assets	28	39
Total assets carried on balance sheet at amounts other than fair value	902	720
Investment contracts, included in contractholder funds	19,077	18,358
Debt	0	0
Total liabilities carried on balance sheet at amounts other than fair value	19,093	18,358
Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	990	571
Equity securities	1,028	1,332
Derivative investments	454	97
Other invested assets		39
Total financial assets at fair value	28,468	23,905
Total financial liabilities at fair value	5,037	3,230
FHLB common stock	63	52
Commercial mortgage loans	460	483
Residential mortgage loans	397	187
Policy loans, included in other invested assets	17	11
Affiliated other invested assets	28	39
Total assets carried on balance sheet at amounts other than fair value	965	772
Investment contracts, included in contractholder funds	19,077	18,358
Debt	583	520
Total liabilities carried on balance sheet at amounts other than fair value	19,676	18,878
Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	990	571
Equity securities	1,028	1,332
Derivative investments	454	97
Other invested assets		39
Total financial assets at fair value	28,468	23,905
Total financial liabilities at fair value	5,037	3,230
FHLB common stock	63	52
Commercial mortgage loans	444	482
Residential mortgage loans	392	185
Policy loans, included in other invested assets	26	22
Affiliated other invested assets	28	39
Total assets carried on balance sheet at amounts other than fair value	953	780
Investment contracts, included in contractholder funds	22,219	20,911
Debt	542	541
Total liabilities carried on balance sheet at amounts other than fair value	22,776	21,452
Fixed indexed annuities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Fixed indexed annuities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Fixed indexed annuities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,136	2,476
Fixed indexed annuities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,136	2,476
Fixed indexed annuities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,136	2,476
Preferred shares reimbursement feature embedded derivative | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Preferred shares reimbursement feature embedded derivative | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Preferred shares reimbursement feature embedded derivative | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	14	29
Preferred shares reimbursement feature embedded derivative | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	14	29
Preferred shares reimbursement feature embedded derivative | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	14	29
Future Policy Benefits | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Future Policy Benefits | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Future Policy Benefits | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,887	725
Future Policy Benefits | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,887	725
Future Policy Benefits | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,887	725
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	5,395	4,832
Asset-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Asset-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	4,803	4,388
Asset-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	592	444
Asset-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	5,395	4,832
Asset-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	5,395	4,832
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,040	2,537
Commercial mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Commercial mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,014	2,470
Commercial mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	26	67
Commercial mortgage-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,040	2,537
Commercial mortgage-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,040	2,537
Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	11,875	10,381
Corporates | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Corporates | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	10,446	9,150
Corporates | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,429	1,231
Corporates | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	11,875	10,381
Corporates | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	11,875	10,381
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,067	901
Hybrids | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	301	265
Hybrids | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	756	626
Hybrids | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	10	10
Hybrids | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,067	901
Hybrids | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,067	901
Municipals | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Municipals | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,292	1,150
Municipals | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	42	37
Municipals | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,334	1,187
Municipals | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,334	1,187
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,003	1,031
Residential mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Residential mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	434	417
Residential mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	569	614
Residential mortgage-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,003	1,031
Residential mortgage-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,003	1,031
U.S. Government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	38	119
U.S. Government | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	30	114
U.S. Government | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	8	5
U.S. Government | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
U.S. Government | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	38	119
U.S. Government | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	38	119
Foreign Governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	155	121
Foreign Governments | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Foreign Governments | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	137	105
Foreign Governments | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	18	16
Foreign Governments | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	155	121
Foreign Governments | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	155	121
Other invested assets | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Other invested assets | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Other invested assets | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	44
Other invested assets | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	44
Other invested assets | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	44
Funds withheld for reinsurance receivables, at fair value | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	447	177
Funds withheld for reinsurance receivables, at fair value | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,584	576
Funds withheld for reinsurance receivables, at fair value | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	14	4
Funds withheld for reinsurance receivables, at fair value | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,045	757
Funds withheld for reinsurance receivables, at fair value | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	$ 2,045	$ 757

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Schedule of Unobservable Inputs Used for Level Three Fair Value Measurements of Financial Instruments on Recurring Basis (Detail) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 2,746,000,000	$ 2,466,000,000
Liabilities, fair value	5,037,000,000	3,230,000,000
Future Policy Benefit		725,000,000
Market Approach | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	566,000,000	405,000,000
Market Approach | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	26,000,000	43,000,000
Market Approach | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	1,429,000,000	577,000,000
Market Approach | Municipals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	42,000,000	37,000,000
Market Approach | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	569,000,000
Residential Mortage Backed securities		614,000,000
Market Approach | Foreign Governments
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	18,000,000	16,000,000
Market Approach | Credit Linked Note
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	25,000,000
Loan Recovery Value		25,000,000
Third Parties | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	26,000,000	15,000,000
Income Approach Valuation Technique | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		654,000,000
Income Approach Valuation Technique | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		10,000,000
Black Scholes Model | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	19,000,000
Matrix Pricing Valuation | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		24,000,000
Matrix Pricing Valuation | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		24,000,000
Matrix Pricing Valuation | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	10,000,000
Matrix Pricing Valuation | Funds withheld for reinsurance receivables, at fair value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	14,000,000
Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Liabilities, fair value	3,136,000,000	2,476,000,000
Preferred shares reimbursement feature embedded derivative | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Liabilities, fair value	$ 14,000,000	$ 29,000,000
Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk Margin To Reflect Uncertainty		0.00%
Minimum | Market Approach | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	89.87%	97.00%
Minimum | Market Approach | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	80.47%	74.63%
Minimum | Market Approach | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	101.95%	96.60%
Minimum | Market Approach | Municipals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	118.57%	111.23%
Minimum | Market Approach | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	93.86%	89.80%
Minimum | Market Approach | Foreign Governments
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	103.01%	98.38%
Minimum | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		96.07%
Minimum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	126.19%	117.72%
Minimum | Income Approach Valuation Technique | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	101.67%	91.74%
Minimum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model	0.00%	0.00%
Minimum | Third Party Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	0.00%	0.00%
Minimum | Future Policy Benefits, Market Value of Option [Member] | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	0.00%
Minimum | Future Policy Benefits, Mortality Multiplier | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	80.00%
Minimum | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	0.00%	0.00%
Fair value inputs, swap rates	1.75%	2.57%
Fair value inputs, mortality multiplier	80.00%	80.00%
Fair value inputs, surrender rates	0.50%	0.50%
Fair value inputs, non performance spread	0.25%	0.25%
Minimum | Fixed indexed annuities | Partial Withdrawls
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, surrender rates	1.00%	1.00%
Minimum | Fixed indexed annuities | Option Cost
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, non performance spread	0.18%	0.01%
Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk Margin To Reflect Uncertainty		0.00%
Maximum | Market Approach | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	106.58%	102.00%
Maximum | Market Approach | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	119.21%	104.62%
Maximum | Market Approach | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	101.95%	96.60%
Maximum | Market Approach | Municipals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	118.57%	111.23%
Maximum | Market Approach | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	106.45%	100.99%
Maximum | Market Approach | Foreign Governments
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	106.03%	99.01%
Maximum | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		96.07%
Maximum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	126.19%	117.72%
Maximum | Income Approach Valuation Technique | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	106.04%	113.25%
Maximum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model	0.10%	0.22%
Maximum | Third Party Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	99.33%	99.29%
Maximum | Future Policy Benefits, Market Value of Option [Member] | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	7.51%
Maximum | Future Policy Benefits, Mortality Multiplier | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	100.00%
Maximum | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	31.74%	31.06%
Fair value inputs, swap rates	1.96%	2.71%
Fair value inputs, mortality multiplier	80.00%	80.00%
Fair value inputs, surrender rates	75.00%	75.00%
Fair value inputs, non performance spread	0.25%	0.25%
Maximum | Fixed indexed annuities | Partial Withdrawls
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, surrender rates	2.50%	2.50%
Maximum | Fixed indexed annuities | Option Cost
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, non performance spread	16.61%	16.61%
Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Credit Spread	$ 0.0410	$ 0.0514
Yield Volatility	0.00%	0.00%
Risk Margin To Reflect Uncertainty		0.00%
Weighted Average | Market Approach | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	100.79%	99.77%
Weighted Average | Market Approach | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	102.29%	97.80%
Weighted Average | Market Approach | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	101.95%	96.60%
Weighted Average | Market Approach | Municipals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	118.57%	111.23%
Weighted Average | Market Approach | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	106.07%	100.73%
Weighted Average | Market Approach | Foreign Governments
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	103.95%	98.58%
Weighted Average | Market Approach | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	100.00%	100.00%
Fair Value Input Recovery Rate		7.15%
Weighted Average | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		96.07%
Weighted Average | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	126.19%	117.72%
Weighted Average | Income Approach Valuation Technique | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	103.41%	98.86%
Weighted Average | Income Approach Valuation Technique | Equity securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Input Recovery Rate	4.42%
Weighted Average | Income Approach Valuation Technique | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model	100.00%	100.00%
Weighted Average | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model	8.00%	0.18%
Weighted Average | Matrix Pricing Valuation | Funds withheld for reinsurance liabilities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model		100.00%
Weighted Average | Third Party Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	34.08%	23.05%
Weighted Average | Third Party Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	87.98%	85.46%
Weighted Average | Future Policy Benefits, Market Value of Option [Member] | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	1.48%
Weighted Average | Future Policy Benefits, Mortality Multiplier | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	90.14%
Weighted Average | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	2.60%	94.00%
Fair value inputs, swap rates	1.85%	2.63%
Fair value inputs, mortality multiplier	80.00%	80.00%
Fair value inputs, surrender rates	5.84%	5.90%
Fair value inputs, non performance spread	0.25%	0.25%
Weighted Average | Fixed indexed annuities | Partial Withdrawls
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, surrender rates	2.00%	2.00%
Weighted Average | Fixed indexed annuities | Option Cost
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, non performance spread	2.16%	2.18%
Insurance Subsidiary | Market Approach | Equity securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		$ 4,000,000
Insurance Subsidiary | Income Approach Valuation Technique | Equity securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 2,000,000
Insurance Subsidiary | Income Approach Valuation Technique | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		$ 14,000,000
Insurance Subsidiary | Minimum | Market Approach | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Inputs, Other Loan Recoveries	84.00%	77.12%
Insurance Subsidiary | Maximum | Market Approach | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair Value Inputs, Other Loan Recoveries	100.15%	100.08%
Loan Participation - JSN Jewelry, Inc. | Market Approach | Funds withheld for reinsurance liabilities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Reinsurance Receivables, Funds Withheld		$ 4,000,000
FSRC | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Liabilities, fair value	$ 1,887,000,000

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Changes to Fair Value of Financial Instruments Level 3 (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Jun. 30, 2019	Dec. 31, 2018	Jun. 30, 2018	Dec. 31, 2017
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		$ 1,961		$ 1,785
Assets, Total Gains (Losses) Included in Earnings		1		2
Assets, Total Gains (Losses) Included in AOCI		(14)		(46)
Assets, Purchases		590		1,212
Assets, Sales		12		12
Assets, Settlements		23		144
Assets, Net transfer In (Out) of Level 3		(146)		(440)
Balance at End of Period		2,357		2,357
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	$ 4,745	3,081	$ 3,230	3,028
Available-for-sale Securities	23,907		23,907			$ 21,109
Liabilities, Total Gains (Losses) Included in Earnings	246	203	788	230
Liabilities, Total Gains (Losses) Included in AOCI	1	1	9	(1)
Liabilities, Purchases	0	0	0	0
Liabilities, Sales	0	0	0	0
Liabilities, Settlements	45	(28)	1,010	0
Liabilities, Net transfer In (Out) of Level 3	0	0	0	0
Balance at End of Period	5,037	3,257	5,037	3,257
FIA embedded derivatives, included in contractholder funds
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	2,934	2,320	2,476	2,277
Liabilities, Total Gains (Losses) Included in Earnings	202	231	660	274
Liabilities, Total Gains (Losses) Included in AOCI	0	0	0	0
Liabilities, Purchases	0	0	0	0
Liabilities, Sales	0	0	0	0
Liabilities, Settlements	0	0	0	0
Liabilities, Net transfer In (Out) of Level 3	0	0	0	0
Balance at End of Period	3,136	2,551	3,136	2,551
Future Policy Benefits
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	1,787	737	725	728
Liabilities, Total Gains (Losses) Included in Earnings	54	(26)	143	(43)
Liabilities, Total Gains (Losses) Included in AOCI	1	1	9	(1)
Liabilities, Purchases	0	0	0	0
Liabilities, Sales	0	0	0	0
Liabilities, Settlements	45	(28)	1,010	0
Liabilities, Net transfer In (Out) of Level 3	0	0	0	0
Balance at End of Period	1,887	684	1,887	684
Preferred shares reimbursement feature embedded derivative
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	14		14			29
Liabilities, Total Gains (Losses) Included in Earnings			(15)
Liabilities, Total Gains (Losses) Included in AOCI			0
Liabilities, Purchases			0
Liabilities, Sales			0
Liabilities, Settlements			0
Liabilities, Net transfer In (Out) of Level 3			0
Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	736	330	444	412
Assets, Total Gains (Losses) Included in Earnings	0	0	0	0
Assets, Total Gains (Losses) Included in AOCI	3	0	16	(2)
Assets, Purchases	14	162	390	342
Assets, Sales	0	0	0	0
Assets, Settlements	(36)	(11)	(79)	(18)
Assets, Net transfer In (Out) of Level 3	(125)	(77)	(179)	(330)
Balance at End of Period	592	404	592	404
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	5,395		5,395			4,832
Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	50	60	67	49
Assets, Total Gains (Losses) Included in Earnings	0	0	0	0
Assets, Total Gains (Losses) Included in AOCI	0	(1)	4	(3)
Assets, Purchases	0	0	1	12
Assets, Sales	0	0	0	0
Assets, Settlements	1	0	10	6
Assets, Net transfer In (Out) of Level 3	(23)	(12)	(36)	(5)
Balance at End of Period	26	47	26	47
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	3,040		3,040			2,537
Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	1,319	1,190	1,231	1,169
Assets, Total Gains (Losses) Included in Earnings	0	0	(1)	0
Assets, Total Gains (Losses) Included in AOCI	17	(9)	67	(36)
Assets, Purchases	107	53	221	252
Assets, Sales	0	0	(25)	0
Assets, Settlements	(14)	(5)	(74)	(108)
Assets, Net transfer In (Out) of Level 3	0	(21)	10	(69)
Balance at End of Period	1,429	1,208	1,429	1,208
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	11,875		11,875			10,381
Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	10	10	10	10
Assets, Total Gains (Losses) Included in Earnings	0	0	0	0
Assets, Total Gains (Losses) Included in AOCI	0	(1)	0	(1)
Assets, Purchases	0	0	0	0
Assets, Sales	0	0	0	0
Assets, Settlements	0	0	0	0
Assets, Net transfer In (Out) of Level 3	0	0	0	0
Balance at End of Period	10	9	10	9
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	1,067		1,067			901
Municipals
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	39	37	37	38
Assets, Total Gains (Losses) Included in Earnings	0	0	0	0
Assets, Total Gains (Losses) Included in AOCI	3	(1)	5	(2)
Assets, Purchases	0	0	0	0
Assets, Sales	0	0	0	0
Assets, Settlements	0	0	0	0
Assets, Net transfer In (Out) of Level 3	0	0	0	0
Balance at End of Period	42	36	42	36
Residential mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	588	242	614	66
Assets, Total Gains (Losses) Included in Earnings	0	0	0	0
Assets, Total Gains (Losses) Included in AOCI	(2)	(2)	28	0
Assets, Purchases	6	375	19	554
Assets, Sales	0	1	0	1
Assets, Settlements	23	3	63	8
Assets, Net transfer In (Out) of Level 3	0	(36)	(29)	(36)
Balance at End of Period	569	575	569	575
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	1,003		1,003			1,031
Foreign Governments
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	17	16	16	17
Assets, Total Gains (Losses) Included in Earnings	0	0	0	0
Assets, Total Gains (Losses) Included in AOCI	1	0	2	(1)
Assets, Purchases	0	0	0	0
Assets, Sales	0	0	0	0
Assets, Settlements	0	0	0	0
Assets, Net transfer In (Out) of Level 3	0	0	0	0
Balance at End of Period	18	16	18	16
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	155		155			121
Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	3	3	4	3
Assets, Total Gains (Losses) Included in Earnings	(1)	1	(1)	2
Assets, Total Gains (Losses) Included in AOCI	0	0	(1)	(1)
Assets, Purchases	0	0	0	0
Assets, Sales	0	0	0	0
Assets, Settlements	0	0	0	0
Assets, Net transfer In (Out) of Level 3	0	0	0	0
Balance at End of Period	2	4	2	4
Available-for-sale embedded derivative
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	18	17	14	17
Assets, Total Gains (Losses) Included in Earnings	1	0	5	0
Assets, Total Gains (Losses) Included in AOCI	0	0	0	0
Assets, Purchases	0	0	0	0
Assets, Sales	0	0	0	0
Assets, Settlements	0	0	0	0
Assets, Net transfer In (Out) of Level 3	0	0	0	0
Balance at End of Period	19	17	19	17
Affiliate bank loans [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period				0
Assets, Total Gains (Losses) Included in Earnings				0
Assets, Total Gains (Losses) Included in AOCI				0
Assets, Purchases				50
Assets, Sales				11
Assets, Settlements				0
Assets, Net transfer In (Out) of Level 3				0
Balance at End of Period		39		39
Bank Loan Obligations [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		50
Assets, Total Gains (Losses) Included in Earnings		0
Assets, Total Gains (Losses) Included in AOCI		0
Assets, Purchases		0
Assets, Sales		11
Assets, Settlements		0
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		39		39
Funds withheld for reinsurance receivables, at fair value
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	0	6	4	4
Assets, Total Gains (Losses) Included in Earnings	0	0	0	0
Assets, Total Gains (Losses) Included in AOCI	0	0	0	0
Assets, Purchases	14	0	19	2
Assets, Sales	0	0	1	0
Assets, Settlements	0	(4)	0	(4)
Assets, Net transfer In (Out) of Level 3	0	0	(8)	0
Balance at End of Period	14	2	14	2
Total assets at level 3 [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	2,805		2,466
Assets, Total Gains (Losses) Included in Earnings	0		3
Assets, Total Gains (Losses) Included in AOCI	22		121
Assets, Purchases	141		650
Assets, Sales	0		26
Assets, Settlements	74		226
Assets, Net transfer In (Out) of Level 3	(148)		(242)
Balance at End of Period	2,746		2,746
Affiliated Entity | Bank Loan Obligations [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	25		25
Assets, Total Gains (Losses) Included in Earnings	0		0
Assets, Total Gains (Losses) Included in AOCI	0		0
Assets, Purchases	0		0
Assets, Sales	0		0
Assets, Settlements	0		0
Assets, Net transfer In (Out) of Level 3	0		0
Balance at End of Period	25		25
Fair Value | Asset-backed securities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	5,395		5,395			4,832
Fair Value | Commercial mortgage-backed securities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	3,040		3,040			2,537
Fair Value | Corporates
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	11,875		11,875			10,381
Fair Value | Hybrids
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	1,067		1,067			901
Fair Value | Municipals
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	1,334		1,334			1,187
Fair Value | Residential mortgage-backed securities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	1,003		1,003			1,031
Fair Value | Foreign Governments
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	155		155			121
Fair Value | Funds withheld for reinsurance receivables, at fair value
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	2,045		2,045			757
Fair Value | Other invested assets
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	44		44
Fair Value | Fixed indexed annuities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	3,136		3,136			2,476
Fair Value | Preferred shares reimbursement feature embedded derivative
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	14		14			$ 29
Fair Value | Preferred shares reimbursement feature embedded derivative | Preferred shares reimbursement feature embedded derivative
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Available-for-sale Securities	14	22	$ 14	22	$ 24		$ 24	$ 23
Liabilities, Total Gains (Losses) Included in Earnings	(10)	(2)		(1)
Liabilities, Total Gains (Losses) Included in AOCI		0		0
Liabilities, Purchases		0		0
Liabilities, Sales		0		0
Liabilities, Settlements		0		0
Liabilities, Net transfer In (Out) of Level 3		$ 0		$ 0

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - NAV (Details) - USD ($) $ in Millions	Sep. 30, 2019	Dec. 31, 2018
Level 1
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	$ 0	$ 0
Level 2
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	0	0
Level 3
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	397	187
Fair Value
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	397	187
Carrying Value
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Investments, Residential Mortgage Loans, Fair Value Disclosure	$ 392	$ 185

Fair Value of Financial Instr_7

Fair Value of Financial Instruments - Narrative (Detail) - USD ($)	Nov. 30, 2017	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings		$ 246,000,000	$ 203,000,000	$ 788,000,000	$ 230,000,000
Assets, net transfer in (out) of Level 3			(146,000,000)		(440,000,000)
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		(125,000,000)	(77,000,000)	(179,000,000)	(330,000,000)
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		(23,000,000)	(12,000,000)	(36,000,000)	(5,000,000)
Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		0	(21,000,000)	10,000,000	(69,000,000)
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		0	0	0	0
States, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		0	0	0	0
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		0	(36,000,000)	(29,000,000)	(36,000,000)
Foreign Governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		0	0	0	0
Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Alternative Investment		69,000,000		69,000,000		$ 50,000,000
Assets, net transfer in (out) of Level 3		0	$ 0	0	$ 0
Preferred Stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred Stock, Call Features, Minimum Term	5 years
Available-for-sale Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held by insurance regulators		17,546,000,000		$ 17,546,000,000		$ 19,930,000,000
Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Risk Margin To Reflect Uncertainty						0.00%
Maximum | Market Approach | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				106.58%		102.00%
Maximum | Market Approach | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				119.21%		104.62%
Maximum | Market Approach | Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				101.95%		96.60%
Maximum | Market Approach | States, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				118.57%		111.23%
Maximum | Market Approach | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				106.45%		100.99%
Maximum | Market Approach | Foreign Governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				106.03%		99.01%
Maximum | Income Approach Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices						96.07%
Maximum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				126.19%		117.72%
Maximum | Income Approach Valuation Technique | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				106.04%		113.25%
Maximum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model				0.10%		0.22%
Maximum | Third Party Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				99.33%		99.29%
Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Risk Margin To Reflect Uncertainty						0.00%
Credit Spread				$ 0.0410		$ 0.0514
Yield Volatility				0.00%		0.00%
Weighted Average | Market Approach | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				100.79%		99.77%
Weighted Average | Market Approach | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				100.00%		100.00%
Fair Value Input Recovery Rate						7.15%
Weighted Average | Market Approach | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				102.29%		97.80%
Weighted Average | Market Approach | Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				101.95%		96.60%
Weighted Average | Market Approach | States, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				118.57%		111.23%
Weighted Average | Market Approach | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				106.07%		100.73%
Weighted Average | Market Approach | Foreign Governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				103.95%		98.58%
Weighted Average | Income Approach Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices						96.07%
Weighted Average | Income Approach Valuation Technique | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model				100.00%		100.00%
Weighted Average | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				126.19%		117.72%
Weighted Average | Income Approach Valuation Technique | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				103.41%		98.86%
Weighted Average | Income Approach Valuation Technique | Equity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Input Recovery Rate				4.42%
Weighted Average | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model				8.00%		0.18%
Weighted Average | Third Party Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				34.08%		23.05%
Weighted Average | Third Party Valuation Technique | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				87.98%		85.46%
Weighted Average | Matrix Pricing Valuation | Funds withheld for reinsurance liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model						100.00%
Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Risk Margin To Reflect Uncertainty						0.00%
Minimum | Market Approach | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				89.87%		97.00%
Minimum | Market Approach | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				80.47%		74.63%
Minimum | Market Approach | Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				101.95%		96.60%
Minimum | Market Approach | States, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				118.57%		111.23%
Minimum | Market Approach | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				93.86%		89.80%
Minimum | Market Approach | Foreign Governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				103.01%		98.38%
Minimum | Income Approach Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices						96.07%
Minimum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				126.19%		117.72%
Minimum | Income Approach Valuation Technique | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				101.67%		91.74%
Minimum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, black scholes model				0.00%		0.00%
Minimum | Third Party Valuation Technique | Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, quoted prices				0.00%		0.00%
Affiliated Entity | Maximum | Market Approach | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Inputs, Other Loan Recoveries				100.15%		100.08%
Affiliated Entity | Minimum | Market Approach | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Inputs, Other Loan Recoveries				84.00%		77.12%
Future Policy Benefits | Maximum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortality, Morbidity and Surrender Rate Assumption				0.02
Fair value inputs, swap rates				55.00%
Fair value inputs, mortality multiplier				4.00%
Fair value inputs, non performance spread				4.58%
Risk Margin To Reflect Uncertainty				0.62%
Future Policy Benefits | Weighted Average | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortality, Morbidity and Surrender Rate Assumption				.08
Fair value inputs, swap rates				20.93%
Fair value inputs, mortality multiplier				1.43%
Fair value inputs, non performance spread				98.00%
Risk Margin To Reflect Uncertainty				32.00%
Future Policy Benefits | Minimum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Mortality, Morbidity and Surrender Rate Assumption				0
Fair value inputs, swap rates				0.00%
Fair value inputs, mortality multiplier				0.00%
Fair value inputs, non performance spread				0.00%
Risk Margin To Reflect Uncertainty				26.00%
Fixed indexed annuities | Maximum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option				31.74%		31.06%
Fair value inputs, swap rates				1.96%		2.71%
Fair value inputs, mortality multiplier				80.00%		80.00%
Fair value inputs, surrender rates				75.00%		75.00%
Fair value inputs, non performance spread				0.25%		0.25%
Fixed indexed annuities | Maximum | Partial Withdrawls
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, surrender rates				2.50%		2.50%
Fixed indexed annuities | Maximum | Option Cost
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, non performance spread				16.61%		16.61%
Fixed indexed annuities | Weighted Average | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option				2.60%		94.00%
Fair value inputs, swap rates				1.85%		2.63%
Fair value inputs, mortality multiplier				80.00%		80.00%
Fair value inputs, surrender rates				5.84%		5.90%
Fair value inputs, non performance spread				0.25%		0.25%
Fixed indexed annuities | Weighted Average | Partial Withdrawls
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, surrender rates				2.00%		2.00%
Fixed indexed annuities | Weighted Average | Option Cost
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, non performance spread				2.16%		2.18%
Fixed indexed annuities | Minimum | Income Approach Valuation Technique
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, market value of option				0.00%		0.00%
Fair value inputs, swap rates				1.75%		2.57%
Fair value inputs, mortality multiplier				80.00%		80.00%
Fair value inputs, surrender rates				0.50%		0.50%
Fair value inputs, non performance spread				0.25%		0.25%
Fixed indexed annuities | Minimum | Partial Withdrawls
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, surrender rates				1.00%		1.00%
Fixed indexed annuities | Minimum | Option Cost
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value inputs, non performance spread				0.18%		0.01%
Private Equity Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Alternative Investment		$ 917,000,000		$ 917,000,000		$ 510,000,000

Fair Value of Financial Instr_8

Fair Value of Financial Instruments - Gross Transfers Into and Out of Certain Fair Value Levels by Asset Class (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	$ 0	$ 30	$ 18	$ 30
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	148	189	324	494
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	0	13	71	69
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	0	13	80	24
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	148	159	322	464
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	0	0	7	45
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	0	0	0	0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	125	90	231	343
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	0	13	52	13
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	0	13	52	13
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	125	90	231	343
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	0	0	0	0
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	0	0	0	0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	23	12	37	13
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	0	0	1	8
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	0	0	1	8
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	23	12	37	13
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	$ 0	0	0	0
Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount		0	0	0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount		21	1	72
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount		0	11	3
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount		0	11	3
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount		21	1	72
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount		0	0	0
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount				0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount				0
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount				20
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount				0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount				0
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount				20
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount		30	18	30
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount		30	18	30
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount		0	7	25
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount		0	16	0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount		0	16	0
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount		0	7	25
Funds withheld for reinsurance receivables, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount			0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount			8
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount			0
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount			0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount			8
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount			0
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount		0	0	0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount		36	29	36
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount		0	0	0
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount		0	0	0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount		36	29	36
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount		$ 0	$ 0	$ 0

Intangible Assets - Schedule of

Intangible Assets - Schedule of Acquired Intangible Assets (Details) - USD ($) $ in Millions	Jun. 30, 2019	Sep. 30, 2019	Dec. 31, 2018
Acquired Finite-Lived Intangible Assets [Line Items]
Carrying amount		$ 1,397	$ 1,359
FGL [Member] | Trademarks and Trade Names [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net		13
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
FGL [Member] | Licensing Agreements [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Carrying amount		$ 6

Intangible Assets - Summary of

Intangible Assets - Summary of Changes in Carrying Amounts of Intangible Assets Including DAC, VOBA , and DSI (Detail) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	Dec. 31, 2017
Finite-Lived Intangible Assets [Line Items]
Deferred Sale Inducement Cost	$ 216	$ 109	$ 149	$ 10
VOBA
VOBA at beginning of period	866	821
Deferrals	0	0
Amortization	(75)	(75)
Interest	14	15
Unlocking	3	(4)
Adjustment for net unrealized investment (gains) losses	(178)	96
VOBA at end of period	630	853
Deferred Sales Inducement Cost, Unrealized Gain (Loss) on Investment	(35)	5
Deferred Sales Inducement Cost, Unlocking Adjustment	(1)	0
Deferred Sales Inducement Cost, Amortization Expense, Accrued Interest	3	1
Deferred Sales Inducement Cost, Amortization Expense	(3)	(5)
Deferred Sale Inducement Cost, Capitalization	103	98
DAC
DAC at beginning of period	551	243	344	22
Deferrals	274	219
Amortization	(3)	(6)
Interest	9	2
Unlocking	(1)	0
Adjustment for net unrealized investment (gains) losses	(72)	6
DAC at end of period	551	243	344	22
Total
Total VOBA and DAC at beginning of period	1,397	1,205	$ 1,359	$ 853
Deferrals	377	317
Amortization	(81)	(86)
Unlocking	1	(4)
Adjustment for net unrealized investment (gains) losses	(285)	107
Interest	$ 26	$ 18
Document Period End Date	Sep. 30, 2019

Intangible Assets - Definite Li

Intangible Assets - Definite Lived Intangible Assets (Details) - USD ($) $ in Millions	Jun. 30, 2019	Sep. 30, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Intangibles, net		$ 1,397	$ 1,359
FGL [Member] | Trademarks and Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross		16
Finite-Lived Intangible Assets, Accumulated Amortization		3
Finite-Lived Intangible Assets, Net		13
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
FGL [Member] | Licensing Agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Net		6
Licensing Agreements [Member] | FGL [Member]
Finite-Lived Intangible Assets [Line Items]
Intangibles, net		$ 6

Intangible Assets - Narrative (

Intangible Assets - Narrative (Detail) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Unearned Revenue, Net	$ (34)	$ (26)
Unearned Revenue, Unlocking Adjustment	(2)	2
Goodwill	$ 467		$ 467
Document Period End Date	Sep. 30, 2019
Deferred Sales Inducement Cost, Unrealized Gain (Loss) on Investment	$ (35)	5
Unearned Revenue, Additions	(30)	(28)
Unearned Revenue, Amortization Expense	5	18
Interest Expense	(1)
Unearned Revenue, Unrealized Gain (Loss) on Investment	$ 35	(18)
Minimum
Finite-Lived Intangible Assets [Line Items]
Value of Business Acquired, Assumption, Interest Rate to Calculate Accretion on Intangible Asset	0.05%
Maximum
Finite-Lived Intangible Assets [Line Items]
Value of Business Acquired, Assumption, Interest Rate to Calculate Accretion on Intangible Asset	4.01%
Voba [Member]
Finite-Lived Intangible Assets [Line Items]
Cumulative Adjustments For Net Unrealized Investment Gains	$ 103	(78)
Dac [Member]
Finite-Lived Intangible Assets [Line Items]
Cumulative Adjustments For Net Unrealized Investment Gains	68	(5)
Deferred Sales Inducement Cost, Unrealized Gain (Loss) on Investment	$ (32)	$ 5

Intangible Assets - Estimated A

Intangible Assets - Estimated Amortization Expense for VOBA in Future Fiscal Periods (Detail) $ in Millions	Sep. 30, 2019USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2019	$ 16
2020	78
2021	87
2022	82
2023	73
Thereafter	$ 397

Debt - Narrative (Detail)

Debt - Narrative (Detail) - USD ($) $ in Millions	Oct. 17, 2019	Oct. 03, 2019	Sep. 30, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Debt Instrument, Face Amount			$ 542
Long-term Debt				$ 541
Revolving credit facility			15	0
Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facility			$ 15	$ 0
Interest rate if revolver drawn			4.85%	5.27%
Remaining borrowing capacity			$ 235	$ 250
Subsequent Event [Member] | Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facility	$ 27	$ 12

Debt - Schedule of Debt (Detail

Debt - Schedule of Debt (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 542		$ 542
Long-term Debt					$ 541
Revolving credit facility	15		15		0
Interest expense excluding amortization	8	$ 7	23	$ 20
Amortization of debt issuance costs	0	1	1	1
Gain on Extinguishment of Debt	0		0
Gain (Loss) on Extinguishment of Debt		0	0	(2)
Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facility	15		15		$ 0
Interest expense excluding amortization	0	0	0	2
Amortization of debt issuance costs	$ 0	$ 0	$ 0	$ 0

Equity - Schedule of Dividends

Equity - Schedule of Dividends (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	Sep. 09, 2019	Aug. 07, 2019	Jun. 10, 2019	May 07, 2019	Apr. 01, 2019	Feb. 27, 2019	Aug. 26, 2019	May 28, 2019	Mar. 18, 2019
Accelerated Share Repurchases [Line Items]
Common stock, shares outstanding (in shares)							221,661	221,661	221,661
Cash dividend per common share (in dollars per share)		$ 0.01		$ 0.01		$ 0.01
Total cash paid	$ 2		$ 2		$ 2

Equity - Schedule of Dividend_2

Equity - Schedule of Dividends Declared (Details) $ / shares in Units, shares in Thousands, shareholder in Thousands, $ in Thousands	Dec. 15, 2020	Nov. 07, 2019$ / shares	Oct. 01, 2019USD ($)shares	Sep. 15, 2019shares	Aug. 07, 2019$ / shares	Jul. 01, 2019USD ($)shares	Jun. 15, 2019shares	May 07, 2019$ / shares	Apr. 01, 2019USD ($)shares	Mar. 15, 2019shares	Feb. 27, 2019$ / shares	Oct. 01, 2018USD ($)shares	Sep. 15, 2018shareholder	Jul. 01, 2018USD ($)shares	Jun. 15, 2018shareholder	Apr. 01, 2018USD ($)shares	Mar. 15, 2018shareholder	Sep. 30, 2019USD ($)shares	Mar. 31, 2019USD ($)	Sep. 30, 2019USD ($)shares
Class of Stock [Line Items]
Stock Repurchase Program, Authorized Amount																		$ 150,000		$ 150,000
Cash dividend per common share (in dollars per share) | $ / shares					$ 0.01			$ 0.01			$ 0.01
Stock Repurchased During Period, Shares | shares																		2,146		6,022
Stock Repurchased During Period, Value																		$ 17,000	$ 30,000	$ 48,000
Total Stock Repurchased During Period, Shares | shares																				6,622
Total Stock Repurchased During Period, Value																				$ 52,000
Preferred Stock | Series A Cumulative Preferred Stock [Member]
Class of Stock [Line Items]
Number of Shareholders				310			304			298			287		282		277
Total cash paid			$ 0			$ 0			$ 0			$ 0		$ 0		$ 0
Total shares paid in kind (in thousands) | shares			6			6			6			5		5		5
Preferred Stock | Series B Cumulative Preferred Stock [Member]
Class of Stock [Line Items]
Number of Shareholders				112			110			108			104		102		101
Total cash paid			$ 0			$ 0			$ 0			$ 0		$ 0		$ 0
Total shares paid in kind (in thousands) | shares			2			2			2			2		2		1
Subsequent Event [Member]
Class of Stock [Line Items]
Cash dividend per common share (in dollars per share) | $ / shares		$ 0.01
Stock Repurchase Program Expiration Date	Dec. 15, 2020

Stock Compensation - Narrative

Stock Compensation - Narrative (Details) - USD ($)	Sep. 30, 2019	Aug. 06, 2019	May 20, 2019	Feb. 26, 2019	Sep. 30, 2019	Dec. 31, 2018	Aug. 08, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	5,689,000				5,689,000
2017 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized for grant (in shares)							15,006,000
FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					5,749,000
Vested and exercisable at end of period (in shares)	436,000
Equity Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date		$ 1,000,000
Equity Option [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date		$ 3	$ 1,000,000	$ 3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value	$ 3,000,000				$ 3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	6 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	6 years
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term	6 years
Restricted Stock Units (RSUs) [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 6.82				$ 6.82	$ 0
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date					$ 1,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period					147,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value					$ 6.82
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	147,000				147,000	0
Phantom Share Units (PSUs) [Member] | Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 9.02				$ 9.02	$ 8.95
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date					$ 5,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period					541,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value					$ 8.54
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period					(59,000)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value					$ 10
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period					(87,000)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value					$ 9.37
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	751,000				751,000	356,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities	$ 1				$ 1
Officer [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		700,000	850,000	1,699,000
Director [Member] | Restricted Stock Units (RSUs) [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period					147,000
Management [Member] | Phantom Share Units (PSUs) [Member] | Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					541,000
FGL Holdings [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Price	$ 7.98				$ 7.98
Service Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		233,000	242,000	485,000
Service and Return on Equity Performance Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		233,000	304,000	607,000
Service and Stock Price Performance Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross		234,000	304,000	0

Stock Compensation - Schedule o

Stock Compensation - Schedule of Stock Based Compensation Costs (Details) - USD ($) shares in Thousands	Aug. 06, 2019	May 20, 2019	Feb. 26, 2019	Sep. 30, 2019	Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Related tax benefit				$ 0	$ 1,000,000
Equity Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date	$ 1,000,000
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense				1,000,000	3,000,000
Phantom Share Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense				1,000,000	4,000,000
Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense				0	1,000,000
Management Incentive Plan [Member] | Phantom Share Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date					5,000,000
Total stock compensation expense				0	$ 1,000,000
FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross					5,749
Total stock compensation expense				1,000,000	$ 3,000,000
FGL Incentive Plan [Member] | Equity Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date	$ 3	$ 1,000,000	$ 3,000,000
FGL Incentive Plan [Member] | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock compensation expense				0	2,000,000
FGL Incentive Plan [Member] | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date					1,000,000
Total stock compensation expense				$ 1,000,000	$ 1,000,000
Service Vesting Mechanism [Member] | FGL Incentive Plan [Member] | Equity Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	233	242	485
Service and Return on Equity Performance Vesting Mechanism [Member] | FGL Incentive Plan [Member] | Equity Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	233	304	607
Service and Stock Price Performance Vesting Mechanism [Member] | FGL Incentive Plan [Member] | Equity Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	234	304	0

Stock Compensation - Summary of

Stock Compensation - Summary of Unrecognized Stock Compensation Expense (Details) $ in Millions	9 Months Ended
	Sep. 30, 2019USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 21
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition	3 years
FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 18
FGL Incentive Plan [Member] | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 18
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition	3 years
FGL Incentive Plan [Member] | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 0
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition	0 years
Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 3
Management Incentive Plan [Member] | Phantom Share Units (PSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 3
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition	2 years

Stock Compensation - Summary _2

Stock Compensation - Summary of Stock Options Outstanding and Related Activity (Details) - USD ($) $ / shares in Units, shares in Thousands	Sep. 30, 2019	Aug. 06, 2019	May 20, 2019	Feb. 26, 2019	Sep. 30, 2019	Dec. 31, 2018
FGL Incentive Plan [Member]
Options (in shares):
Stock options outstanding at beginning of period (in shares)					13,007
Granted (in shares)					5,749
Exercised (in shares)					0
Forfeited or expired (in shares)					(3,519)
Stock options outstanding at end (in shares)	15,237				15,237
Vested and exercisable at end of period (in shares)	436
Vested or projected to vest (in shares)	15,237				15,237
Weighted Average Exercise Price (in dollars per share):
Stock options outstanding at beginning of period (USD per share)					$ 9.68
Granted (USD per share)					8.92
Exercised (USD per share)					0
Forfeited or expired (USD per share)					10
Stock options outstanding at end of period (USD per share)	$ 9.31				9.31
Vested and exercisable at end of period (USD per share)	10
Vested and projected to vest (in dollars per share)	$ 9.31				$ 9.31
Equity Option [Member]
Options (in shares):
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date		$ 1,000,000
Equity Option [Member] | FGL Incentive Plan [Member]
Options (in shares):
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date		$ 3	$ 1,000,000	$ 3,000,000
Equity Option [Member] | Officer [Member] | FGL Incentive Plan [Member]
Options (in shares):
Granted (in shares)		700	850	1,699
Restricted Stock Units (RSUs) [Member] | FGL Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	147				147	0
Options (in shares):
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date					$ 1,000,000
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 6.82				$ 6.82	$ 0
Granted (in shares)					147
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value					$ 6.82
Phantom Share Units (PSUs) [Member] | Management Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number	751				751	356
Options (in shares):
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date					$ 5,000,000
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value	$ 9.02				$ 9.02	$ 8.95
Granted (in shares)					541
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value					$ 8.54
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period					(59)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value					$ 10
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period					(87)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value					$ 9.37
Service Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Options (in shares):
Granted (in shares)		233	242	485
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value					$ 1.72
Service and Return on Equity Performance Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Options (in shares):
Granted (in shares)		233	304	607
Vested or projected to vest (in shares)	1,250				1,250
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value					$ 1.63
Service and Stock Price Performance Vesting Mechanism [Member] | Equity Option [Member] | FGL Incentive Plan [Member]
Options (in shares):
Granted (in shares)		234	304	0
Vested or projected to vest (in shares)	1,250				1,250
Weighted Average Exercise Price (in dollars per share):
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value					$ 0.97
Service and Stock Price Performance Vesting Mechanism 2019 through 2023 | Equity Option [Member] | FGL Incentive Plan [Member]
Options (in shares):
Granted (in shares)		0	0	607

Stock Compensation - Summary _3

Stock Compensation - Summary of Options Subject To Vesting Conditions (Details) - FGL Incentive Plan [Member] shares in Thousands	Sep. 30, 2019shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested or projected to vest (in shares)	15,237
Equity Option [Member] | Service and Stock Price Performance Vesting Mechanism [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested or projected to vest (in shares)	1,250
Equity Option [Member] | Service and Return on Equity Performance Vesting Mechanism [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested or projected to vest (in shares)	1,250

Stock Compensation - Assumption

Stock Compensation - Assumptions Used in Determination of Grant Date Fair Values Using Black-Scholes Option Pricing Model (Details) - Equity Option [Member] - FGL Incentive Plan [Member]	9 Months Ended
	Sep. 30, 2019$ / shares
Service Vesting Mechanism [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (USD per share)	$ 1.72
Volatility	26.00%
Service Vesting Mechanism [Member] | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	1.53%
Assumed dividend yield	0.46%
Expected option term	4 years 6 months
Service Vesting Mechanism [Member] | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	2.48%
Assumed dividend yield	0.56%
Expected option term	5 years 9 months 18 days
Service and Return on Equity Performance Vesting Mechanism [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (USD per share)	$ 1.63
Volatility	26.00%
Service and Return on Equity Performance Vesting Mechanism [Member] | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	1.53%
Assumed dividend yield	0.46%
Expected option term	4 years 9 months 18 days
Service and Return on Equity Performance Vesting Mechanism [Member] | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	2.50%
Assumed dividend yield	0.56%
Expected option term	6 years
Service and Stock Price Performance Vesting Mechanism [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (USD per share)	$ 0.97
Volatility	26.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Early Exercise Multiple	2.8
Service and Stock Price Performance Vesting Mechanism [Member] | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	1.62%
Assumed dividend yield	0.46%
share-based compensation arrangement by share-based payment award, fair value assumptions, contractual term	6 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Cost of Equity	9.39%
Service and Stock Price Performance Vesting Mechanism [Member] | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	2.30%
Assumed dividend yield	0.56%
share-based compensation arrangement by share-based payment award, fair value assumptions, contractual term	7 years
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Cost of Equity	10.50%

Stock Compensation - Summary _4

Stock Compensation - Summary of Restricted Stock and Restricted Stock Units Outstanding and Related Activity (Details) - FGL Incentive Plan [Member] - Restricted shares shares in Thousands	9 Months Ended
	Sep. 30, 2019$ / sharesshares
Shares:
Restricted shares outstanding at beginning of period (in shares) | shares	0
Granted (in shares) | shares	147
Restricted shares outstanding at end of period (in shares) | shares	147
Weighted Average Grant Date Fair Value (in dollars per share):
Average grant date fair value outstanding at beginning of period (USD per share) | $ / shares	$ 0
Average grant date fair value, Granted (USD per share) | $ / shares	6.82
Average grant date fair value outstanding at end of period (USD per share) | $ / shares	$ 6.82

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Tax Credit Carryforward [Line Items]
Effective tax rate	(16.00%)	21.00%	4.00%	29.00%
Valuation allowance	$ 11		$ 11
Deferred Tax Assets, Gross	$ 103		$ 103

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Investment Commitments (Details) - Commitment to Invest $ in Millions	Sep. 30, 2019USD ($)
Other Commitments [Line Items]
Unfunded investment commitment	$ 1,156
Bank Loan Obligations [Member]
Other Commitments [Line Items]
Unfunded investment commitment	5
Other invested assets
Other Commitments [Line Items]
Unfunded investment commitment	1,073
Equity securities
Other Commitments [Line Items]
Unfunded investment commitment	7
Fixed maturity securities, available-for-sale
Other Commitments [Line Items]
Unfunded investment commitment	17
Other assets
Other Commitments [Line Items]
Unfunded investment commitment	46
Residential Mortgage [Member]
Other Commitments [Line Items]
Unfunded investment commitment	$ 8

Commitments and Contingencies_2

Commitments and Contingencies - Narrative (Details)	Sep. 30, 2019USD ($)
Loss Contingencies [Line Items]
Accrued amount of guaranty fund assessments	$ 2
Estimated future premium tax deductions	$ 2

Reinsurance - Effect of Reinsur

Reinsurance - Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Effects of Reinsurance [Line Items]
Document Period End Date			Sep. 30, 2019
Benefits and Other Changes in Insurance Policy Reserves:
Net	$ 331	$ 297	$ 938	$ 475
Traditional life insurance premiums
Premiums and other considerations:
Direct	50	54	158	172
Assumed	0	0	0	0
Ceded	(41)	(42)	(125)	(127)
Net	9	12	33	45
Benefits and Other Changes in Insurance Policy Reserves:
Direct	336	336	1,067	653
Assumed	42	12	23	(14)
Ceded	(47)	(51)	(152)	(164)
Net	$ 331	$ 297	$ 938	$ 475

Reinsurance - Narrative (Detail

Reinsurance - Narrative (Details)	Jun. 28, 2019USD ($)	Dec. 28, 2018USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)	Sep. 30, 2018USD ($)	Apr. 01, 2019USD ($)	Dec. 31, 2018USD ($)
Ceded Credit Risk [Line Items]
Document Period End Date					Sep. 30, 2019
Reinsurance, Loss on Uncollectible Accounts in Period, Amount			$ 0	$ 0	$ 0	$ 0
Reinsurance Risk Charge Fee			$ 4		$ 12,000,000
Number of policies reinsured by foreign company not engaged in insurance			0		0
Funds withheld for reinsurance receivables, at fair value			$ 2,045,000,000		$ 2,045,000,000			$ 757,000,000
Funds Held under Reinsurance Agreements, Liability			838,000,000		838,000,000			722,000,000
Liability for Future Policy Benefit, before Reinsurance			5,714,000,000		5,714,000,000			$ 4,641,000,000
Life and Annuity Insurance Product Line
Ceded Credit Risk [Line Items]
Ceded			0	$ 0	0	$ 0
Reinsurance Retention Policy, Amount Retained	$ 185,000,000	$ 758
Fixed indexed annuities
Ceded Credit Risk [Line Items]
Reinsurance Retention Policy, Amount Retained	$ 1,000,000,000	$ 4,000,000,000
FSRC
Ceded Credit Risk [Line Items]
Funds withheld for reinsurance receivables, at fair value			308,000,000		308,000,000
Funds Held under Reinsurance Agreements, Liability			282,000,000		282,000,000
F&G Re [Member]
Ceded Credit Risk [Line Items]
Funds withheld for reinsurance receivables, at fair value			1,737,000,000		1,737,000,000		$ 983,000,000
Funds Held under Reinsurance Agreements, Liability			$ 1,605,000,000		$ 1,605,000,000		$ 896,000,000

Related Party Transactions - Na

Related Party Transactions - Narrative (Details) - USD ($) shares in Thousands	Sep. 30, 2019	Dec. 31, 2018	Dec. 17, 2018	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Related Party Transaction [Line Items]
Document Period End Date						Sep. 30, 2019
Related Party Transactions, Gain (Loss)				$ 0	$ 0	$ 0	$ 0
Management Fee Payable	$ 30,000,000	$ 20,000,000		30,000,000		30,000,000
Reimbursement Fees				2,000,000	$ 2,000,000	7,000,000	$ 7,000,000
Related Party Transaction, Asset Carrying Value	1,932,000,000	1,461,000,000		1,932,000,000		1,932,000,000
Unrealized Loss on Foreign Currency Derivatives, before Tax	(6,000,000)	(2,000,000)
BTO FNF [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Amounts of Transaction						4
Commitment to Invest
Related Party Transaction [Line Items]
Unfunded investment commitment	1,156,000,000			1,156,000,000		1,156,000,000
Commitment to Invest | Affiliated Entity
Related Party Transaction [Line Items]
Unfunded investment commitment	$ 927,000,000	$ 990,000,000		$ 927,000,000		$ 927,000,000
Preferred Stock | Affiliated Entity
Related Party Transaction [Line Items]
Total shares paid in kind (in thousands)				6		18
Residential Portfolio Segment [Member]
Related Party Transaction [Line Items]
Residential Mortgage Loans Purchased			$ 185,000,000			$ 37,000,000

Earnings Per Share - Summary of

Earnings Per Share - Summary of Basic and Diluted EPS (Detail) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended					9 Months Ended
	Sep. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2019	Sep. 30, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Document Period End Date						Sep. 30, 2019
Net income (loss)	$ 65	$ 171	$ 56	$ 40	$ 65	$ 282	$ 161
Less Preferred stock dividend	7		7			23	21
Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic	$ 58		$ 49			$ 259	$ 140
Weighted-average common shares outstanding - basic (in shares)	216,441,948		214,370,000			217,745,826	214,370,000
Dilutive effect of unvested restricted stock and unvested performance restricted stock (in shares)	99,000		49,000			69,000	21,000
Weighted-average shares outstanding - diluted (in shares)	216,540,885		214,418,693			217,814,942	214,390,931
Net income (loss) per common share:
Basic (in USD per share)	$ 0.26		$ 0.23			$ 1.19	$ 0.65
Diluted (in USD per share)	$ 0.26		$ 0.23			$ 1.19	$ 0.65
Common Stock Warrants Outstanding	6,000,000		70,000,000
Preferred Stock
Net income (loss) per common share:
Antidilutive securities excluded from computation of EPS, less than, amount (shares)						422,000	391,000
Stock Option Awards
Net income (loss) per common share:
Antidilutive securities excluded from computation of EPS, less than, amount (shares)	1,591,000		1,384,000			1,569,000	609,000

Insurance Subsidiary Financia_2

Insurance Subsidiary Financial Information and Regulatory Matters - Narrative (Details) - USD ($)	3 Months Ended
	Jun. 30, 2019	Sep. 30, 2019	Dec. 31, 2018
Statutory Accounting Practices [Line Items]
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries	$ 20
Change in statutory capital surplus		$ 100,000,000	$ 110,000,000
Non-permitted statutory accounting practices		(19,000,000)	(16,000,000)
Statutory capital and surplus		84,000,000	94,000,000
Increase (decrease) in statutory capital surplus		95,000,000	30,000,000
IOWA
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus		$ 3,000,000	$ 0